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ABSTRACT
1. Regulation of airways smooth muscle contraction and relaxation 
was studied in vitro by using a strip preparation of guinea- 
pig trachea. Changes in the cyclic AMP content of the guinea- 
pig tracheal muscle were also determined.
2. Drug-induced contractions of the tracheal muscle were diminished, 
but not abolished, in the absence of extracellular calcium ions, 
indicating that contractile responses involve both the influx
of Ca2+ from the extracellular space and release of Ca2+ from
o +intracellular sites. The relative contributions of these two Ca 
sources depended on both the contractile agent and its concentra­
tion. Repeated additions of histamine or acetylcholine in the 
absence of extracellular Ca resulted in progressively smaller
2  *4"contractile responses, reflecting depletion of intracellular Ca 
stores.
3. Tracheal muscle depolarized with high concentrations of KC1 still 
contracted in response to histamine and acetylcholine, indicating 
the involvement of pharmacomechanical coupling mechanisms. In 
calcium-depleted tissues, KC1 potentiated contractile responses 
to histamine and prostaglandin F2CU
4. Calcium metabolism of the tracheal muscle was also investigated 
using the calcium ionophore A23187, which contracted the muscle, 
and the Ca2+ antagonist TMB-8, which caused relaxation and 
inhibited drug-induced contractures.
5. The basal level of cyclic AMP in the tracheal muscle was 2.7 
pmoles/mg protein. Cyclic AMP levels increased in response to 
isoprenaline and prostaglandin Ei supporting the concept of 
cyclic AMP-mediated smooth muscle relaxation. However, histamine,
Va bronchoconstrictor agent, also caused a dose-dependent increase 
of cyclic AMP levels. 100 yM histamine caused a 3-fold increase 
of cyclic AMP content after 2 minutes. The increase was not 
affected by propranolol or atropine, but partially inhibited by 
mepyramine.
6. Imidazole (0.1 to 30 mM) contracted the tracheal muscle, and this 
response was partially inhibited by atropine and mepyramine. 
Imidazole did not affect the cyclic AMP content of the muscle, 
indicating that its contractile action is unrelated to stimulation 
of cyclic nucleotide phosphodiesterase.
7. Low concentrations of imidazole (0.05 to 2 mM) potentiated 
contractile responses to histamine, but not to other agents.
The histamine concentration-response curve was shifted to the 
left in the presence of imidazole, but the maximum response was 
not affected. Imidazole (0.5 mM) did not affect the accumulation 
of cyclic AMP induced by histamine, prostaglandin Ei or isopre- 
naline. Imidazole-induced hyperreactivity was not affected by 
atropine or indomethacin, and was more pronounced in the absence 
of extracellular calcium ions. The results suggest that-the 
potentiating effect of imidazole on histamine contractions is 
unrelated to activation of phosphodiesterase, enhancement of 
acetylcholine release or inhibition of prostaglandin or throm­
boxane synthesis. The phenomenon may involve enhanced release
of Ca2+ from intracellular sites, or, more likely, inhibition 
of the enzyme histaminase.
8. Indomethacin relaxed the guinea-pig tracheal muscle and also 
potentiated contractile responses to histamine and acetylcholine. 
Indomethacin alone did not affect cyclic AMP levels, but abolished 
the histamine-induced accumulation of cyclic AMP.
9. The results suggest that the contractile response of guinea-pig 
tracheal smooth muscle to histamine is modulated by a negative 
feedback regulatory mechanism involving the release of prosta­
glandins and elevation of cyclic AMP levels.
10. The possible significance of this and other regulatory phenomena 
to the pathogenesis of bronchial hyperreactivity in asthma is
vi
discussed.
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1CHAPTER 1 
INTRODUCTION
Asthma is a disease of the respiratory tract in which wheezing and 
dyspnoea are caused by widespread narrowing of the airways. This narrow­
ing is characteristically reversible, either spontaneously or by treat­
ment, and is due to abnormal contraction of smooth muscle in the airways. 
Other factors, such as oedema of bronchial mucosa and hypersecretion of 
mucus may also contribute to airways obstruction in asthma (Hayes, 1976).
The basic abnormality in asthma involves hyperreactivity of smooth 
muscle in the airways: bronchoconstriction is induced by various
stimuli that are without effect on the airways of normal subjects.
These stimuli include allergens, exercise, emotional upsets, and exposure 
to dusts, cold and chemical irritants. Bronchial hyperreactivity is 
discussed further in Section 1.1.
Several explanations of bronchial hyperreactivity in asthma have 
been proposed, and almost all of them involve a defect in the normal 
regulatory mechanisms controlling airways smooth muscle tone. These 
mechanisms range from intracellular biochemical processes to hormonal or 
neural control involving the whole organism. Nervous regulation of 
airways smooth muscle involves both the sympathetic and parasympathetic 
systems (Sections 1.3 and 1.4 respectively). Smooth muscle tone may 
also be modulated by various biologically active substances, either in 
the circulation or released locally. These include catecholamines 
(Section 1.3), histamine and other mediators (Section 1.2), and 
prostaglandins (Section 1.5). At the intracellular level, smooth muscle 
function is controlled by calcium ions (Section 1.6), and modulated by 
cyclic nucleotides (Section 1.7). An understanding of these various 
regulatory mechanisms is necessary for the identification of possible 
sites where a defect might explain bronchial hyperreactivity.
21.1 Bronchial hyperreactivity in asthma
Bronchial hyperreactivity to histamine and cholinergic agents 
has been recognized in asthmatic patients for many years (Weiss, 1928; 
Curry, 1946, 1947; Tiffeneau, 1958), and has been demonstrated in 
many studies since (reviewed by Benson, 1975). However, it is only 
recently that bronchial hyperreactivity has been acknowledged as the 
underlying common abnormality in all forms of asthma (Cade and Pain,
1971) , and demonstration of bronchial hyperractivity by bronchial 
provocation testing with methacholine has been proposed as a means of 
diagnosing asthma (Parker et al., 1965; Chai et al., 1975).
Some studies of bronchial hyperreactivity measure the changes in 
pulmonary function parameters such as forced expiratory volume in one 
second (FEVi) or specific airways conductance (SG ) in response to a 
standard dose of the bronchoconstrictor (usually aerosols of histamine 
or methacholine). Others determine the threshold dose of the broncho­
constrictor agent required to produce significant airways obstruction 
(20% decrease in FEVi or 25% increase in SG ). In the former type of 
study, the response of asthmatic patients is greater than that of normal 
subjects (Parker et al., 1965), and in the latter experiments, 10- to 
100-fold differences in sensitivity have been shown between asthmatic and 
normal subjects (Miller et al., 1977). However, Orehek et al. (1977) 
compared full dose-response curves to methacholine in asthmatic and 
control subjects, and showed that there is a difference in both the 
threshold doses for a 25% decrease in SGaw (bronchial sensitivity) and 
in the slopes of the curves (bronchial reactivity). The mean difference 
in bronchial reactivity was greater than that in bronchial sensitivity, 
but there was no correlation between the two parameters. This suggests 
that different mechanisms may determine sensitivity and reactivity of 
airways smooth muscle, and an abnormality in either could lead to the 
characteristic bronchial hyperreactivity in asthma.
3It is possible that the enhanced bronchoconstrictor responses to 
histamine observed in asthmatic patients are due to an increased initial 
bronchomotor tone or some degree of airways obstruction existing before 
the bronchial provocation test (Benson and Graf, 1977; Brown et al.,
1977) rather than an inherent hypersensitivity of the smooth muscle to 
histamine. This suggestion, however, is not consistent with other 
results (Rubinfeld and Pain, 1977) which show that bronchial reactivity 
to methacholine is not related to initial level of airways obstruction. 
Furthermore, in dogs, bronchial reactivity to histamine is not related 
to baseline pulmonary function (Snapper et al., 1978).
Although methacholine and histamine are most commonly used in studies 
of bronchial hyperreactivity, asthmatic patients also show abnormal sensi­
tivity to other bronchoconstricting agents and stimuli. Most notable 
amongst these is prostaglandin F201 to which asthmatic patients are about 
8000-fold more sensitive than normal controls, whereas the difference in 
sensitivity to histamine is only about 10-fold (Mathe et al., 1972). 
Bronchial hyperreactivity to bradykinin and to SRS-A has also been reported 
in asthmatics (Herxheimer and Stresemann,1961 and 1963), but it is 
probable that the SRS-A preparation used in the latter study contained 
prostaglandins, and that the observed responses resulted from PGF20t- 
induced bronchoconstriction.
Asthmatic patients also respond with bronchoconstriction to 
3-adrenergic blockers (McNeill, 1964; MacDonald et al., 1967), including 
the cardioselective 3 1-antagonists (Bernecker and Roetscher, 1970;
Singh et al., 1976). Furthermore, asthmatic subjects are hypersensitive 
to a-adrenergic stimulants in the presence of 3-blockade (Kerr and Patel, 
1975 ; Snashall, 1978). These observations are pertinent to the 3- 
adrenergic blockade theory of asthma, and will be further discussed in Sec­
tion 1.3.2. Further examples of stimuli to which the airways of asthmatic 
patients are hyperreactive include exercise (McNeill et al., 1976), cold air 
(Wells et al., 1960; Simonsson et al., 1967), aerosol propellants
4(Sterling and Batten, 1969), and citric acid (Simonsson et al., 1967).
The diversity of agents and stimuli which cause bronchoconstriction 
in susceptible patients suggests a fundamental abnormality in the airways 
of these people. However, one factor which may contribute to the heigh­
tened bronchial sensitivity in asthma is the increased amount of bronchial 
smooth muscle which exists in asthmatic airways (Hossain, 1973). It 
was suggested that this increased volume of bronchial smooth muscle 
is the result of the disease process, rather than a genetically determined 
fundamental abnormality (Hossain, 1973).
Other possible explanations of bronchical hyperreactivity in asthma 
are increased sensitivity of irritant receptors in the airways (Section 
1.4.2) and a defective ß-adrenergic receptor system (Section 1.3.2).
1.2 Immunological mechanisms in asthma
Perhaps the most common precipitating factor in asthma is an 
allergic reaction, known as an immediate hypersensitivity or Typ.e I 
immunological reaction. It involves the interaction of an allergen 
(antigen) with specific reaginic antibodies fixed to target cells, the 
release of various chemical mediators from these cells, and their actions 
on secondary target tissues to produce the characteristic symptoms of 
asthma.
1.2.1 Mechanism of mediator release
Mediator release has been studied in a variety of cell types and 
tissues including rat peritoneal mast cells, human basophilic leucocytes, 
sensitized guinea-pig lung and passively sensitized human lung. The 
following discussion concentrates on studies of mediator release from 
passively sensitized human lung, which have been reviewed by Kaliner 
and Austen (1975 and 1976).
Human lung is passively sensitized by incubation in serum from
5allergic patients, after which challenge with specific antigen induces 
the release of histamine and slow reacting substance of anaphylaxis 
(SRS-A) (Sheard et al., 1967). Sensitization occurs by transfer of 
antibodies of the immunoglobulin E class (IgE; reaginic antibody) from 
the sensitizing serum to target cells in the lung (Ishizaka et al.,
1966 a, b). The target cells which bind IgE and which are responsible 
for mediator release have been identified as mast cells (Parish, 1967), 
large cells containing electron-dense granules. Histamine is stored 
within these granules, and its release is effected by exocytosis of the 
granules (Orr, 1977).
When sensitized human lung is challenged with specific antigen, 
the antigen is bound by two molecules of IgE on the mast cell surface. 
Bridging of IgE molecules in this manner leads to a complex sequence of 
biochemical events in the mast cell which eventually leads to mediator 
release (Kaliner and Austen, 1975). The mechanism involves activation 
of a serine esterase, and is dependent on extracellular calcium ions and 
glycolytic activity. The microfilament system of the mast cell also 
appears to have a major role in the process of mediator release (Orange, 
1973; Kaliner, 1977).
1.2.2 The mediators of allergic reactions
The chemical mediators released during antigenic challenge of 
passively sensitized human lung are histamine, SRS-A, eosinophil chemo- 
tactic factor of anaphylaxis (ECF-A), platelet activating factor (PAF) , 
prostaglandins and bradykinin (Austen and Orange, 1975). Of these, 
histamine and ECF-A are stored preformed within the mast cell granules, 
whilst SRS-A and PAF are formed from inactive precursors in the mast 
cell subsequent to antigenic stimulation. Prostaglandins are also syn­
thesized de novo during allergic reactions, and may be released from 
cell types additional to mast cells.
61.2.2.1 Histamine
The major pathophysiological effects of histamine in the lung are 
increased vascular permeability and bronchoconstriction (Beaven, 1976). 
Histamine contracts the isolated smooth muscle of human bronchus (Hawkins 
and Schild, 1951) and guinea-pig trachea (Ak^asu, 1959). Atropine reduces 
the severity of histamine-induced bronchoconstriction in vivo (Simonsson 
et al., 1967), suggesting that vagal reflexes initiated by stimulation 
of irritant receptors in the airways may contribute to the response 
(Section 1.4). The in vitro contractile actions of histamine on airways 
smooth muscle are inhibited by classic antihistaminic drugs (mepyramine, 
diphenhydramine), indicating the involvement of histamine Hi-receptors. 
However, histamine H.2-receptors are also present in guinea-pig trachea 
and mediate a relaxant effect on the smooth muscle (Okpako et al., 1978). 
Treatment of guinea-pig tracheal smooth muscle with the H2-antagonist 
metiamide enhances the contractile response to histamine (Okpako et al., 
1978), suggesting that these receptors constitute an important regulatory 
mechanism in the control of airways calibre.
1.2.2.2 Slow reacting substance of anaphylaxis
SRS-A was discovered in 1940 in the perfusate of antigenically 
challenged guinea-pig lung (Kellaway and Trethewie, 1940), and its 
release from human lung was later shown by Brocklehurst (1960). SRS-A 
has been reported to cause bronchoconstriction in vivo in guinea-pigs 
(Berry and Collier, 1964) and asthmatic humans (Herxheimer and Stresemann, 
1963) , and to contract isolated smooth muscle of guinea-pig trachea 
(Berry and Collier, 1964) and human bronchus (Brocklehurst, 1962).
However, the preparations of SRS-A used in these studies may have con­
tained prostaglandins, which are also released during allergic reactions 
(Piper and Vane, 1969; Section 1.5.1), and which may have contributed to 
the observed bronchoconstrictor effects. Later studies avoided this
7possibility and showed the bronchonconstrictor effects of a prostaglandin- 
free SRS-A preparation on guinea-pigs in vivo (Strandberg and Hedqvist, 
1975) , and on both guinea-pig and human airways smooth muscle in vitro 
(Mathe and Strandberg, 1971; Drazen et al., 1979). However, guinea- 
pig tracheal smooth muscle is 100 times less sensitive to SRS-A than 
peripheral airways smooth muscle (Drazen et al., 1979), and the site 
of the bronchoconstrictor action of SRS-A in vivo appears to be the 
peripheral rather than the central airways (Drazen and Austen, 1974) .
The in vitro contractile effects of SRS-A are antagonized by polyphlore- 
tin phosphate (Mathe and Strandberg, 1971), which also inhibits the 
effects of prostaglandins (Mathe et al., 1971a). A more selective 
antagonist of SRS-A, FPL 55712, has recently been reported (Augstein 
et al., 1973; Sheard et al., 1977).
SRS-A is an acidic unsaturated lipid containing sulphur and having 
a molecular weight of about 400 (Orange et al., 1973 and 1974; Morris 
et al., 1978), but its structure is still unknown. Studies with radio- 
labelled arachidonic acid in rat monocytes and basophils have suggested 
that SRS-A released from these cells is derived from this fatty acid 
(Bach et al., 1977; Jakschik et al., 1977). Since the release of SRS-A 
from rat mononuclear cells appears to be reduced by indomethacin, an 
inhibitor of cyclooxygenase (Vane, 1971; Figure 1.1), Bach et al. (1977) 
concluded that SRS-A was derived from cyclic endoperoxides. On the other 
hand, Jakschik et al. (1977) showed that eicosatetraynoic acid (an 
inhibitor of both cyclooxygenase and lipoxygenase; Flower, 1974), but 
not indomethacin, reduced the release of SRS-A, and suggested that SRS-A 
is formed by the lipoxygenase pathway (see Figure 1.1). Other inhibitors 
of lipoxygenase (l-phenyl-3-pyrazolidine) and 15-hydroperoxy arachidonic 
acid, as well as inhibitors of phospholipase (dexamethasone, mepacrine), 
also inhibit the release of SRS-A from rat peritoneal cells (Burka and 
Flower, 1979), further evidence that SRS-A is synthesized from arachidonic
8acid by lipoxygenase,at least in some cell types. SRS-A release from 
guinea-pig lung is not inhibited by either indomethacin or eicosatetray- 
noic acid (Dawson and Tomlinson, 1974; Engineer et al., 1978b), 
indicating that it is unlikely that SRS-A is derived from arachidonic 
acid in this tissue. Thus, the biosynthetic pathway of SRS-A may vary 
between species or cell types, and its structure remains unknown.
1.2.2.3 Other mediators
ECF-A and PAF are the other two primary mediators released during 
antigenic challenge of sensitized human lung (Austen and Orange, 1975) . 
Unlike histamine and SRS-A, these agents do not affect bronchial smooth 
muscle. Rather, their roles in allergic reactions are attraction and 
deactivation of eosinophils, and stimulation of platelet aggregation 
and release reaction respectively (Austen and Orange, 1975) . ECF-A 
is a tetrapeptide (Goetzl and Austen, 1975), whilst PAF is a lipid-like 
substance of unknown structure (Kater et al., 1976).
In spite of the potent effects of prostaglandins on airways smooth 
muscle (Section 1.5.2), they are not considered as primary mediators 
(Austen and Orange, 1975). They may however, play an important role 
in the modulation of the release of other mediators (Section 1.2.3).
Their involvement in allergic reactions is discussed in Section 1.5.1.
1.2.3 Regulation of mediator release
Histamine release during antigenic challenge of sensitized human 
lung is inhibited by $-adrenergic agents and methylxanthines (Assem and 
Schild, 1969), and Orange et al. (1971) proposed that these effects 
were due to increased levels of cyclic AMP in mast cells resulting 
from activation of adenylate cyclase or inhibition of cyclic nucleotide 
phosphodiesterase respectively. This hypothesis has been confirmed 
in human basophilic leucocytes by measurement of intracellular cyclic
9AMP levels (Bourne et al., 1972). Lung cyclic AMP levels also rise 
in response to catecholamines (Vaughan, 1976), but the contribution of 
the mast cell subpopulation to this effect is uncertain. On the other 
hand, a-adrenergic stimulation with phenylephrine decreases cyclic AMP 
levels and enhances mediator release (Kaliner et al., 1972). Thus, mast 
cells possess both a- and 3-adrenergic receptors which mediate opposing 
effects on intracellular cyclic AMP levels and mediator release.
Cholinergic stimulation of sensitized lung also enhances mediator 
release in response to antigen, but this effect is not associated with 
any change in cyclic AMP levels (Kaliner et al., 1972). Rather, 
acetylcholine increases cyclic GMP levels in lung (Stoner et al., 1973, 
Kaliner, 1977). Both effects of acetylcholine are blocked by atropine 
(Kaliner, 1977).
Prostaglandins Ei and E2 inhibit mediator release from human lung, 
and these effects are accompanied by increased levels of cyclic AMP 
(Tauber et al., 1973). Both responses are independent of the 3-adrenergic 
receptor. PGF201, on the other hand, reduces cyclic AMP levels and 
augments histamine release in response to antigen (Tauber et al., 1973; 
Hitchcock, 1978). PGF201 also increases cyclic GMP levels in human 
lung (Kaliner, 1977). Since prostaglandins are released during antigen 
challenge of sensitized lung (Section 1.6.1), these observations suggest 
that prostaglandins may have an important role in regulating mediator 
release. Indeed, treatment of guinea-pig lungs with indomethacin (an 
inhibitor of prostaglandin synthesis) before anaphylactic challenge 
increases the amounts of histamine and SRS-A released (Engineer et al., 
1978b; Hitchcock, 1978), and sodium meclofenamate (another inhibitor 
of prostaglandin synthesis) potentiates anaphylactic bronchonconstriction 
of guinea-pigs in vivo (Miller and Robson, 1976).
Another important regulatory mechanism in the release of chemical
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mediators is the negative feedback inhibition of histamine release by 
histamine itself. In basophilic leucocytes, this effect is accompanied 
by an increase of cyclic AMP levels (Bourne et al., 1971), and is medi­
ated by histamine H2-receptors (Lichtenstein and Gillespie, 1973 and 
1975).
Thus modulation of mediator release by adrenergic or cholinergic 
stimulation, by prostaglandins or by histamine, is associated with 
changes in the levels of cyclic nucleotides, with cyclic AMP and cyclic 
GMP having opposing effects. Further evidence for this hypothesis is 
the effect of imidazole, an activator of cyclic nucleotide phosphodie­
sterase (Section 5.1) which simultaneously reduces lung cyclic AMP levels 
and enhances the release of mediators (Kaliner and Austen, 1974; Austen 
and Orange, 1976).
Antigen-induced mediator release from human lung in vitro is also 
inhibited by disodium cromoglycate (Sheard and Blair 1970; Orange and 
Austen, 1971). The action of disodium cromoglycate is thought to be 
independent of cyclic nucleotide metabolism but rather the result of 
mast cell membrane stabilization (Cox, 1976). However, disodium cromogly­
cate does have an inhibitory effect on cyclic nucleotide phosphodiesterase 
from another tissue (Roy and Warren, 1974; Lavin et al., 1976). The 
importance of the inhibitory effect of disodium cromoglycate on mediator 
release is seen in the widespread use of this drug in the treatment of 
asthma (Cox, 1976) .
1.2.4 Mediator release in asthma
The release of various chemical mediators following the interaction 
of an allergen with IgE fixed to mast cells in the lung, and the effects 
of these mediators on pulmonary vascular and airways smooth muscle is a 
possible explanation for the symptoms of allergic asthma. Mediator 
release has also been implicated in exercise-induced asthma (Sly, 1976)
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and aspirin-sensitive asthma (Section 1.5.4).
The involvement of histamine in allergic asthma was suggested 
many years ago (Epstein, 1932), but the importance of its contribution 
to allergic bronchoconstriction is still unclear. Histamine is released 
upon antigen challenge of isolated lung and bronchial tissue of asthmatic 
patients (Schild et al., 1951). Plasma histamine levels in asthmatic 
patients are increased during naturally occurring asthmatic attacks 
(Simon et al., 1977), and after experimental challenge with specific
antigen (Bhat et al., 1976), methacholine (Rosenblum et al., 1978), 
or exercise (Anderson et al., 1978) . Histamine levels are also elevated 
in sputum of patients with allergic asthma (Turnbull et al., 1977).
On the other hand, antihistaminic drugs are of limited benefit 
in most asthmatic patients (Karlin, 1972), mainly because of their 
dessicant action on the airways which increases bronchial obstruction 
(Bodes, 1976) . Also, antihistamines themselves have bronchoconstrictor 
activity which may limit their therapeutic effectiveness in asthma 
(Hawkins, 1955). However, these drugs do prevent allergen-induced 
bronchoconstriction in some asthmatic patients (Itkin and Anand, 1970), 
and some have significant bronchodilator activity when administered as 
aerosols (Nogrady et al., 1978).
Thus, histamine appears to play some role in allergic bronchocon­
striction in asthma, but the relative importance of this involvement is 
unclear, and other mediators may be more significant. SRS-A, as well 
as histamine, is detectable in sputum of patients with allergic asthma 
and bronchitis, but not other lung diseases (Turnbull et al., 1977). 
Brocklehurst (1970) compared the bronchoconstricting activity attribut­
able to histamine and SRS-A released during antigen challenge of 
asthmatic lung, and concluded that SRS-A is more important than histamine. 
The longer duration of the contractile response to SRS-A also favours
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this hypothesis, which has gained widespread acceptance. However, more 
direct evidence is lacking because of the unavailability of clinically 
acceptable selective inhibitors of SRS-A release and action.
The release of histamine and SRS-A in response to antigen exposure 
and their effects on airways smooth muscle may therefore explain bron- 
choconstriction in allergic asthma. However, this explanation does not 
account for the bronchial hyperreactivity characteristic of bronchial 
asthma (Section 1.1). The release of histamine in allergic asthma does 
not explain why exogenous histamine causes severe bronchoconstriction in 
asthmatic patients in doses which have no effect on normal airways.
Indeed the bronchoconstrictor response to allergen exposure is influenced 
by the degree of underlying bronchial hyperreactivity determined by 
histamine inhalation challenge, so that allergen-induced asthma is 
triggered more easily as the level of hyperreactivity increases (Killian 
et al., 1976) .
One explanation of this discrepancy may be that the defect in 
asthma involves an impaired degradative metabolism of histamine. An in 
vitro model of this possibility is the potentiation of the contractile 
responses of guinea-pig tracheal smooth muscle by inhibitors of diamine 
oxidase (histaminase), the enzyme responsible for histamine degradation 
in this species (Arunlakshana et al., 1954). However, in man the 
principal route of histamine catabolism is methylation by histamine 
methyltransferase (Schayer, 1956), and this activity is normal in asth­
matic patients (Thom et al., 1973). The possibility remains, however, 
that impaired degradation of SRS-A may contribute to bronchial hyperreac­
tivity.
Another possible explanation of bronchial hyperreactivity involving 
mediator release is that continual exposure of the airways to mediators 
released locally during allergic reactions non-specifically increases 
reactivity of the smooth muscle (Newball, 1976). However, this concept
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does not  e x p l a in  th e  n a t u r e  o f  the  d e f e c t  r e s p o n s i b l e  fo r  b r o n c h ia l  
h y p e r r e a c t i v i t y .
Thus,  a l l e r g i c  m ed ia to r  r e l e a s e  i s  a common s t im u lu s  f o r  a s th m a t i c  
b r o n c h o c o n s t r i c t i o n , b u t  th e  concept  o f  asthma as a p u r e l y  immunological 
d i s e a s e  i s  u n t e n a b l e ,  s i n c e  i t  f a i l s  t o  e x p la in  the  fundamenta l  abno rm a l i ty  
i n  asthma. Under ly ing  a l l e r g i c  b r o n c h o c o n s t r i c t i o n ,  t h e r e  i s  a non­
s p e c i f i c  h y p e r r e a c t i v i t y  o f  ai rways smooth muscle t o  the  m ed ia to rs  
r e l e a s e d  d u r in g  a n t ig e n  exposure .
1 .3  A drenerg ic  mechanisms and asthma
1 .3 .1  Adrenerg ic  r e g u l a t i o n  o f  ai rways smooth muscle
Adrenerg ic  r e g u l a t i o n  o f  the  ai rways  in v o lv e s  both  t h e  sym pa the t ic  
nervous  system and c i r c u l a t i n g  ca techo lam ines  from th e  a d re n a l  g la n d s .  
N o rad ren a l in e  r e l e a s e d  from sym pa the t i c  ne rve  t e rm i n a l s  and c i r c u l a t i n g  
ca techo lam ines  a c t  on a d r e n e rg i c  r e c e p t o r s  in  ai rways  smooth muscle 
t o  produce b r o n c h o d i l a t i o n  i n  many animal s p e c i e s .  The impor tance  of  
a d r e n e r g i c a l l y  media ted  b r o n c h o d i l a t i o n  i s  shown by the  widespread  u se  
o f  sympathomimetic a e r o s o l s  i n  t h e  t r e a t m e n t  o f  asthma.
The p r e s e n c e  o f  a d r e n e rg i c  ne rves  i n  th e  ai rways  o f  v a r io u s  s p e c ie s  
has been dem ons t ra ted  by f l u o r e s c e n c e  h i s t o c h e m i s t r y  (Mann, 1971;
O’Donnell  and S a a r ,  1973) . A drenerg ic  i n n e r v a t i o n  i s  most dense a t  the  
l a ry n g e a l  end o f  t h e  t r a c h e a ,  d e c r e a s e s  down t h e  t r a c h e a  and b r o n c h i ,  
and i s  s c a r c e  in  p e r i p h e r a l  ai rways  smooth muscle (O'Donnell  e t  a l . ,
1978).  I t  has been sugges ted  t h a t  a d r e n e rg i c  ne rves  r e g u l a t e  only  t h e  
c e n t r a l  a i rw ays ,  and t h a t  o t h e r  f a c t o r s  such as n o n -a d r e n e r g i c  nerves  
or  c i r c u l a t i n g  ca techo lam ine s  c o n t r o l  r e l a x a t i o n  o f  th e  s m a l l e r  ai rways 
(O'Donnell  e t  a l . ,  1978).  A n o n -a d re n e rg i c  i n h i b i t o r y  nervous  system 
has  been dem ons t ra ted  in  g u in e a -p ig  t r a c h e a  (Coburn and Tomita ,  1973; 
Coleman and Levy, 1974; Richardson and Bouchard, 1975),  and i n  human 
airways  (Richardson and Beland,  1976).
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The order of potency of catecholamines in relaxing isolated 
airways smooth muscle (isoprenaline > adrenaline > noradrenaline > 
phenylephrine), and inhibition of the response by the ß-adrenergic 
antagonist propranolol, indicate that bronchodilation is mediated by 
ß-adrenergic receptors (Ahlquist, 1948; Foster, 1966). However, after 
ß-adrenergic blockade, adrenaline and noradrenaline contract isolated 
smooth muscle of guinea-pig trachea (Everitt and Cairncross, 1969;
Fleisch et al., 1970) and human bronchus (Adolphson et al., 1971;
Mathe et al., 1971b), and cause bronchoconstriction in guinea-pigs in 
vivo (Persson and Johnson, 1970). These responses are blocked by oi- 
adrenergic receptor antagonists, indicating the presence of a-adrenergic 
receptors in airways smooth muscle.
ß-adrenergic receptors have been further classified into ßi- and 
ß2-subtypes (Lands et al., 1967), and bronchial smooth muscle has pre­
dominantly ß2-adrenoceptors (Lands et al., 1967; Daly et al., 1971).
This observation has led to the development of specific ß2-adrenergic 
agents such as salbutamol (Cullum et al., 1969) and terbutaline 
(Carlström, 1970), which have minimal cardiac stimulant effect (mediated 
by ßi-adrenoceptors).
The relaxant effects of adrenergic agents on airways smooth muscle 
are associated with an increase of intracellular cyclic AMP levels 
(Section 1.7.3) and it is widely accepted that cyclic AMP is the "second 
messenger" for the bronchodilator actions of these compounds. Indeed, 
it was suggested that the ß-adrenergic receptor is identical to the 
adenylate cyclase enzyme (Robison et al., 1967). However, more recently 
it has been shown that adenylate cyclase and the ß-adrenoceptor are 
distinct proteins (Insel et al., 1976; Schramm et al., 1977), but that 
there is a close association between them in the smooth muscle cell 
membrane. -
The importance of ß-adrenergic bronchodilator activity in vivo can
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be assessed by the administration of 3-adrenergic antagonists. Although 
propranolol contracts isolated human bronchial smooth muscle (Mathe et al., 
1971), it has little or no effect on the airways of normal subjects 
(McNeill and Ingram, 1966; Turner et al., 1971; Tattersfield et al.,
1973; Bradley et al., 1976), indicating the absence of any significant 
bronchodilating influences mediated by 3-adrenergic mechanisms. However, 
administration of propranolol to asthmatic patients causes severe bron- 
choconstriction (McNeill, 1964; MacDonald et al., 1967; Richardson and 
Sterling, 1969). The slight bronchoconstriction sometimes observed in 
normal subjects and the greater response in asthmatic patients are both 
inhibited by atropine (Langer, 1967; MacDonald et al., 1967; Grieco 
and Pierson, 1971). This observation could indicate that cholinergically 
mediated reflex mechanisms are involved (Section 1.4.1), but a more 
like.ly explanation is that after 3-blockade with propranolol, bronchocon­
striction is caused by unopposed vagal activity, which would be blocked 
by atropine. Stimulation of a-adrenergic receptors may also contribute 
to the bronchoconstriction observed after propranolol (MacDonald et al., 
1967).
Propranolol also causes bronchoconstriction in vivo in dogs 
(Woolcock et al., 1969b) and guinea-pigs (Herxheimer, 1967; MacLagan and 
Ney, 1977) . Although prior administration of atropine delays the onset 
of dyspnoea (Herxheimer, 1967), it does not reduce the severity of the 
bronchoconstriction (MacLagan and Ney, 1977), indicating that parasympa­
thetic mechanisms do not mediate the airways response. Practolol, a 
selective 3i-adrenoceptor antagonist, and (+)-propranolol, the stereoiso­
mer devoid of 3-blocking activity, also causes bronchoconstriction in 
guinea-pigs (MacLagan and Ney, 1977), suggesting that the bronchoconstric- 
tor response to propranolol may not be related to blockade of 32- 
adrenoceptors. Similarly, practolol may cause bronchoconstriction in 
some asthmatic patients (Bernecker and Roetscher, 1970; Singh et al.,
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1976; Formgren, 1977), although the effect is not as common or as 
severe as propranolol-induced bronchoconstriction (MacDonald and McNeill, 
1968).
Apart from mediating resting bronchodilator activity in guinea- 
pigs and asthmatic humans, adrenergic mechanisms are also important in 
regulating airways smooth muscle during exposure to bronchoconstrictor 
stimuli. Bronchoconstriction induced by antigen challenge of sensitized 
guinea-pigs, or by the administration of histamine, SRS-A or bradykinin, 
is accompanied by the release of catecholamines from the adrenal medulla 
into the circulation (Staszewska-Barczak and Vane, 1965; Piper et al., 
1967; Bernauer et al., 1971). Furthermore, prior administration of 
ß-adrenergic blocking drugs enhances bronchoconstriction induced in 
guinea-pigs by bradykinin (Collier et al., 1965) and histamine (McCulloch 
et al., 1967; Diamond, 1972; Douglas et al., 1973). Adrenalectomized 
guinea-pigs also display increased reactivity to histamine (Diamond,
1972), and this effect is additive to that of propranolol administration 
(McCulloch et al., 1967). This suggests that histamine-induced-broncho- 
constriction is modulated by both adrenaline released from the adrenal 
glands and by noradrenaline released from adrenergic neurones in the 
airways. Non-neuronal catecholamine stores in the lung may also be 
involved (Drazen, 1978) .
Similar mechanisms have been demonstrated in other species: 
adrenalectomy enhances histamine-induced bronchoconstriction in cats 
(Colebatch and Engel, 1974), and administration of propranolol to dogs 
potentiates the effects of vagal stimulation (Woolcock et al., 1969b) 
and histamine (Diamond, 1972). The situation in normal humans is not 
clear. Some studies claim that propranolol does not increase bronchial 
sensitivity to methacholine or histamine in normal subjects, although 
in asthmatic patients propranolol, in addition to causing bronchocon­
striction by itself, also increases bronchial sensitivity (Zaid and Beall,
1966; Ryo and Townley, 1976). However, other studies have shown that 
administration of propranolol to normal subjects increases airways 
sensitivity to histamine (Ploy-Song-Sang et al., 1978), acetylcholine 
(Orehek et al., 1975) , and cigarette smoke (Zuskin et al., 1974) .
Studies demonstrating bronchial hyperreactivity induced by 
3-blockade in experimental animals have all been in vivo, and some have 
shown that in vitro, propranolol does not enhance histamine-induced 
contractions (McCulloch et al., 1967). On the other hand, another 
3-adrenergic antagonist, practolol, does potentiate the contractile 
responses of isolated guinea-pig trachea to histamine, acetylcholine and 
serotonin (Chang et al., 1978). However, it seems unlikely that this 
effect is related to 3-adrenergic blockade, since practolol is a 
cardioselective 3u-adrenoceptor antagonist, and would be expected to have 
much less of an effect than propranolol on the predominantly 32-adreno­
ceptors of airways smooth muscle. The mechanism of action of practolol 
on guinea-pig trachea remains obscure.
Thus, 3-adrenergic mechanisms may constitute an important negative 
feedback regulatory system modulating the bronchoconstrictor effects of 
various agents in vivo, and serve as a protective mechanism against 
excessive bronchoconstriction in response to allergic or other stimuli. 
Although the evidence for such a mechanism in healthy humans is not as 
strong as for guinea-pigs and other experimental animals, it is possible 
that a defect in the normal 3-adrenergic regulatory system of airways 
smooth muscle underlies the bronchial hyperreactivity characteristic of 
asthma.
1.3.2 Beta-adrenergic blockade in asthma
A current popular theory explaining bronchial hyperreactivity in 
asthma is that of 3-adrenergic blockade (Szentivanyi, 1968; Middleton, 
1972; Szentivanyi and Fishel, 1976), which postulates that the
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underlying abnormality is a diminished responsiveness of B-adrenergic 
receptors in the airways. B-adrenergic regulation of airways smooth 
muscle is thus impaired, and exposure to contractile stimuli results in 
unopposed bronchoconstriction.
Some indirect evidence for the theory of B-adrenergic blockade 
comes from the studies described in the preceding section, in which 
administration of propranolol to experimental animals enhances the airways 
responses to bronchoconstrictor stimuli. However, similar studies in 
humans are few, and the results conflicting (Section 1.3.1).
Further indirect evidence is derived from studies of B-adrenergic 
function in various tissues and metabolic processes in asthmatic patients. 
For example, the hyperglycaemic and cardiac stimulant responses to 
infused adrenaline or isoprenaline are less in asthmatic patients than 
in normal controls (Cookson and Reed, 1963; Lockey et al., 1967;
Middleton and Finke, 1968) , and the impairment of these responses 
correlates with the degree of bronchial hyperreactivity. Also the normal 
increases in plasma and urinary cyclic AMP levels after adrenaline are 
diminished in patients with asthma (Bernstein et al., 1972; Schwartz 
et al., 1973), and an inverse correlation exists between the plasma 
cyclic AMP response to adrenaline and bronchial sensitivity to histamine 
(Apold and Aksnes, 1976). Inhalation of salbutamol aerosol also increases 
urinary and plasma cyclic AMP levels in normal subjects, but not in 
asthmatic patients (Raij et al., 1976).
The effect of B-adrenergic stimulation on cyclic AMP metabolism 
has also been studied in lymphocytes and polymorphonuclear leucocytes. 
Cyclic AMP in lymphocytes from normal patients increases three-to four­
fold after in vitro exposure to isoprenaline, but this response is 
diminished in cells from patients with asthma (Smith and Parker, 1970; 
Logsdon et al., 1972; Parker and Smith, 1973). The decreased
responsiveness of the cells correlates with the severity of the donor's
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asthmatic condition, being most marked during severe active asthma 
and returning towards normal during periods of remission. On the other 
hand, increases in cyclic AMP levels induced by PGEi are no different 
in lymphocytes from asthmatic and normal patients (Parker et al., 1973), 
indicating that the defect in catecholamine responsiveness is associated 
with the B-adrenergic receptor rather than with the adenylate cyclase 
enzyme or some other component of the cyclic AMP metabolic pathway.
Similar results have also been obtained in polymorphonuclear leucocytes 
(Busse, 1977) . Furthermore, the cyclic AMP response of lymphocytes 
from asthmatic patients to noradrenaline, predominantly a Bi-adrenostimu- 
lant, was not as impaired as the response to salbutamol (predominantly 
a B2-adrenostimulant), suggesting that the abnormality underlying asthma 
is associated with B2-adrenoceptors (Makino et al., 1977). Further 
investigation of B-adrenergic receptors of asthmatic patients by measure­
ment of adrenaline binding to leucocytes has shown that there is no 
difference in either the number or binding affinity of adrenergic 
receptors between cells from normal and asthmatic subjects, in spite of 
decreased cyclic AMP production in the latter (Sokol and Beall, 1975).
One criticism of all of the above studies is that many asthmatic 
patients are treated with B-adrenostimulant drugs, and the diminished 
B-adrenergic responsiveness may result from this treatment, rather than 
being the underlying cause of asthma. For example, administration of 
ephedrine or terbutaline to normal subjects for one week depresses the 
metabolic and cardiovascular responses to adrenaline (Nelson et al.,
1975 and 1977). Desensitization of B-adrenergic receptors also occurs 
in vitro after exposure of leucocytes or airways smooth muscle to adrener­
gic agents (Kalisker et al., 1977; Douglas et al., 1977). However, 
some reports indicate that B-adrenergic function is still impaired in 
leucocytes from asthmatic patients who have not taken bronchodilators for 
two weeks (Busse, 1977; Lee et al., 1977), and normal subjects treated
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with ephedrine for two weeks show no changes in the lymphocyte cyclic 
AMP response to isoprenaline (Parker and Smith, 1973). On the other 
hand, cyclic AMP responses to adrenergic agents are normal in leucocytes 
from asthmatic children who have never received sympathomimetic bron- 
chodilators (Kalisker et al., 1977), or who have not received sympathomi- 
metics for one week (Morris et al., 1977) . In the latter study, 
leucocyte cyclic AMP responses decreased after one week of 3-adrenostimu- 
lant therapy. (3-adrenoceptor desensitization may also occur in asthma 
as a result of exposure to increased amounts of catecholamines released 
during asthmatic attacks, and this could explain why asthmatic patients 
in remission show less impairment of (3-adrenergic function than patients 
with active asthma (Parker and Smith, 1973; Alston et al., 1974).
Since asymptomatic asthmatic patients still display bronchial hyperreacti­
vity (Cade and Pain, 1971), these observations may indicate that impaired 
3-adrenergic function is a result rather than the cause of asthma.
In spite of the wealth of information showing impaired 3-adrenergic 
function in a variety of cell types and metabolic processes, there has > 
been no report of a similar defect in the airways smooth muscle of 
asthmatic patients. On the contrary, Svedmyr et al. (1976) found normal 
responses to isoprenaline in bronchial smooth muscle removed from three 
asthmatic patients undergoing surgery for bronchial carcinoma.
Thus asthma is associated with impaired 3-adrenergic function in 
various cell types and tissues, but it is not certain if this defect 
underlies bronchial hyperreactivity or results from the symptoms and/or 
treatment of the disease, or if it extends to airways smooth muscle.
1.3.3 Alpha-adrenergic receptors in asthma
Another proposed mechanism which could explain bronchial 
hyperreactivity involves an increased sensitivity of a-adrenoceptors 
rather than impaired 3-adrenoceptors. a-adrenergic antagonists
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(phentolamine, phenoxybenzamine) inhibit histamine-induced bronchocon- 
striction in asthmatic patients (Kerr et al., 1970). Although these 
drugs have other actions, such as anti-histaminic activity and inhibition 
of catecholamine uptake (Nickerson, 1970), these results were taken to 
indicate the participation of a-adrenergic receptors in the constriction 
of asthmatic airways in response to histamine. The existence of 
a-adrenergic receptors in human bronchial smooth muscle has been confirmed 
in vitro (Mathe et al., 1971), and Patel and Kerr (1973) suggested that 
increased a-receptor activity may lead to bronchial hyperreactivity in 
asthma. Simonsson et al., (1972) found that bacterial endotoxins poten­
tiate contraction of airways smooth muscle in response to a-adrenergic 
stimulation in vitro and proposed that a-adrenoceptors were involved in 
bronchoconstriction occurring during bronchial infections.
Inhalation of phenylephrine (an a-adrenergic stimulant) by asthmatic 
patients after (3-blockade induces bronchoconstriction, but has no effect 
on normal airways (Kerr and Patel, 1975). In vitro, platelets of 
asthmatic children have an ATPase activity (an a-adrenergic function) 
twice as great as normal platelets (Coffey and Middleton, 1975). Also, 
the enhancement by a-adrenergic blockade of the cyclic AMP response to 
isoprenaline is greater in leucocytes from asthmatic patients than in 
normal cells (Alston et al., 1974) indicating that the impaired cyclic 
AMP response of asthmatic leucocytes is due to overactivity of 
a-adrenoceptors rather than reduced (3-adrenergic function. All these 
observations lend support to the concept that asthma is associated with 
increased a-adrenergic activity. Furthermore, a-adrenergic hypersensiti­
vity, determined by pupil dilation in response to phenylephrine, is found 
exclusively in asthmatic patients, whereas (3-adrenergic hyposensitivity 
also occurs in non-asthmatic atopic patients (Shelhamer et al., 1978) .
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1.4 Cholinergic regulation of airways smooth muscle 
1.4.1 Normal airways
The parasympathetic nervous system plays an important role in the 
normal regulation of airways smooth muscle (reviewed by Nadel, 1976), and 
provides one site where a defect may contribute to bronchial hyperreacti­
vity in asthma.
Parasympathetic (cholinergic) innervation has been demonstrated 
by acetylcholinesterase staining in the bronchial smooth muscle of 
all species studied (Spencer and Leof, 1964; Nadel, 1975), and this 
innervation is derived from the pulmonary branches of the vagus 
nerve. Cutting the vagus nerve of experimental animals or blocking 
cholinergic transmission with atropine in humans causes bronchodila- 
tion (Severinghaus and Stupfel, 1955; Dautebrande et al., 1962;
Nadel and Widdicombe, 1963), indicating that the airways are subject to 
a resting cholinergic tonic constriction. In humans, the maximum 
bronchodilator effect of atropine is similar to that of a ß-adrenostimu- 
lant such as isoprenaline (Altounyan, 1974) . Electrical stimulation 
of the vagus in animals causes acetylcholine release from nerve terminals 
within airways smooth muscle and constriction of the larger airways 
(Olsen et al., 1965; Woolcock et al., 1969a).
Parasympathetic regulation of airway calibre depends on various 
receptors in the tracheobronchial tree, which are of three main types:
1) cough receptors, located mainly in the tracheal and larger 
bronchi,
2) irritant receptors, located in the more peripheral bronchi, 
and
3) stretch receptors, in the smaller airways (Sterling, 1974) . 
Stretch receptors are stimulated by lung inflation, resulting in inhibi­
tion of vagal efferent activity and dilation of the airways (Widdicombe
23
et al., 1962; Sellick and Widdicombe, 1971). Stimuli capable of 
inducing reflex bronchoconstriction include chemicals (sulphur dioxide, 
citric acid) (Nadel et al., 1965; Simonsson et al., 1967), chemically 
inert dusts (charcoal, cigarette smoke) (Widdicombe et al., 1962;
Sterling 1967), cold air (Simonsson et al., 1967), mechanical stimulation 
(Nadel and Widdicombe, 1962b), hypoxaemia and hypercapnia (Nadel and 
Widdicombe, 1962a), and hyperinflation (Simonsson et al., 1967). 
Inhibition of the bronchoconstrictor responses to these stimuli by 
atropine, vagotomy or vagal cooling demonstrates their parasympathetic 
reflex nature. Furthermore, increased activity of single vagal nerve 
fibres has been recorded in response to some of these stimuli, indicating 
stimulation of irritant receptors in the lung (Mills et al., 1969;
Sellick and Widdicombe, 1969 and 1971).
1.4.2 Cholinergic mechanisms in asthma
Asthmatic patients display bronchial hyperreactivity to a variety 
of stimuli (Section 1.2), and it is noteworthy that many of these 
stimuli cause reflex bronchoconstriction, even in healthy subjects.
On this basis, Simonsson et al. (1967) suggested that increased sensiti­
vity of irritant receptors in the airways could be a cause of bronchial 
hyperreactivity in asthma. That is, a lower threshold of stimulation 
of sensory nerve endings in asthmatic airways results in reflex broncho­
constriction at stimulus levels which are without effect in normal 
subjects. The involvement of cholinergic pathways is indicated by 
inhibition of the abnormal bronchoconstrictor responses by atropine.
Some evidence for this hypothesis comes from animal experiments 
in which sensitization of airway receptors is achieved by lung infections 
or by inhalation of ammonia or ozone, resulting in increased responsive­
ness to bronchoconstrictor stimuli (Widdicombe, 1961; Easton and Murphy, 
1967; Lee et al., 1977). Furthermore, transient sensitization of
s enso ry  r e c e p t o r s  by e p i t h e l i a l  damage may e x p la in  th e  b r o n c h ia l  h y p e r ­
r e a c t i v i t y  to  h i s t a m in e  and c i t r i c  ac id  observed  dur ing  r e c o v e ry  from 
a c u t e  v i r a l  r e s p i r a t o r y  i n f e c t i o n s  (Empey e t  a l . ,  1976).
However, acc ep tanc e  o f  any h y p o t h e s i s  im p l i c a t i n g  t h e  parasym pa the­
t i c  nervous  system in  b r o n c h ia l  h y p e r r e a c t i v i t y  must depend on a demon­
s t r a t i o n  t h a t  a l l  s t i m u l i  t o  which a s th m a t i c  p a t i e n t s  a r e  h y p e r r e a c t i v e  
do o p e r a t e  by a c h o l i n e r g i c  r e f l e x  mechanism. The evidence  f o r  such a 
mechanism in  th e  b r o n c h o c o n s t r i c t o r  r e s p o n s e s  to  a l l e r g e n s ,  m e d ia to r s  
o f  a l l e r g y  and e x e r c i s e  i s  d i s c u s s e d  below.
(a) Chemical m e d ia to r s  o f  a l l e r g y . I t  i s  well  known t h a t  some 
o f  t h e  m e d ia to r s  l i b e r a t e d  fo l low ing  a l l e r g e n  exposure  (h i s t a m in e ,  
b r a d y k i n i n ,  SRS-A, PGF2 CO have a d i r e c t  c o n t r a c t i l e  a c t i o n  on b r o n c h ia l  
muscle  (S ec t io n  1 . 2 . 2 ) .  However, i t  has  been sugges ted  t h a t  p a r t  o f  
t h e i r  b r o n c h o c o n s t r i c t o r  a c t i o n  in  vivo  i s  mediated  by a vaga l  r e f l e x .  
S ev e ra l  s t u d i e s  have shown t h a t  h i s t a m in e - in d u c e d  b r o n c h o c o n s t r i c t i o n  
i s  p a r t i a l l y  i n h i b i t e d  by vagotomy in  an im a ls  o r  by hexamethonium or  
a t r o p i n e  in  humans (Bouhuys e t  a l . ,  1960; DeCock 1966; Simonsson e t  a l . ,  
1967),  i n d i c a t i n g  t h a t  h i s t a m in e  has  bo th  d i r e c t  and r e f l e x  b ronchocon­
s t r i c t o r  a c t i o n s  on b r o n c h ia l  smooth muscle .  Fur therm ore ,  Mi l l s  e t  a l . 
(1969) showed t h a t  h i s t a m in e - in d u c e d  bronchospasm in r a b b i t s  was 
accompanied by i n c re a s e d  vaga l  a f f e r e n t  nervous  a c t i v i t y ,  and concluded 
t h a t  s t i m u l a t i o n  o f  i r r i t a n t  r e c e p t o r s  by h i s t a m in e  c o n t r i b u t e s  t o  t h e  
bronchospasm. However, more r e c e n t  s t u d i e s  have conc luded  t h a t  c h o l i n e r ­
g i c  mechanisms a r e  no t  invo lved  in  t h e  ai rways  r e sp o n se  t o  h i s t a m in e ,  
s i n c e  a t r o p i n e  and SCH 1000 ( ip r a t ro p iu m  bromide,  a more r e c e n t  a n t i ­
c h o l i n e r g i c  agen t )  f a i l e d  t o  s i g n i f i c a n t l y  i n h i b i t  th e  re s p o n s e  a t  doses  
which com ple te ly  a b o l i s h e d  m e th ach o l in e - in d u c ed  b r o n c h o c o n s t r i c t i o n  
( C a s t e r l i n e  e t  a l . ,  1976; C a s t e r l i n e  and Evans, 1977; Woenne e t  a l . ,
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1978).
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Cholinergic mechanisms have also been proposed to contribute to 
the bronchoconstrictor responses of SRS-A (Drazen and Austen, 1975), 
bradykinin (Simonsson et al., 1973), and PGF2a (Alanko and Poppius,
1973; Orehek et al., 1977). However, the suggestion of a vagal reflex 
in PGF2a-induced bronchoconstriction is contradicted by other studies 
which showed no inhibitory effect of atropine on the airways response 
of asthmatic patients to PGF201 (Newball et al., 1974; .Smith et al., 1975).
(b) Allergens. The suggested involvement of cholinergic reflex 
pathways in the bronchoconstrictor responses to various mediators 
raises the possibility of parasympathetic nervous effects in the broncho­
constriction associated with allergic asthma or experimental anaphylaxis. 
Irritant receptors are stimulated during anaphylaxis (Mills et al., 1969), 
and vagotomy reduces the bronchoconstriction caused by allergen exposure 
in sensitized rabbits, guinea-pigs and dogs (Mills and Widdicombe, 1970; 
Karkzewski and Widdicombe, 1969; Gold et al., 1972). Furthermore, 
unilateral challenge of one dog lung with antigen causes bronchoconstric­
tion in both lungs, indicating an indirect mechanism in the second lung 
(Gold et al., 1972).
A similar experiment in humans, however, showed that vagal 
reflexes are not important in allergen-induced bronchoconstriction, 
since unilateral challenge with antigen induced bronchoconstriction only 
in the challenged lung (Aborelius et al., 1962) . The effectiveness 
of atropine in preventing human airways responses to inhaled allergens 
is controversial. Some studies have shown that administration of 
atropine to asthmatic patients has a protective effect in some, but not 
all, cases (Itkin and Anand, 1970; Yu et al., 1972). More recent 
investigations have demonstrated that atropine pretreatment has no 
effect on the bronchoconstriction induced by inhaled allergens, indicat­
ing that parasympathetic reflexes are not a major component of this
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response (Fish et al., 1977; Rosenthal et al., 1977).
(c) Exercise. It has been suggested that exercise-induced 
bronchoconstriction in asthmatic patients is caused by release or 
formation of bronchoconstrictor agents, possibly identical to those 
released during allergen provocation (histamine, bradykinin, SRS-A,
PGF2CO (Sly, 1976). Since cholinergic reflex mechanisms may be involved 
in the bronchoconstrictor actions of these mediators, they may also 
contribute to exercise-induced bronchospasm. However, atropine does 
not prevent exercise-induced asthma in most cases (Sly et al., 1967; 
Fisher et al., 1968; Chan-Yeung et al., 1971), indicating that the 
parasympathetic nervous system is not involved in the response.
Bronchial hyperreactivity to exercise is a wel1-documented 
characteristic feature of asthma (McNeill et al., 1966), and is used as 
a diagnostic test for asthma (Anderson et al., 1975). Exercise and 
allergy are perhaps the two most common precipitating factors in asthma, 
and unless the involvement of cholinergic pathways can be definitely 
established in the bronchoconstrictor actions of these stimuli, it is 
difficult to accept an explanation of bronchial hyperreactivity involving 
a defect in the parasympathetic reflex nervous system.
Another criticism of the theory implicating reflex cholinergic 
mechanisms in bronchial hyperreactivity is that inhibition of bronchocon­
strictor responses by cholinergic blockade does not necessarily prove the 
involvement of a parasympathetic reflex. Atropine alone acts as a 
bronchodilator by abolishing resting bronchial muscle tone, and changes 
in reactivity to bronchoconstrictor stimuli may simply result from this 
change in baseline conditions (Benson, 1975).
1.5 Prostaglandins
Prostaglandins are biologically active lipids which have been
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implicated in many physiological and pathological processes. Their 
presence in human lung (Anggärd, 1965; Karim et al., 1967), their 
release during allergic reactions (Section 1.6.1), and their effects 
on bronchial smooth muscle (Section 1.6.2) raise the possibility that 
prostaglandins play an important role in the pathogenesis of human 
asthma. The biosynthetic pathways of the major prostaglandins are shown 
in Figure 1.1.
1.5.1 Prostaglandin release in allergic reactions
When a perfused lung of a sensitized guinea-pig is challenged 
with antigen, PGF201 and PGE2 can be identified amongst the biologically 
active substances released into the effluent by bioassay on various 
isolated smooth muscle preparations (Piper and Vane, 1969). Another 
prostaglandin-like substance apparent in the effluent is very unstable, 
contracts isolated strips of rabbit aorta, and was called "rabbit aorta 
contracting substance" (RCS) (Piper and Vane, 1969). RCS was later 
shown to consist mainly of thromboxane A2 (Hamberg et al., 1975a;
Bunting et al., 1976), with a minor contribution from the cyclic endopero- 
xides (PGG2 and PGH2) (Svensson et al., 1975). More detailed analysis 
of the effluent from challenged guinea-pig lungs by gas liquid chromato­
graphy and mass spectrometry has identified nine different prostaglandin­
like substances (Boot et al., 1976; Dawson et al., 1976). These include 
various metabolites of the previously identified prostaglandins and 
thromboxanes, as well as 6-oxo PGFia, the metabolite of prostacyclin 
(PGI2). PGI2 itself has been detected in the perfusate of guinea-pig 
lungs challenged with arachidonic acid (Alabaster and Hawkeswood, 1978) , 
so it seems likely that PGI2 is also released during anaphylactic 
challenge.
Stimuli other than anaphylactic challenge also release prosta­
glandins from guinea-pig lung. These include arachidonic acid (Anggärd
MEMBRANE PHOSPHOLIPID
phospholipase
ARACHIDONIC ACID
lipoxygenase (?) cyclooxygenase
SRS-A+++
OTHE
- v e  indomethacin,aspirin
other NSAID
CYCLIC ENDOPEROXIDES 
(PGG?/PGH.)
++
1
 ^ r '
R PGs PC
t  '
r  '
;E2 PC
r '
f +
* 2 «  r<
r  ^
r _   ^
312 THRO
thromboxane synthetase
r +++  
MBOXANE A2
r
15- 0X0 - 13, 14-d ihydro m etab o lites 6 -o x o  PGFja THROMBOXANE B2
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A rach idon ic  a c id  r e l e a s e d  by th e  a c t i o n  o f  p h o s p h o l ip a s e  on membrane 
p h o s p h o l ip id s  i s  m e ta b o liz ed  to  a r an g e  o f  p r o d u c t s ,  some o f  which 
have b r o n c h o d i l a to r  ( - )  o r  b r o n c h o c o n s t r i c t o r  (+) a c t i v i t y  on a irw a y s
smooth m usc le .  The d e r i v a t i o n  o f  SRS-A from a ra c h id o n a te  i s  t e n t a t i v e  
(S e c t io n  1 .2 .2 .2 )  .
29
and Samuelsson, 1965), histamine (Bahkle and Smith, 1972; Alabaster 
and Bahkle, 1976), SRS-A (Engineer et al., 1978a; Seale and Piper,
1978), and mechanical irritation (Palmer et al., 1973). These 
observations suggest that prostaglandin release during antigen challenge 
of sensitized lung is -secondary to either histamine release or 
anaphylactic smooth muscle contraction (Piper and Walker, 1973; Parrot 
et al., 1977).
Prostaglandins are also released during antigen challenge of 
passively sensitized human lung (Piper, 1973; Piper and Walker, 1973), 
and airways smooth muscle (Dunlop and Smith, 1975). However, these 
studies have been limited to identification of only two prostaglandins, 
PGF2a (lung and bronchus) and PGE2 (lung only).
The release of prostaglandins from challenged guinea-pig and 
human lungs is blocked by indomethacin (Piper and Vane, 1969; Piper 
and Walker, 1973), which inhibits the conversion of arachidonic acid 
to cyclic endoperoxides (Figure 1.1) (Vane, 1971). This indicates that 
prostaglandins, unlike histamine, are synthesized de novo during antigen 
challenge, rather than being released from pre-formed stores. Catechol­
amines also inhibit the release of prostaglandins from challenged guinea- 
pig lungs (Mathe and Levine, 1973; Liebig et al., 1974).
1.5.2 Effects of prostaglandins on airways smooth muscle
Since PGF201 and PGE2 are the major prostaglandins released during 
antigen challenge of sensitized lungs, the effects of these prostaglandins 
on airways smooth muscle have been extensively investigated.
PGF2a contracts isolated tracheal muscle from guinea-pigs 
(Änggärd and Bergstrom, 1963; Puglisi, 1973) and dogs (Wasserman and 
Griffin, 1976), although its potency is not as great as on other smooth 
muscle preparations (Änggärd and Bergström, 1963). PGF201 also constricts 
isolated human bronchial smooth muscle (Sweatman and Collier, 1968;
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Mathe et al., 1971a). Cat trachea, on the other hand, is relaxed 
by PGF2CI (Horton and Main, 1965) .
In vitro contractile responses of airways smooth muscle to PGF201 
are not affected by mepyramine or atropine (Sweatman and Collier, 1968), 
indicating a direct action of PGF201 on the smooth muscle. They are, 
however, inhibited by prostaglandin antagonists such as polyphloretin 
phosphate and SC-19220 which do not affect contractions induced by 
histamine, serotonin or acetylcholine (Mathe et al., 1971a; Farmer et al., 
1974). Non-steroidal anti-inflammatory drugs, such as flufenamic acid, 
aspirin and indomethacin at high concentrations, also antagonize 
PGF20i-induced contraction (Collier and Sweatman, 1968; McIntyre and 
Temple, 1977) . Low concentrations of indomethacin, on the other hand, 
potentiate the contractile effects of PGF2CI on guinea-pig tracheal 
smooth muscle (Farmer et al., 1974; Lambley and Smith, 1975). This 
effect may be related to the inhibitory action of indomethacin on the 
synthesis of relaxant prostaglandins induced by exogenous PFG201 
(Panczenko et al., 1975).
The bronchonconstrictor action of PGF201 has been confirmed by 
in vivo studies of guinea-pigs (Mathe et al., 1972), dogs (Said, 1967; 
Wasserman, 1975; Spannhake et al., 1978a), and humans (Hedqvist et al., 
1971; Smith and Cuthbert, 1972a). In vivo bronchoconstrictor responses 
to PFG201 may be partially due to cholinergically mediated reflex 
bronchoconstriction (Manko and Poppius, 1973; Wasserman, 1976; Section 
1.4.2) .
Prostaglandins of the E series generally have opposite effects to 
PGF201 on airways smooth muscle. PGEi and PGE2 relax isolated tracheal 
preparations from cats, dogs and guinea-pigs (Main, 1964; Turker and 
Khairallah, 1969; Puglisi, 1973). They also relax human bronchial 
smooth muscle (Sweatman and Collier, 1968; Sheard, 1968), although PGE2
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may sometimes have a contractile effect (Gardiner, 1975) .
The in vitro effects of the E prostaglandins are blocked by the 
prostaglandin antagonists, polyphloretin phosphate and SC-19220 (Puglisi, 
1972), but are not affected by propranolol (Turker and Khairallah,
1969) . Their bronchodilator activity is therefore independent of 
3-adrenergic receptors, although their mechanism of action, like that 
of ß-adrenergic agents, appears to involve stimulation.of adenylate 
cyclase and elevation of cyclic AMP levels in smooth muscle cells 
(Section 1.7.3.3).
In vivo studies of experimental animals have shown that PGEs 
decrease airways resistance, or reverse increases in airways resistance 
induced by vagal stimulation, histamine or other bronchoconstrictor 
drugs (Main, 1964; Rosenthale et al., 1970; Large et al., 1969), 
although in dogs their bronchodilator action is very weak (Rosenthale 
et al. , 1970; Spannhake et al., 1978a). Anaphylactic bronchoconstric- 
tion in guinea-pigs is also inhibited by PGEi and PGE2 (Herxheimer,
1974) . PGEs are more effective bronchodilators as aerosols than when 
administered intravenously (Large et al., 1969; Rosenthale et al., 1971), 
probably because of the rapid inactivation of prostaglandins during 
passage through the pulmonary circulation (Piper et al., 1970). The 
in vivo bronchodilator actions of the E prostaglandins are independent 
of cholinergic and adrenergic mechanisms (Rosenthale et al., 1968).
Aerosols of PGEi and PGE2 also decrease airways resistance in 
both normal and asthmatic subjects (Cuthbert, 1969 and 1971; Herxheimer 
and Roetscher, 1971; Smith and Cuthbert, 1972) and are about ten 
times more potent than isoprenaline. However, intravenous administration 
of PGE2 to patients undergoing termination of pregnancy causes bronchocon- 
striction (Smith, 1973) .
The major drawback to the therapeutic use of PGEi and PGE2
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as bronchodilators is their irritant effect on the airways. However, 
analogues of the E prostaglandins which retain bronchodilator activity 
but lack such irritant properties, may be useful in the treatment of 
bronchial asthma (Greenberg and Smorong, 1975; Strandberg and Hedqvist, 
1977) . Alternatively, the irritant effects of the PGEs may be avoided 
by intravenous or oral administration of analogues resistant to degrada­
tion during passage through the pulmonary circulation (Tomioka et al.,
1977) .
Prostaglandin-like substances other than PGEs and PGF2CI have 
also been studied for possible actions on airways smooth muscle. These 
include the prostaglandin metabolites, cyclic endoperoxides, and thrombox­
anes, which are released during antigen challenge of sensitized guinea- 
pig lung (Section 1.5.1), and which may contribute to anaphylactic 
bronchospasm by contracting airways smooth muscle.
The 15-oxo metabolite of PGF201 was initially reported to be more 
potent than PGF201 in contracting both guinea-pig trachea and human 
bronchus (Dawson et al., 1974). However, this observation was later 
found to be erroneous, the activity of 15-oxo PGF20t on guinea-pig trachea 
being only about 10% of the parent prostaglandin (Boot et al., 1977) .
In vivo, 15-oxo PGF2CI is also less active than PGF2a in producing broncho- 
constriction in dogs and guinea-pigs, although another metabolite, 13,14- 
dihydro PGF201 has similar or greater activity than PGF201 (Wasserman,
1975; Lo, 1977) . The metabolites of PGE2 are less potent bronchodilators 
than PGE2 both in vivo and in vitro (Boot et al., 1976; Lo, 1977), 
although Crutchley and Piper (1975) found 15-oxo PGE2 to be more potent 
that PGE2 -
The cyclic endoperoxides, PGG2 and PGH2 , are unstable intermediates 
in the synthesis of both prostaglandins E2 and F201, and are also precur­
sors of the thromboxanes (Figure 1.1). Cyclic endoperoxides contract
33
isolated airways smooth muscle of guinea-pigs and humans, and cause 
bronchoconstriction in anaesthetized cats and guinea-pigs (Hedqvist 
et al., 1978). Stable analogues of the prostaglandin endoperoxides 
also have bronchoconstrictor activity (Wasserman, 1976; Hedqvist et al., 
1978; Spannhake et al., 1978b). Thromboxane Ä2 constricts guinea-pig 
airways, both in vitro and in vivo, being 37 times more potent than 
PGG2 in vivo and over 500 times more potent that PGF20t (Sevensson et al., 
1977). Thromboxane B2 , the degradative product of thromboxane A2 , has 
only weak bronchoconstrictor activity on guinea-pig trachea in vitro and 
in dogs in vivo (Wasserman and Griffin, 1977).
Prostaglandins A1 and A2 have a weak contractile effect on guinea- 
pig tracheal and human bronchial smooth muscles (Lo et al., 1976;
Takano et al., 1978), and cause bronchonconstriction in cats and dogs 
in vivo (Hirose and Said, 1971; Ballantyne et al., 1973). However they 
have a weak bronchodilator action and inhibit drug-induced bronchoconstric­
tion in intact guinea-pigs (Dessy et al., 1973). Prostaglandins B2 and 
D2 contract isolated guinea-pig tracheal smooth muscle (Takano et al.,
1978; Dawson et al., 1974), and PGD2 aerosol also produces bronchocon­
striction in vivo in guinea-pigs (Hamberg et al., 1975b) and dogs 
(Wasserman et al., 1977; Spannhake et al., 1978a). PGF2B, a stereoisomer 
of PGF2a, relaxes airways smooth muscle in vitro (Baum et al., 1974), 
and antagonizes PGF20(,-induced bronchoconstriction in both cats and 
guinea-pigs in vivo (Rosenthale et al., 1973). Prostacyclin (PGI2) 
prevents exercise-induced bronchoconstriction in asthmatic patients 
(Bianco et al., 1978) .
The fatty acid precursors of prostaglandins, arachidonic acid and 
dihomo-y-linolenic acids induce bronchoconstriction in experimental 
animals (Spannhake et al., 1978a; Hyman et al., 1978a). These responses 
are antagonized by indomethacin indicating that these precursors are 
transformed by cyclooxygenase into active intermediates and/or prosta-
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glandins and thromboxanes.
Thus many prostaglandin-like substances can affect airways smooth 
muscle in a variety of species, some causing bronchoconstriction and 
others bronchodilation (Figure 1.1). It is difficult to assess which 
of them, if any, are involved in the regulation of either normal or 
hyperreactive airways.
1.5.3 The role of prostaglandins in asthma
The release of prostaglandins during allergic reactions (Section 
1.5.1) and their potent effects on airways smooth muscle (Section 1.5.2) 
suggest that these compounds may play a role in bronchial hyperreactivity 
and bronchoconstriction in asthma. Several hypotheses have been proposed 
to explain the nature of prostaglandin involvement in asthma.
Sweatman and Collier (1968) suggested that PGF201 may be involved 
in bronchoconstriction in asthma, since it contracts isolated human 
bronchial smooth muscle. Horton (1969) pointed out that overproduction 
of PGF201 at the expense of the bronchodilator PGE2 could account for 
asthmatic bronchoconstriction. However, the demonstration that asthmatic 
patients are hyperreactive to PGF201 (Hedqvist et al., 1971; Mathe et al., 
1973) indicated that mere release of PGF201 is not the cause of broncho­
constriction in asthma. Gardiner (1975) proposed that the airways of 
asthmatic patients have an increased number of PFG201 receptors, which 
could explain bronchial hyperreactivity to PGF201, but not to other 
mediators.
Smith and Cuthbert (1972) pointed out differences between PGF201- 
induced bronchoconstriction and asthma, such as the different susceptibi­
lity to inhibition of PGE2 and isoprenaline, and suggested that PGF201 
may release another mediator or be metabolized to a more active form, 
rather than directly causing bronchoconstriction. Dawson et al., (1974)
proposed 15-oxo PGF2a to be more important than PGF201 because of its
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greater potency, but this was not confirmed (Boot et al., 1977).
Other prostaglandin-like substances with greater bronchoconstrictor 
activities than PGF201, such as the cyclic endoperoxides and thromboxane 
A2 , may also contribute to bronchoconstriction in asthma (Wasserman and 
Griffin, 1976) .
Another possible role of prostaglandins in asthma may be to 
increase the sensitivity of airways smooth muscle to other mediators 
(Dawson and Sweatman, 1974). For example, PGA2 enhances acetylcholine- 
induced contraction of guinea-pig tracheal smooth muscle (Takano et al., 
1978), and a mixture of PGE2 and PGF201 potentiates histamine-induced 
bronchoconstriction in dogs (Nakano et al., 1973).
Apart from their direct effects on airways smooth muscle, 
prostaglandins also act on other cell types in the lung, such as 
vascular smooth muscle and mast cells. Impaired regulation of pulmonary 
circulation by prostaglandins (reviewed by Kadowitz et al., 1975;
Hyman et al., 1978b) could contribute to both bronchoconstriction and 
oedema in bronchial asthma. The release of histamine and SRS-A during 
antigen challenge of sensitized lung is inhibited by PGEi and PGE2, 
and enhanced by PGF2a (Walker, 1972; Tauber et al., 1973). These 
observations suggest an important role for prostaglandins in the 
regulation of allergic mediator release, and a defect in this system 
could underly bronchial hyperreactivity.
In order to demonstrate the involvement of prostaglandins in asthma, 
several investigators have measured plasma levels of PGE2 and PGF201 in 
asthmatic patients. Asthmatic patients in remission have higher levels 
of PGE2 than normal subjects, and their levels of PGF2& are elevated 
in serum, but not plasma (Allegra et al., 1976; Nemoto et al., 1976; 
Okazaki et al., 1976 and 1978). The plasma levels of these two prosta­
glandins do not change during exercise-induced bronchospasm in asthmatic
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p a t i e n t s  ( F i e l d  e t  a l . ,  1976).  However, plasma l e v e l s  o f  15-oxo-13,  
14-d ihydro  PGF2CI, th e  major  m e t a b o l i t e  o f  PGF201 i n  humans, a re  e l e v a t e d  
up to  e i g h t - f o l d  d u r ing  a l l e rg e n -p ro v o k e d  b r o n c h o c o n s t r i c t i o n  in  a s th m a t i c  
p a t i e n t s  (Green e t  a l . ,  1974).  Fu r therm ore ,  th e  i n c r e a s e s  in  th e  l e v e l s  
o f  th e  PGF20t m e t a b o l i t e  seemed t o  c o r r e l a t e  w i th  th e  s e v e r i t y  o f  the  b r o n ­
c h o c o n s t r i c t i o n ,  s u g g e s t in g  t h a t  PGF2CX, may c o n t r i b u t e  t o  a l l e r g e n - i n d u c e d  
asthma.
D i r e c t  ev idence  f o r  any th e o ry  i m p l i c a t i n g  p r o s t a g l a n d i n s  in  
asthma i s  l a c k in g .  I f  PGF201 or  any o t h e r  p r o s t a g l a n d i n  i s  a major 
m e d ia to r  i n  asthma, then  n o n - s t e r o i d a l  a n t i - i n f l a m m a to r y  drugs (NSAID), 
such as a s p i r i n  and indom ethac in ,  which i n h i b i t  p r o s t a g l a n d i n  s y n t h e s i s ,  
should  i n h i b i t  a s th m a t i c  b r o n c h o c o n s t r i c t i o n .  However, indomethac in  
does n o t  p r o t e c t  a s th m a t i c  p a t i e n t s  a g a i n s t  b r o n c h o c o n s t r i c t i o n  induced 
by e x e r c i s e  or  a n t ig e n  c h a l l e n g e  (Smith,  1975; Smith and Dunlop, 1975), 
s u g g e s t i n g  t h a t  p r o s t a g l a n d i n s  do n o t  a c t  as chemical  m e d ia to r s  in  asthma. 
On th e  o t h e r  hand,  Kordansky e t  a l . (1978) and S z c z e k l ik  e t  a l . (1978) 
s tu d i e d  s i n g l e  a s th m a t i c  p a t i e n t s ,  and concluded t h a t  NSAID may be 
b e n e f i c i a l  in  some p a t i e n t s .  Converse ly ,  i n g e s t i o n  o f  a s p i r i n  by some 
p a t i e n t s  may cause  b r o n c h o c o n s t r i c t i o n  (S e c t io n  1 . 5 . 4 ) .
S i m i l a r l y ,  a d m i n i s t r a t i o n  o f  i n h i b i t o r s  o f  p r o s t a g l a n d i n  s y n t h e s i s  
t o  g u in e a - p ig s  has  f a i l e d  t o  i n d i c a t e  any im por tan t  r o l e  f o r  p r o s t a g l a n ­
d in s  in  e x p e r im en ta l  a n a p h y la x i s .  I n c r e a s e d  amounts o f  p r o s t a g l a n d i n  
m e t a b o l i t e s  a re  e x c r e t e d  i n  th e  u r in e  by s e n s i t i z e d  g u in e a - p ig s  a f t e r  
a n t ig e n  c h a l l e n g e  (S t r an d b e rg  and Hamberg, 1974). P r i o r  t r e a t m e n t  
w i th  indomethac in  a b o l i s h e s  t h i s  r e s p o n s e ,  bu t  has no e f f e c t  on the  a i r ­
ways r e sp o n se  t o  t h e  a n t ig e n  (Michoud and Hogg, 1974; S t r a n d b e rg  and 
Hamberg, 1974).  These r e s u l t s  may i n d i c a t e  t h a t  th e  b r o n c h o c o n s t r i c t o r  
e f f e c t s  o f  r e l e a s e d  PGF20L, c y c l i c  endoperox ides  and thromboxanes a re  
ba lanced  by th e  i n h i b i t o r y  e f f e c t s  o f  r e l e a s e d  PGE2 . On th e  o t h e r  hand,  
sodium m eclo fenam ate , a n o th e r  i n h i b i t o r  o f  p r o s t a g l a n d i n  s y n t h e s i s ,
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potentiates the bronchoconstrictor response to submaximal doses of 
antigen (Miller and Robson, 1976), suggesting that the bronchodilator 
activity of PGE2 normally predominates. Furthermore, indomethacin 
potentiates antigen-induced bronchoconstriction in allergic monkeys 
(Patterson et al., 1978), but the mechanism of this action is not clear 
since arachidonic acid has a similar effect. Investigation of the effects 
of NSAID on allergic responses is complicated by the observation that 
such drugs enhance the synthesis of SRS-A (Walker, 1973; Engineer et al., 
1978b) .
Thus the role of prostaglandins in allergic asthma, if any, is 
unclear, and its investigation is made difficult by the diversity of 
effects of various prostaglandins, both on airways smooth muscle and on 
mediator release.
1.5.4 Aspirin-sensitive asthma
Among patients with bronchial asthma there is a group characteri­
zed by their intolerance of aspirin and other analgesics. Ingestion of 
aspirin by these patients is followed by severe bronchoconstriction.
The incidence of aspirin hypersensitivity in asthmatics may be as high 
as 16% (McDonald et al., 1972). These patients are also sensitive to 
other NSAID besides aspirin, such as indomethacin, amidopyrine and 
fenamates (Samter and Beers, 1968; Smith, 1971). The structural 
diversity of these compounds suggest that the reaction is not an allergic 
one, and this has been confirmed by extensive immunological studies 
(Giraldo et al., 1969) .
The discovery that aspirin and other NSAID inhibit the synthesis 
of prostaglandins (Vane, 1971; Flower et al., 1972) suggests that this 
action may be involved in aspirin-induced asthma (Szczeklik et al., 1975 
and 1977a). However, an attempt to show changes in plasma levels of 
prostaglandins after aspirin challenge of aspirin-sensitive patients was
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unsuccessful (Delaney et al., 1975). On the other hand, evidence for the 
involvement of inhibition of prostaglandin synthesis is the correlation 
between the potencies of a range of NSAID as prostaglandin synthesis 
inhibitors and their ability to induce bronchoconstriction in aspirin 
sensitive patients (Szczeklik et al., 1976 and 1977b). Furthermore, 
prostaglandin synthesis in nasal polyps from aspirin-sensitive patients 
has an increased susceptibility to the inhibitory action of aspirin 
(Szczeklik et al., 1977c).
Thus, inhibition of prostaglandin synthesis following ingestion 
of NSAID may be responsible for the bronchoconstriction observed in 
these patients, but the mechanism of the response is not clear. Aspirin- 
sensitive asthmatic patients may depend mainly on production of E 
prostaglandins to counteract the effects of endogenous bronchoconstrictors, 
whereas the (3-adrenergic system is more important in non-aspirin-sensitive 
asthmatics. Inhibition of prostaglandin synthesis in aspirin-sensitive 
patients would then allow unopposed bronchoconstriction by endogenous 
bronchoconstrictors (Szczeklik et al., 1975). An in vitro model of this 
possible mechanism is the indomethacin-induced potentiation of contractile 
responses of the guinea-pig trachea (Orehek et al., 1973; Chapter 7). 
Another possibility, however, is that removal of PGEs results in increased 
release of histamine and SRS-A, since PGEs are known to inhibit histamine 
release from sensitized human lung (Walker, 1973; Tauber et al., 1973). 
Plasma histamine levels increase after ingestion of aspirin by aspirin- 
sensitive patients (Arroyave et al., 1976; Stevenson et al., 1976), and 
the aspirin-induced bronchoconstriction can be blocked by disodium 
cromoglycate (Martelli and Usandivaras, 1977), an inhibitor of mediator 
release. These observations support the hypothesis that NSAID cause 
enhanced mediator release, usually inhibited by PGEs in aspirin-sensitive 
patients. Bronchial hyperreactivity in these patients (Szczeklik et al., 
1977d) would further augment the bronchoconstriction induced by increased
39
mediator release.
Thus, although evidence is lacking to support a role of prosta­
glandins in most types of asthma, it seems likely that aspirin-sensitive 
asthma involves an abnormality of prostaglandin metabolism.
1.6 Calcium metabolism of smooth muscle
It is generally accepted that the major determinant of the 
contractile state of smooth muscle, like that of skeletal muscle, is 
the cytoplasmic concentration of calcium ions (Hurwitz and Suria, 1971). 
An understanding of the regulation of smooth muscle function depends on 
information regarding calcium ion movements during contraction and 
relaxation. In skeletal muscle, the release of calcium ions into the 
cytoplasm during contraction and their uptake during relaxation are con­
trolled by the sarcoplasmic reticulum. However, sarcoplasmic reticulum 
in smooth muscle is less well developed than in skeletal muscle, and the 
T-tubule system, which initiates contraction in skeletal muscle, is 
absent in smooth muscle (Prosser, 1974), suggesting that alternative 
mechanisms of calcium regulation may operate in smooth muscle.
Contraction of smooth muscle can result from the mobilization of 
calcium ions into the cytoplasm from two different sources (Hurwitz,
1977). Evidence for this hypothesis is derived from experiments in 
which contractile responses to various pharmacological agents are compared 
in the absence and presence of calcium ions in the bathing medium. The 
omission of extracellular calcium ions generally results in diminished 
contractile responses (Hinke et al., 1964; Hudgins and Weiss, 1968), 
suggesting that influx of calcium ions from the extracellular space and 
release of calcium ions from intracellular storage sites may both contri­
bute to contraction. The relative contributions of these two sources of 
calcium may vary depending on the contractile agent used and the type 
of smooth muscle under investigation. For example, noradrenaline and
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serotonin contract vascular smooth muscle by releasing firmly bound 
calcium ions from intracellular stores, whilst the responses to 
potassium and histamine are more dependent on extracellular calcium 
(Hudgins and Weiss, 1968; Yamashita et al., 1977). In intestinal 
smooth muscle, histamine responses are inhibited more than acetylcholine 
responses by omission of calcium ions from the medium (Takayanagi et al., 
1977). The responses of venous and. intestinal smooth muscle to contrac­
tile stimuli are more dependent on extracellular calcium ions than 
arterial smooth muscle (Devine et al., 1972).
Smooth muscle relaxation is achieved by removal of calcium ions 
from the cytoplasm, but the nature of the subcellular structures 
responsible for this process have not been clearly established. Sar­
coplasmic reticulum has been identified in smooth muscle by electron 
microscopy but the amount varies widely between different smooth muscles 
(Devine et al., 1972). Subcellular fractionation of various types of 
smooth muscle produces microsomal fractions which accumulate calcium ions
o  *4" *in the presence of ATP and Mg (reviewed by Janis and Daniel, 1977).
Such studies indicate that sarcoplasmic reticulum may be responsible for 
calcium uptake during smooth muscle relaxation. However, in some smooth 
muscles, the plasma membrane may be more important than intracellular 
membranes in regulating cytoplasmic calcium ion concentrations (Hurwitz 
et al., 1973; Uchida, 1976; Wuytack et al., 1978). Mitochondrial 
calcium uptake has also been implicated in relaxation of uterine (Batra, 
1973; Janis et al., 1977) and vascular smooth muscle (Vallieres et al., 
1975) .
Thus smooth muscle contraction results from an increased cytoplas­
mic ion concentration of calcium ions derived from both intracellular and 
extracellular sources, and relaxation is achieved by calcium uptake by
various subcellular structures. The contributions of different calcium
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pools and the involvement of the various calcium sequestering organelles 
varies between different types of smooth muscle. The interaction of 
calcium ions with contractile proteins in smooth muscle is similar to 
that of skeletal muscle (Sparrow and van Bockxmeer, 1972), although it has 
been suggested that myosin itself, rather than troponin, is the calcium 
sensing mechanism (Mrwa and Ruegg, 1975) .
1.6.1 Calcium metabolism in airways smooth muscle
Most investigations of smooth muscle calcium metabolism have used 
vascular, uterine or intestinal smooth muscle, with very little attention 
being paid to airways smooth muscle. However, Kirkpatrick et al.
(1975) and Farley and Miles (1978) have studied the calcium dependence 
of drug-induced contractions of bovine and canine tracheal smooth muscles 
respectively.
In bovine tracheal smooth muscle, potassium-induced responses 
were completely abolished by removal of extracellular calcium, whilst 
contractions induced by acetylcholine or histamine were considerably but 
not completely reduced. Acetylcholine responses were less dependent on 
extracellular calcium than contractions induced by histamine. Thus 
bovine tracheal smooth muscle contraction in response to histamine and 
acetylcholine is largely dependent on influx of calcium ions across the 
plasma membrane, but also involves release from intracellular storage 
sites (Kirkpatrick et al., 1975). On the other hand, contraction in 
response to depolarizing solutions of potassium depends solely on extra­
cellular calcium ions. However, in these experiments the muscle was 
treated with the calcium-chelating agent EGTA, which may deplete calcium 
stores associated with the plasma membrane, as well as lowering the extra­
cellular calcium ion concentration. Calcium ions bound to the plasma 
membrane may therefore also contribute to both potassium- and drug-induced 
contractions of bovine tracheal smooth muscle.
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In canine tracheal smooth muscle, only the calcium dependence 
of acetylcholine-induced contractions has been studied (Farley and 
Miles, 1978). In the absence of extracellular calcium, contractions 
became diminished with time as calcium ions were removed from two 
distinguishable sites. The contributions of these two calcium pools to 
acetylcholine-induced contractions depended on the dose of the drug: at
low acetylcholine concentrations, the contractile response involved an 
influx of loosely bound calcium ions associated with membrane depolariza­
tion, whilst at higher drug doses depolarization-independent release of 
tightly bound calcium ions was more important.
Active calcium uptake by microsomes of bovine tracheal muscle 
has been demonstrated, and is similar to that observed in microsomes 
from vascular and intestinal smooth muscles (Sands et al., 1977).
However, no other information is available regarding the nature of 
intracellular structures which may contribute to calcium accumulation 
during relaxation, and which are involved in calcium ion release during 
contraction of airways smooth muscle.
1.7 Cyclic nucleotide metabolism of smooth muscle 
1.7.1 Cyclic AMP
The observation that adrenaline stimulates the formation of cyclic 
AMP in a variety of tissues (Rail and Sutherland, 1958) led to the 
suggestion that the actions of catecholamines, including smooth muscle 
relaxation, are mediated by increased intracellular levels of cyclic AMP 
(Sutherland and Rail, 1960). The first evidence for this hypothesis 
in smooth muscle was the demonstration that the relaxant action of 
adrenaline on uterine and intestinal smooth muscle is associated with an 
increased content of cyclic AMP (Butcher et al., 1965; Bueding et al., 
1966). Later studies showed that the cyclic AMP response to catechola­
mines involved ß-adrenergic receptors, and resulted from activation of
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adenylate cyclase (Figure 1.2) (Dobbs and Robison, 1968; Triner et al., 
1970).
Other smooth muscle relaxing drugs, such as papaverine and theo­
phylline, inhibit cyclic nucleotide phosphodiesterase (Figure 1.2), 
leading to increased intracellular levels of cyclic AMP (Kukovetz and 
Pöch, 1970). Furthermore, these drugs potentiate both the relaxant and 
cyclic AMP stimulating effects of 3-adrenergic agents (Dobbs and Robison, 
1968). The elevation of cyclic AMP levels produced by both 3-adrenergic 
stimulants and phosphodiesterase inhibitors precedes their relaxant 
effects (Andersson, 1972b; Pöch and Kukovetz, 1972), and the increase in 
cyclic AMP is correlated with the magnitude of relaxation (Triner et al., 
1971; Andersson et al., 1972b). These results support the concept of 
cyclic AMP-mediated relaxation of smooth muscle by these drugs.
Further evidence for a role of cyclic AMP in smooth muscle 
relaxation comes from studies in which cyclic AMP or its dibutyryl 
derivative have been shown to relax various smooth muscle preparations 
(reviewed by Bär, 1974). The greater effectiveness of dibutyryl cyclic 
AMP has been attributed to its easier passage through biological membranes 
to an intracellular site of action, and its resistance to inactivation by 
phosphodiesterase (Posternak et al., 1962).
Thus, smooth muscle relaxation by various drugs is associated with 
elevated cyclic AMP levels, and there is evidence that this cyclic AMP 
response mediates the relaxant effects of these drugs. This does not 
imply that all smooth muscle relaxants act by this mechanism. Drugs 
such as verapamil relax smooth muscles without affecting phosphodiester­
ase or cyclic AMP levels (Pöch and Umfahrer, 1976) . Rather, their 
effects are mediated by direct antagonism of calcium metabolism (Section 
1.6). Also, relaxation of intestinal smooth muscle mediated by 
a-adrenoceptors is associated with a decrease in the cyclic AMP level
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of the muscle (Andersson, 1972) . Even ß-adrenergic relaxation of smooth 
muscle may have a component which is independent of any action on cyclic 
AMP metabolism (Overweg and Schiff, 1978) .
The mechanism of cyclic AMP-mediated relaxation is postulated to 
be stimulation of calcium ion uptake by intracellular organelles 
(Andersson and Nilsson, 1972). Evidence for this theory is that cyclic 
AMP enhances calcium uptake by microsomal fractions of'intestinal smooth 
muscle (Andersson and Nilsson, 1972 and 1977). In aortic microsomes a 
similar effect is observed, and involves a cyclic AMP-dependent protein 
kinase (Fitzpatrick and Szentivanyi, 1977), suggesting that regulation 
of calcium uptake by cyclic AMP depends on phosphorylation of membrane 
proteins. Another possible mechanism of cyclic AMP-mediated relaxation 
is hyperpolarization of the plasma membrane of the smooth muscle cell 
(Somlyo et al., 1970; Kroeger and Marshall, 1973). This effect may be 
related to altered calcium transport or binding by the plasma membrane 
(Andersson and Nilsson, 1977) .
The theory of cyclic AMP-mediated smooth muscle relaxation led to 
the corollary hypothesis that smooth muscle contraction is mediated by a 
reduced intracellular concentration of cyclic AMP (Andersson et al.,
1975) . Although cyclic AMP levels are decreased in association with 
drug-induced contraction of some smooth muscles (Volicer and Hynie, 1971; 
Andersson, 1973a, b) such effects are not generally observed, and their 
significance has been questioned (Andersson and Nilsson, 1977) .
Elevation of cyclic AMP levels during contraction of various 
smooth muscles has also been reported (Vesin and Harbon, 1974;
Andersson et al., 1975; Diamond, 1977), and such effects suggest that 
the theory of cyclic AMP-mediated relaxation may be inadequate. Diamond 
(1977) completely rejects the theory on these grounds, whilst other 
authors have postulated that compartmentalization of cyclic AMP within
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the cell could explain the paradoxical increases in cyclic AMP levels 
during contraction (Vesin and Harbon, 1972). However, a more likely 
explanation is that the effect represents a negative feedback mechanism 
limiting the contractile effect of the drug-induced increase of cytoplas­
mic calcium ion concentration, and possibly mediated by local prostaglan­
din release (Andersson and Nilsson, 1977).
1.7.2 Cyclic GMP
Cyclic GMP has also been proposed to have a role in the regulation 
of smooth muscle tone. Evidence for such a role is the observation that 
cholinergic agents elevate cyclic GMP levels in the vas deferens of the 
rat (Schultz et al., 1972). This effect is inhibited by atropine, and 
is dependent on the presence of extracellular calcium ions (Schultz 
et al., 1973). Other contractile agents also increase cyclic GMP 
levels in a variety of smooth muscles (reviewed by Goldberg et al.,
1975). These observations led to the hypothesis that cyclic GMP is 
involved in smooth muscle contraction (Goldberg et al., 1973). , However,
the dependence of cyclic GMP accumulation on calcium ions, and the 
observation that the contractile response usually precedes any increase 
in cyclic GMP levels (Andersson et al., 1975; Diamond and Hartle, 1976), 
suggest that the effect of contractile agents on cyclic GMP metabolism 
is a consequence of raised cytoplasmic calcium ion concentration, rather 
than its cause. Indeed, guanylate cyclase activity in cell-free prepara- 
tions is increased by high concentrations of Ca , but unaffected by 
cholinergic agents (Nilsson and Andersson, 1977).
Although it is evident that an elevation of cyclic GMP levels is 
not involved in the initiation of contractile responses, other roles 
for cyclic GMP are possible. The nucleotide may act as a positive feed­
back mechanism, promoting contraction by enhancing calcium ion release 
from intracellular stores (Andersson e t a l ., 1975; Nilsson and Andersson,
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1977). However, elevation of cyclic GMP levels during relaxation of 
smooth muscles by some agents (Diamond and Blisard, 1976; Schultz et al., 
1977) argues against this hypothesis, and favours the opposite proposal - 
that cyclic GMP acts as a negative feedback inhibitor of calcium ion 
influx (Schultz et al., 1977). This concept has also been rejected by 
Diamond and Janis (1978) , who found no correlation between the effects 
of smooth muscle relaxant drugs on tension and on cyclic GMP content.
Thus, the role of cyclic GMP in smooth muscle function, if any, 
remains obscure.
1.7.3 Cyclic AMP metabolism in airways smooth muscle
The general concept of cyclic AMP-dependent regulation of smooth 
muscle tone (Section 1.7.1) has important implications for the control 
of airways smooth muscle (Figure 1.2). A defect in such a regulatory 
mechanism could explain the underlying bronchial hyperreactivity in 
asthma. The ß-adrenergic blockade theory (Section 1.3.2) is one example.
Several in vitro studies have reported various aspects of cyclic 
nucleotide metabolism of airways smooth muscle in a variety of species. 
These include the effects of ß-adrenergic agents, prostaglandins, 
phosphodiesterase inhibitors and bronchoconstrictor agents.
1.7.3.1 Adrenergic agents
Catecholamines (adrenaline, noradrenaline, isoprenaline) increase 
the levels of cyclic AMP in various airways smooth muscle preparations, 
such as bovine trachea (Katsuki and Murad, 1977; Lohmann et al.,
1977; Andersson et al., 1978a), canine bronchus (Vulliemoz et al., 1975; 
Triner et al., 1977), and guinea-pig trachea (Murad, 1973a; Murad and 
Kimura, 1974; Ohkubo et al., 1976; Wong and Buckner, 1978). The dose- 
response relationships and time-courses of these effects parallel those 
for catecholamine-induced relaxation of the airways smooth muscle (Lau
47
histamine
acetylcholine
contraction
Ca2+ influx/release
Ca2* efflux/uptake
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ladenylate cyclase
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FIGURE 1.2 Regulation of  airways smooth muscle
Contraction induced by bronchoconstrictor  agents (h istam ine, a c e ty lc h o l in e ,  
prostag landin  F2 0Q in v o lv es  e le v a t io n  o f  cytoplasm ic calcium ion  
co n c e n tr a t io n s .  Calcium ions may enter the cytoplasm across the  plasma 
membrane or may be r e le a sed  from in t r a c e l lu la r  s to r e s .  Relaxation of  
the muscle by ß-adrenergic agents (adren a line , isop ren a lin e )  or by 
E prostag land ins  invo lves  s t im u la t ion  o f  adenylate  c y c la se  and in t r a ­
c e l l u la r  accumulation of  c y c l i c  AMP. In h ib i t io n  o f  phosphodiesterase  
by th e o p h y l l in e  a l so  in crea ses  c y c l i c  AMP l e v e l s .  C yclic  AMP a c c e le r a te s  
the removal o f  calcium ions from the cytoplasm, thereby re la x in g  the  
m uscle.
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and Lum, 1977). Also, the rank order of potency of three catecholamines 
is the same for their ability to increase cyclic AMP levels and to relax 
bronchial smooth muscle (isoprenaline > adrenaline > noradrenaline;
Triner et al., 1977). Furthermore, both effects of the catecholamines 
are antagonized by propranolol (Lohmann et al., 1977; Katsuki and Murad, 
1977; Triner et al., 1977). These observations all support the hypo­
thesis that relaxation of airways smooth muscle by catecholamines is 
mediated by increased levels of cyclic AMP.
Although most of the evidence favours this hypothesis, Kolbeck 
et al. (1978) failed to find any effect of isoprenaline on cyclic AMP 
levels in guinea-pig tracheal rings. The isoprenaline concentration 
(10 9 M) was lower than that used in other studies, but still sufficient 
to cause relaxation of tracheal muscle (Douglas et al., 1977). Wong 
and Buckner (1978) also noted a large difference in isoprenaline concen­
trations required to relax guinea-pig tracheal smooth muscle on the one 
hand and to increase cyclic AMP levels on the other, but explained this 
discrepancy on the basis of a large receptor reserve for ß-agonists.
The above studies which did demonstrate catecholamine-induced 
increases in cyclic AMP also showed that these effects are blocked by 
the beta-adrenergic blocker propranolol, but not by alpha-adrenergic 
antagonists, indicating that the cyclic AMP response results from 
stimulation of ß-adrenoceptors. Furthermore, Murad (1973a) found that 
practolol, a selective ßi-antagonist had only a slight inhibitory 
effect on adrenaline-induced increases in cyclic AMP levels in guinea- 
pig trachea, whereas it was equally as effective as propranolol in cardiac 
muscle. This observation supports the previous’ subclassification of 
ß-adrenoceptors into ßi-(heart) and ß2-(trachea) types (see Section 1.3.1).
Besides the catecholamines, non-catechol adrenergic agonists also 
affect cyclic AMP in airways smooth muscle. The selective ß2-adrenergic 
agents, albuterol and terbutaline increase cyclic AMP levels in canine
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bronchial smooth muscle, but the maximum response is less than the effect 
of isoprenaline (Vulliemoz et al., 1975). Inamasu et al. (1974) found 
that another synthetic 3-adrenergic bronchodilator, trimetoquinol, 
increased cyclic AMP levels in guinea-pig tracheal smooth muscle to the 
same extent as isoprenaline, and showed that this effect preceded 
relaxation of the muscle by the drug. On the other hand, Lau and Lum 
(1977) suggested that salbutamol had no effect on cyclic AMP levels at 
concentrations which induced relaxation of bovine tracheal muscle.
1.7.3.2 Phosphodiesterase inhibitors
Theophylline and papaverine are well known smooth muscle relaxants, 
whose mode of action involves inhibition of the enzyme, cyclic nucleotide 
phosphodiesterase. These agents also relax airways smooth muscle, and 
are widely used as bronchodilators in the treatment of asthma. They 
increase cyclic AMP levels in bovine tracheal muscle (Katsuki and Murad, 
1977), guinea-pig tracheal rings (Murad and Kimura, 1974) and guinea-pig 
tracheal muscle (Ohkubo et al., 1976). On the other hand, Lohmann et al. 
(1977) were unable to show any increase of cyclic AMP levels in bovine 
tracheal muscle in response to theophylline. Theophylline did, however, 
potentiate the isoprenaline-induced increase in cyclic AMP levels. 
Synergism between theophylline and 3-adrenergic agents has also been 
shown in guinea-pig airways smooth muscle (Lefcoe et al., 1975;
Frandsen et al., 1978). This phenomenon reflects the potentiation by 
theophylline of the bronchodilation produced by 3-adrenergic agents both 
in vitro and in vivo (Bertelli et al., 1973), and results from the 
different modes of action of the two types of drug (adenylate cyclase 
stimulation by 3-agonists and inhibition of phosphodiesterase by 
theophylline) .
Cyclic AMP phosphodiesterase activity in airways smooth muscle 
results from two enzymes, with different affinities for cyclic AMP
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(Triner et al., 1977; Newman et al., 1978), as it does in a variety 
of other tissues (Appleman et al., 1973). Theophylline and papaverine 
competitively inhibit the high affinity form of the enzyme from dog 
bronchus, and the relative potencies of the two drugs in inhibiting the 
enzyme and relaxing the muscle are comparable (Triner et al., 1977). 
Similarly, good correlation has been shown in two larger series of 
phosphodiesterase inhibitors between their activities as inhibitors of 
phosphodiesterase and as tracheal smooth muscle relaxants (Newman et al., 
1978; Poison et al., 1978), supporting the hypothesis that inhibition of 
phosphodiesterase leads to bronchodilation. However, drug concentrations 
necessary for inhibition of phosphodiesterase are usually higher than 
those required for smooth muscle relaxation, suggesting that these drugs 
may have other actions besides inhibition of phosphodiesterase. Indeed, 
Kolbeck et al. (1977)were unable to show any effect of therapeutic 
concentrations of theophylline (an order of magnitude lower than other 
studies) on cyclic AMP levels in guinea-pig tracheal rings, and suggested 
that the relaxant action of theophylline resulted from a direct effect on 
calcium ion metabolism.
/
1.7.3.3 Prostaglandins
Prostaglandins of the E series relax airways smooth muscle 
(Section 1.5.2), and it has been suggested that their mechanism of 
action is by stimulation of adenylate cyclase (Fanburg, 1973). PGEi, 
which relaxes guinea-pig tracheal smooth muscle(Main, 1964), increases 
cyclic AMP levels in the same tissue (Murad and Kimura, 1974) . The 
maximum stimulatory effect of PGEi on cyclic AMP accumulation is greater 
than that of adrenaline, but not additive to it. Propranolol has no 
effect on the PGEi-induced increase in cyclic AMP levels, indicating that 
the prostaglandin is acting at a receptor site distinct from the 
B-adrenergic receptor. PGF20t does not affect cyclic AMP levels in guinea-
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pig tracheal rings (Murad and Kimura, 1974) , consistent with its 
bronchoconstrictor effect opposite to that of PGEi (see Section 1.5.2).
In bovine tracheal muscle PGEi has only a slight stimulatory effect on 
cyclic AMP accumulation, and fails to relax smooth muscle tone (Katsuki 
and Murad, 1977).
1.7.3.4 Other bronchodilators
Adrenocorticotrophic hormone (ACTH) has an in vitro relaxing 
effect on human bronchial muscle (Svedmyr et al., 1970), and Andersson 
et al. (1972a) showed that this effect is accompanied by an increase in 
cyclic AMP. However, no similar response to ACTH is observed in guinea- 
pig trachea (Murad and Kimura, 1974). Vasoactive intestinal polypeptide 
(VIP) has a bronchodilator action on the guinea-pig trachea (Said et al., 
1974), and this effect is also associated with a slight increase in 
cyclic AMP which is potentiated by theophylline (Frandsen et al., 1978). 
The effects of VIP, but not of ACTH, are independent of ß-adrenoceptors.
f •
Hydrocortisone relaxes isolated human bronchial, and bovine and 
guinea-pig tracheal smooth muscles, and also increases the cyclic AMP 
concentration in the muscle (Andersson and Kövesi, 1974). Furthermore, 
both the relaxation and the accumulation of cyclic AMP induced by 
isoprenaline are enhanced by pretreatment with hydrocortisone (Andersson 
and Kövesi, 1974).
Halothane and similar anaesthetics have bronchodilating properties 
in vivo (Shnider and Papper, 1961). In vitro, these agents relax rat 
trachea and concomitantly increase the rate of cyclic AMP formation 
(Triner et al., 1975). Neither effect is affected by propranolol, 
suggesting a direct stimulation of adenylate cyclase.
These observations, with a few exceptions, all support the concept 
that relaxation of airways smooth muscle by a variety of bronchodilators 
is mediated by an increase in the intracellular concentration of cyclic
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AMP. Such an increase may be effected either by stimulation of 
adenylate cyclase by $-adrenergic and other receptors, or by inhibition 
of cyclic AMP hydrolysis by phosphodiesterase.
1.7.3.5 Bronchoconstrictors
Although the above discussion has indicated the association 
between bronchodilation and cyclic AMP accumulation, bronchoconstriction 
may also be accompanied by increases in cyclic AMP levels. For example, 
acetylcholine and carbachol increase the levels of cyclic AMP in guinea- 
pig trachea (Murad and Kimura, 1974; Wong and Buckner, 1978). These 
effects are prevented by both atropine and propranolol, suggesting the 
involvement of catecholamines released by acetylcholine (Murad and 
Kimura, 1974). The cyclic AMP response to acetylcholine is also 
dependent on the presence of extracellular calcium ions (Wong and 
Buckner, 1978). Similar results have been obtained in intestinal smooth 
muscle (Andersson et al., 1972), which suggested that cyclic AMP levels 
are regulated by intracellular calcium ions which have an inhibitory 
effect on phosphodiesterase. Thus, increased myoplasmic Ca in response 
to acetylcholine inhibits phosphodiesterase and increases cyclic AMP 
levels. An alternative explanation may be that the contractile 
response per se is responsible for release of agents (catecholamines, 
prostaglandins) which stimulate adenylate cyclase.
One early report suggested that histamine had no effect on cyclic 
AMP levels in guinea-pig tracheal rings (Murad, 1973b). However, it 
was later shown that over a shorter incubation time, two minutes rather 
than six, high concentrations of histamine do increase cyclic AMP 
accumulation (Murad and Kimura, 1974). This effect is inhibited by the 
histamine Hi-antagonist diphenhydramine and also by atropine (Murad and 
Kimura, 1974), suggesting the involvement of histamine-induced release 
of acetylcholine. The released acetylcholine presumably, in turn,
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releases catecholamines which act to increase cyclic AMP levels. However, 
the effect of propranolol on histamine-induced cyclic AMP accumulation 
was not investigated.
Stimulation of adenylate cyclase by histamine and histamine- 
induced increases in cyclic AMP levels have also been described in other 
tissues, including brain (Hegstrand et al., 1976), heart (Reinhardt 
et al. , 1977), gastric mucosa (Dousa and Code, 1974) and lymphocytes 
(Bourne et al., 1971). These effects are mediated by histamine H2- 
receptors and direct stimulation of adenylate cyclase. The possible 
involvement of histamine H2-receptors in histamine-induced cyclic AMP 
accumulation in airways smooth muscle has not been investigated.
In bovine tracheal muscle, in addition to acetylcholine and 
histamine, high concentrations of potassium ions, which contract the 
muscle, also increase cyclic AMP levels (Katsuki and Murad, 1977) .
Other bronchoconstricting agents (PGF201, calcium ionophore A23187 
and serotonin) appear to have no effect on cyclic AMP levels in airways 
smooth muscle (Murad and Kimura, 1974; Katsuki and Murad, 1977) .
Cyclic AMP accumulation in response to contractile agents such 
as acetylcholine and histamine is not consistent with the concept of 
cyclic AMP-mediated relaxation of airways smooth muscle. However, the 
phenomenon may represent a negative feedback control mechanism regulating 
the contractile responses to these agents.
1.7.4 Cyclic GMP metabolism in airways smooth muscle
As in other types of smooth muscle, choline esters (acetylcholine, 
carbachol) increase the cyclic GMP content of guinea-pig tracheal rings 
(Murad and Kimura, 1974), and this effect is prevented by atropine. 
Histamine also elevates cyclic GMP levels in the same preparation, but 
this effect is blocked by atropine, suggesting that it is secondary to 
histamine-induced acetylcholine release (Murad, 1974). In bovine
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tracheal smooth muscle cyclic GMP levels are raised by acetylcholine, 
histamine, serotonin, calcium ionophore A23187 and depolarizing potassium 
solutions (Katsuki and Murad, 1977; Lohmann et al., 1977). These 
increases are dependent on extracellular calcium, and are preceded by 
contraction (Katsuki and Murad, 1977), indicating that they probably
r\ -f*result from Ca -induced activation of guanylate cyclase. These 
results accord with the generalization derived from studies of other 
types of smooth muscle (Section 1.7.2) that contraction is associated 
with increased levels of cyclic GMP. However, PGF201, which contracts 
guinea-pig tracheal smooth muscle, has no effect on cyclic GMP levels 
(Murad and Kimura, 1974) .
Cyclic GMP levels of bovine or guinea-pig tracheal tissue are not 
affected by ß-adrenergic agents or by prostaglandin Ei, but theophylline 
and other inhibitors of cyclic nucleotide phosphodiesterase stimulate 
accumulation of both cyclic nucleotides (Murad and Kimura, 1974;
Katsuki and Murad, 1977). The effect of phosphodiesterase inhibitors is 
somewhat greater on cyclic GMP levels (3- to 4-fold increase) than on 
cyclic AMP levels. The inhibitory effects of these agents on hydrolysis 
of cyclic GMP has been demonstrated in homogenates of canine tracheal 
muscle (Poison et al., 1978) .
Another group of smooth muscle relaxants also increases the cyclic 
GMP content of tracheal smooth muscle, but has no effect on cyclic AMP 
(Katsuki and Murad, 1977). These agents include sodium azide, hydroxyla- 
mine, nitroglycerin and sodium nitroprusside, which stimulate guanylate 
cyclase (Kimura et al., 1975). The effects of these agents on cyclic 
GMP levels are potentiated by theophylline, and are not dependent on 
extracellular calcium.
Thus levels of cyclic GMP in airways smooth muscle usually increase 
in association with contractile stimuli, but are also elevated during 
relaxation by some agents. The role of cyclic GMP in the control of
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airways smooth muscle, as in other types of smooth muscle, therefore 
remains obscure.
1.8 Summary
Various interrelated factors involved in the control of airways 
smooth muscle have been described. Neuronal regulation of the airways 
involves both the parasympathetic and the sympathetic nervous systems, 
which mediate bronchoconstriction and bronchodilation respectively. 
Airways smooth muscle tone is also affected by circulating catechola­
mines, chemical mediators released during allergic reactions, and 
probably by prostaglandins. At the intracellular level, smooth muscle 
contraction involves an elevation of cytoplasmic calcium ion concentra­
tion, and relaxation is achieved by removal of calcium ions, a process 
which is stimulated by intracellular accumulation of cyclic AMP.
Bronchial hyperreactivity, a characteristic feature of human 
asthma, may involve a defect in one or more of these control mechanisms. 
Possible explanations include enhancement of mediator release, partial 
(3-adrenergic blockade, increased sensitivity of irritant receptors 
associated with parasympathetic reflex bronchoconstriction, and an 
abnormality of prostaglandin metabolism. It is also possible that a 
defect in the movements of calcium ions or the metabolism of cyclic 
nucleotides in airways smooth muscle cells could be involved in bronchial 
hyperreactivity. More precise identification of the abnormality under­
lying bronchial hyperreactivity depends on a better understanding of the 
normal control of airways smooth muscle.
1.9 Aims of the project
Some aspects of airways smooth muscle may be investigated using 
in vitro preparations of guinea-pig tracheal smooth muscle. These 
include the effects of neurotransmitters (acetylcholine, noradrenaline),
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chemical mediators (histamine and SRS-A) and prostaglandins on the 
contractile state of the tracheal smooth muscle, and their modification 
by drugs commonly used in the therapy of bronchial asthma. Biochemical 
regulation of airways smooth muscle (calcium and cyclic nucleotide 
metabolism) can also be studied in the guinea-pig trachea. Although 
the lung is the primary shock organ in allergic reactions in vivo, 
mediator release and anaphylactic contraction of airways smooth muscle 
can also be conveniently investigated in vitro using sensitized guinea- 
pig tracheal preparations (Sorenby, 1975) .
Guinea-pig tracheal smooth muscle may also serve to study possible 
mechanisms of bronchial hyperreactivity in vitro. Pharamacological 
modification of specific regulatory mechanisms, such as prostaglandin 
synthesis or cyclic AMP metabolism, alters the pattern of responsive­
ness to bronchoconstrictor agents, and can provide in vitro models of 
bronchial hyperreactivity.
Thus, the broad basis of this project is an investigation of those 
aspects of the control of airways smooth muscle which may be studied 
in vitro using isolated guinea-pig tracheal smooth muscle. These 
include:
(a) Calcium metabolism, in particular the relative contributions 
of intracellular and extracellular calcium ion sources to the contrac­
tions elicited by various agents.
(b) Cyclic AMP metabolism, and the paradoxical increases in 
cyclic AMP levels in response to contractile stimuli.
(c) Release of prostaglandins during contraction, and their 
role as modulators of the contractile response.
Furthermore, the effects of modifying these regulatory mechanisms 
(e.g. activation of cyclic nucleotide phosphodiesterase, inhibition of 
prostaglandin synthesis) on the responsiveness of the tracheal smooth
r>/
muscle to contractile stimuli will be investigated in order to determine 
whether such modifications mimic bronchial hyperreactivity.
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CHAPTER 2
MATERIALS AND METHODS
2.1 Preparation of guinea-pig tracheal strips
Guinea-pigs of either sex and weighing between 600 and 1000 grams 
were stunned and bled. The trachea was removed and placed in ice-cold 
modified Ringer solution (121 mM NaCl, 5.4 mM KC1, 1.2 mM MgS04.7H20,
1.2 mM NaH2P04.2H20, 15 mM NaHC03, 11.5 mM d-glucose, 2.5 mM CaCl2.2H20; 
pH 7.4) bubbled with 95%02/5%C02. The trachea was dissected free of 
surrounding tissue, and cut into rings of about 3 mm length. Eight 
rings were usually obtained from each trachea. Each ring was opened
by a longitudinal cut on the ventral side, opposite the smooth muscle 
layer, producing a strip with a central region of smooth muscle attached 
to cartilage at either end (Figure 2.1). These cartilaginous ends were 
tied to metal rings, and the preparation suspended in an organ bath with 
25 ml of the modified Ringer solution. One end of the strip was fixed 
to a glass hook, and the other to a force transducer (Watson Victor).
The isometric tension of the smooth muscle preparation was recorded 
after amplification (San-Ei 6M52 strain amplifier). The preparation 
was allowed to equilibrate for 60 minutes under a resting tension of 1.5 
to 2.0 grams.
2.2 Experimental procedures
After equilibration of the tracheal muscle strips for at least 60 
minutes, drugs were added to the organ bath in volumes of less than 
250 yl (1% of the volume of bathing medium) using Hamilton microsyringes. 
Inhibition or potentiation of contractile responses was determined by 
comparing control and drug-treated responses (in that order) on the 
same muscle strip, allowing 15 minutes and replacing the bathing medium 
twice between the two responses. It was not possible to repeat
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s m o o th  muscle
C - r in g s  of c a r t i l a g e
lu m e n
FIGURE 2.1 Method of  p r e p a r a t i o n  o f  g u i n e a - p ig  t r a c h e a l  smooth muscle  
s t r i p
The t r a c h e a  i s  a tube  about  25 mm long,  c o n s i s t i n g  o f  a framework of  
incomple te  r i n g s  (C - r ings )  o f  c a r t i l a g e  u n i t e d  by a f i b r o u s  membrane.
The smooth muscle i s  l o c a t e d  d o r s a l l y ,  ex tend ing  between t h e  ends of  
t h e  c a r t i l a g e .  The tube  was c u t  t r a n s v e r s e l y  (A) i n t o  e ig h t  r i n g s ,  each of  
which was t h e n  opened to  form a s t r i p  by a l o n g i t u d i n a l  c u t  (B) . The 
c a r t i l a g i n o u s  ends o f  t h e  s t r i p  were t i e d  t o  metal  r i n g s ,  one o f  which 
was t hen  a t t a c h e d  t o  a g l a s s  hook and th e  o t h e r  to  a f o r c e  t r a n s d u c e r .
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additions of some drugs, whose effects were not reversible by washing 
(e.g. mepyramine, indomethacin, A23187 and TMB-8). In some experiments, 
cumulative concentration-response curves for contractile agents were 
obtained as described by Van Rossum (1963). Investigation of the effects 
of the absence of extracellular calcium ions was done by incubating the 
tracheal preparations for 40 minutes in Mzero-calcium medium”, which was 
prepared by omitting CaCl2 from the usual modified Ringer solution.
2.3 Determination of intracellular cyclic AMP levels
Tracheae were removed as described above. Two longitudinal cuts 
yielded a single muscle strip from each trachea, about 25 mm in length, 
free of cartilage, and weighing 33.0 - 8.9 mg (mean ± S.D., n=156).
The experimental procedure is described in Figure 2.2. The 
isolated tracheal muscle strips were incubated at 37°C in 25 ml modified 
Ringer solution in Erlenmeyer flasks, bubbled with 95% 02/5% CO2 through 
Pasteur pipettes. After drug treatment, the strips were removed into 
ice-cold TCA and homogenized using an all glass homogeniser driven by an 
Anderman multispeed stirrer. The homogenates were transferred to 
Eppendorf tubes and centrifuged in an Eppendorf microfuge. Since 
approximately 20% of the protein precipitate remained in the homogeniser 
after transfer of the homogenate, the homogeniser was rinsed with alkali. 
The protein pellet after centrifugation was also resuspended in alkali 
and combined with the homogeniser washing for determination of protein 
(Section 2.4).
The supernatants were acidified and TCA was removed by ether 
extraction. After lyophilisation, the samples were redissolved (50 mM 
Tris/HCl, 4 mM EDTA, pH 7.5), and cyclic AMP was assayed using a kit 
(The Radiochemical Centre, Amersham) based on the competitive protein 
binding method (Gilman, 1970) . The samples were added to 10 ml of a 
liquid scintillant mixture (Bray, 1960) and counted in a Packard Tri-
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t r a c h e a l  muscle s t r i p
I
p r e i n c u b a t i o n  (90-120 minu tes ,  37 C) 
------------- drug a d d i t i o n
V
" T K'  ‘ ” 0homogenised (0.5ml co ld  5% TCA)
f
homogeniser r i n s e d homogenate c e n t r i f u g e d
(Eppendorf  mic ro fuge ,  8000g, 2 mins)
l
s u p e rn a t an t
p e l l e t
a c i d i f i e d  (50 pi  IN HC1)
p r o t e i n  s o l u t i o n
l
Lowry assay
l
e x t r a c t e d  (5 t imes wi th  3m 1 
water  s a t u r a t e d  d i e t h y l  e the r )
l y o p h i l i s e d
I
r e d i s s o lv e d  (150 p i  Tris/EGTA)
l
Gilman c y c l i c  AMP assay
F igure  2.2 Experimental  p rocedure  used in  the  d e te r m in a t io n  of
c y c l i c  AMP l e v e l s  in gu inea -p ig  t r a c h e a l  smooth muscle .
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Carb Liquid Scintillation Spectrometer. Results were expressed as 
pmoles cAMP/mg protein.
2.4 Determination of protein
50 yl of the combined wash/pellet protein samples were assayed by 
the method of Lowry et al. (1951) . Bovine serum albumin was used to 
construct a two point log-log standard curve (Peterson, 1977). The 
protein content of the tracheal muscle strips used in the determination 
of cyclic AMP levels was 2.20 - 0.59 mg, equivalent to 6.6 - 1.1% of the 
wet weight (means - S.D. of 156 muscle strips).
2.5 Active sensitization of guinea-pigs
Male guinea-pigs weighing about 700 grams were injected intraperi- 
toneally with 0.1 ml of a sterile solution of ovalbumin (50 mg/ml).
These animals were killed after 20 to 28 days, and tracheal muscle 
strips prepared as described in Section 2.1. These preparations 
responded to the addition of ovalbumin in vitro (see Section 3.3).
2.6 Analysis of data
Unless otherwise stated, results were expressed as means - 
standard errors of mean (S.E.M.), and compared using the Student's t-test. 
In experiments where control and drug-pretreated responses were obtained 
on the same preparation, a paired t-test was used. Analysis of variance 
was used to examine the variation of contractile responses along the 
length of the trachea.
Cumulative-concentration response data were used to calculate pÖ2 
and EC50 values. The pÖ2 value is defined as the negative logarithm of 
EC5 0, the concentration producing 50% of the maximal response. Concentra­
tion-response curves were assumed to be linear between 25 and 75% of 
the maximum response (Van Rossum, 1963). Standard deviation of drug- 
induced changes of pÖ2 values were obtained from pooled variances.
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2.7 Materials
Acetylsalicyclic acid (aspirin), atropine sulphate, EGTA, 
histamine acid phosphate, indomethacin, isoprenaline hydrochloride, 
ovalbumin, propranolol hydrochloride and theophylline were obtained 
from Sigma Chemical Company. Acetylcholine chloride was from British 
Drug Houses, mepyramine maleate from May and Baker, and imidazole 
from Fluka. Prostaglandins Ei and F 201 were the generous gift of Dr.
J. Pike, Upjohn Company, and A23187 was kindly supplied by Eli Lilly 
Research Laboratories. TMB-8 was synthesized by Dr. D.J. Brown, Medical 
Chemistry Unit, John Curtin School of Medical Research, Canberra, 
Australia, by the method of Malagodi and Chiou (1974a).
Indomethacin was prepared as a stock solution of 10 mM in ethanol. 
Prostaglandins Ei and F201 were prepared as stock solutions of 10 mg/ml 
in ethanol. A23187 was prepared as a stock solution of either 0.1 M 
in dimethyl sulphoxide, or 1.45 mM in 75% ethanol/0.7 mM CaCl2 . All 
other drugs were dissolved in distilled water, and added in volumes of
less than 250 yl.
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CHAPTER 3
CHARACTERIZATION OF GUINEA-PIG TRACHEAL STRIPS 
3.1 Introduction
Isolated preparations of guinea-pig trachea have been widely used 
to study contractile responses of airways smooth muscle and for in vitro 
testing of bronchodilator drugs. The reason for this ‘is that, from a 
pharmacological viewpoint, guinea-pig tracheal smooth muscle resembles 
human bronchial muscle more closely than that of any other species. 
Histamine, which may have an important role in the pathogenesis of asthma 
(Section 1.2.4) contracts both guinea-pig tracheal and human bronchial 
muscles, whereas tracheae of rats, cats and rabbits are insensitive to 
this agent (Ak^asu, 1959). Guinea-pig trachea and human bronchus also 
respond similarly to SRS-A (Section 1.2.2.2), adrenergic agents (Section 
1.3.1), phosphodiesterase inhibitors (Section 1.7.3.2), various 
prostaglandins (Section 1.5.2) and choline esters. Although canine 
bronchial smooth muscle is also similar in many respects to human 
airways smooth muscle, it fails to contract in response to prostaglandin 
F2ot (Krell, 1978). Thus, preparations of guinea-pig trachea serve as 
the most useful in vitro models of human bronchial smooth muscle for 
the study of bronchoconstrictor agents and bronchodilator drugs.
Anaphylactic contractions of airways smooth muscle can be observed 
in isolated tracheal preparations from guinea-pigs sensitized to foreign 
proteins such as ovalbumin or BSA (Castillo, 1948; Alonso-deFlorida and 
Cordoba, 1965; Sorenby, 1975; Adams and Lichtenstein, 1977; Lulich and 
Paterson, 1978). Antigen-induced contraction of guinea-pig tracheal 
muscle involves the release of histamine and SRS-A from the tissue, 
which then act to contract the smooth muscle (Adams and Lichtenstein, 
1977). Thus mediator release and allergic bronchospasm can also be 
studied using isolated guinea-pig tracheal preparations.
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The first in vitro studies of guinea-pig airways smooth muscle 
function utilized preparations consisting of a chain of several 
tracheal rings tied together (Epstein, 1932; Castillo and De Beer, 1947) . 
However, such preparations were of limited usefulness because of the 
small sizes of contractile responses (measured isotonically), the slow­
ness of responses to contractile agents and recovery therefrom, and the 
complexity of the preparation (Foster, 1960; Jamieson, 1962;
Constantine, 1965; Timmerman and Scheffer, 1968). The sensitivity of 
chain preparations was increased by opening the tracheal rings with a 
cut through the cartilage opposite the smooth muscle layer (Ak^asu,
1952 and 1959) . The tracheal chain preparation was also improved by 
forming paired chains consisting of alternate rings from two different 
animals, thereby avoiding the problem of variability between animals 
and reducing the time required between successive responses (Foster,
1960). Other methods of preparation, less tedious than forming chains 
of rings, have also been developed (Patterson, 1958; Constantine, 1965; 
Timmerman and Scheffer, 1968) . The spirally cut tracheal preparation 
(Constantine, 1965) is now widely used, although it has been suggested 
that one disadvantage of this method is the "torsion strength" developed 
by the spiral strip (Timmerman and Scheffer, 1968). Contractile 
responses of guinea-pig tracheal spiral strips have been extensively 
characterized (Drazen and Schneider, 1978; Hanna and Roth, 1978), and 
a comparison of the sensitivity and reproducibility of spiral and chain 
preparations led to the conclusion that spiral strips are better suited 
for the study of responses to contractile agents (Ushinski et al.,
1971). Intact tracheal preparations have also been described, in which 
smooth muscle contraction and relaxation are measured by changes in the 
intraluminal pressure of the isolated tracheal tube (Farmer and Coleman, 
1970), or volume displacement from the tube (Jamieson, 1962).
Single rings of guinea-pig trachea have rarely been used. However
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by opening the ring as suggested by Ak^asu (1959) to form a strip, and 
using isometric recording techniques with suitable amplification, 
sufficient sensitivity can be gained to measure contractile responses of 
a single ring (Alonso-deFlorida and Cordoba, 1965) . This Chapter 
characterizes responses of such a preparation (described in Section 2.1) 
to bronchoconstrictor drugs and anaphylactic challenge.
Because of the important role of cyclic AMP in the regulation of 
airways smooth muscle, guinea-pig tracheal muscle has been used to 
determine the actions of drugs, both bronchoconstrictor and brochodila- 
tor, on cyclic AMP metabolism. However, the techniques used by various 
investigators have varied.- Determinations of cyclic AMP in incubations 
of tracheal rings (Murad and Kimura, 1974; Fransden et al., 1978) 
include the cyclic AMP content of the cartilage attached to the smooth 
muscle, and of the bathing medium. Other investigators have isolated 
the smooth muscle from the attached cartilage before incubation (Wong 
and Buckner, 1978), or separated the tissue from the incubation medium 
before determining cyclic AMP levels (Kolbeck et al., 1978), or both 
(Inamasu et al., 1974; Ohkubo et al., 1976). In order to relate cyclic 
AMP concentrations to the contractility of airways smooth muscle, it is 
preferable to discount any cyclic AMP present in the attached cartilage 
or released into the incubation medium, and to measure only the cyclic 
AMP content of the tracheal muscle strip. Furthermore, a study of the 
effects of isoprenaline on cyclic AMP levels in guinea-pig trachea 
showed that the response of tracheal muscle (with cartilage removed) 
was a 400% increase in cyclic AMP content, compared to only 100% 
increase in tracheal rings containing cartilage (Elfellah and Turnbull, 
1978). The studies described in this thesis have used determinations 
of cyclic AMP in strips of tracheal tissue obtained by two longitudinal 
cuts along the ends of the C-rings of cartilage, in which the smooth
muscle cells reside.
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This Chapter characterizes the strip preparation of guinea-pig 
trachea by summarizing concentration-response data for various contrac­
tile agents, and reporting antigen-induced contractions of preparations 
from guinea-pigs sensitized to ovalbumin. Cyclic AMP levels in tracheal 
muscle (without attached cartilage) and in the incubation medium are 
also reported.
3.2 Contractile responses
The isolated guinea-pig tracheal strip preparation contracts in 
response to bronchoconstricting agents such as histamine, acetylcholine 
and prostaglandin F201, and. also to depolarizing solutions in which 
potassium ions isotonically replace sodium ions. Figure 3.1 shows 
typical responses of the muscle strip to these stimuli, represented as 
a plot of isometric tension as a function of time. PGF20t, histamine and 
acetylcholine produce rapid increases in tension which are sustained 
in the continued presence of the agonist, but which disappear when the 
preparation is washed with fresh buffer. The response to depolarizing 
potassium-rich solutions is less rapid than the other responses.
Concentration-response data from several experiments were pooled 
to give the curves shown in Figure 3.2, and the values for maximum 
responses, pÖ2 (negative logarithm of EC50) and slopes of the concentra­
tion-response curves in Table 3.1. The order of relative drug effec­
tiveness, in terms of maximum contractile responses, was acetylcholine > 
histamine - KCl > PGF2CI. The maximum response to histamine was signifi­
cantly greater than that to prostaglandin F201 (p < 0.05; df = 48), and 
significantly less than that to acetylcholine (p < 0.05; df = 65).
In order to determine whether the sensitivity of tracheal strip 
preparations depends on their position along the length of the trachea, 
contractile responses to histamine (10 and 500 yM) and acetylcholine 
(1 mM) were determined for tracheal strips originating from various
T
E
N
SI
O
N
 
(g
ra
m
s)
68
10 minutes
FIGURE 3.1 C on trac ti le  responses o f  the guinea-p ig  tracheal s tr ip
The traces  show isom etric  ten sion  of tracheal s t r i p s .  KC1 (20 mM), 
prostaglandin  F2& (2.1 pM), histamine (10 pM) and a c e ty lc h o l in e  (10 pM) 
were added where in d ica ted .  When the ten sion  reached a steady l e v e l ,  
the c o n t r a c t i l e  agent was removed by rep lac ing  the bathing medium with 
fresh  Ringer s o lu t io n  (W).
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l o g  AGONIST CONCENTRATION (M)
FIGURE 3. 2  C o n c e n tra t io n - re sp o n se  curves  fo r  c o n t r a c t i l e  agen ts
Cumulative c o n c e n t ra t io n - r e s p o n s e  curves fo r  h is ta m in e  (HA), 
a c e ty lc h o l in e  (ACh), p r o s ta g la n d in  F201 (PGF201) and KC1 were ob ta ined  
as d e s c r ib e d  in  S e c t io n  2 . 2 , and p l o t t e d  as th e  change in  i s o m e tr ic  
t e n s io n  v e rsu s  th e  lo gar i thm  o f  th e  a g o n is t  c o n c e n t r a t io n .
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TABLE 3.1
MAXIMUM RESPONSES, pD2 VALUES AND SLOPES OF CONCENTRATION- 
RESPONSE CURVES FOR CONTRACTILE AGENTS
AGONIST MAXIMUM RESPONSE 
(grams)
pD2 SLOPE
(grams/log unit)
N
Histamine 3.73 ± 0.21 5.05 ± 0.05 1.91 ± 0.11 42
Acetylcholine 4.65 ± 0.39 5.03 + 0.09 1.28 ± 0.11 25
Prostaglandin F2a 2.47 ± 0.47 5.95 ± 0.12 1.34 ± 0.19 8
KC1 3.59 ± 0.27 6
Results are expressed as means ± S.E.M. of values derived from the 
indicated number (N) of cumulative concentration-response curves.
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positions (Figure 3.3). Tracheal strips taken from near the bronchial 
end (positions 7 and 8) tended to be less responsive than strips 
derived from the rest of the trachea. Analysis of variance showed 
that this trend was only significant in the case of 500 pM histamine 
(F 7 > 32 = 3.29, p < 0.01).
3.3 Anaphylactic contractures
Tracheal preparations from animals sensitized to ovalbumin 
(Section 2.5) contracted in response to antigen added to the organ bath 
(Figure 3.4). There was a characteristic delay of 15-30 seconds after 
the addition of antigen before any increase in tension was observed.
The maximum response was observed with ovalbumin concentrations of 0.1 
yg/ml or greater (Table 3.2), and this maximum response was 53.1 - 5.5% 
of the maximum contraction produced by histamine. Anaphylactic 
contractions were not significantly reduced in the presence of 
mepyramine (Table 3.2).
3.4 Cyclic AMP levels
The basal content of cyclic AMP in guinea-pig tracheal muscle was 
5.55 - 0.35 pmoles/muscle strip (n=20). This value was equivalent to 
0.18 - 0.01 pmoles/mg wet weight, or 2.69 - 0.21 pmoles/mg protein 
(n=20) .
Incubations for determination of cyclic AMP content were normally 
done in 25 mis of Ringer solution, but in order to determine how much 
cyclic AMP was released into the incubation medium, tracheal strips 
were incubated in 5 ml of Ringer solution. After the 90 minutes pre­
incubation in the absence of any drug, the cyclic AMP content of the 
bathing medium was 3.46 - 0.38 pmoles (n=2). After 6 minutes incubation 
with prostaglandin Ei (2.8 pM) , the concentration in the medium 
increased only slightly to 5.82 - 1.53 pmoles/5 mis (n=2). The tissue 
content, however, was elevated 15-fold to 85.8 - 5.3 pmoles. Thus,
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FIGURE 3.3 C o n t r a c t i l e  r e s p o n s e s  of  muscle s t r i p s  from d i f f e r e n t  
p o s i t i o n s  along the  t r a c h e a .
The t r a c h e a l  tube was cu t  i n t o  e ig h t  r i n g s ,  which were opened to  form 
muscle s t r i p s  (as d e s c r ib e d  i n  Sec t ion  2 . 1 ) ,  and numbered from 
the  upper  ( l a r y n g e a l )  end t o  the  lower (b ro n c h ia l )  end. The graphs 
show c o n t r a c t i l e  r e sponses  of  s t r i p s  from v a r i o u s  p o s i t i o n s  to  (A) 10 3M 
a c e t y l c h o l i n e ,  (b) 5 x 10 4 M h i s t a m in e ,  and (C) 10 5M h i s t a m in e .
R e s u l t s  a r e  means 4 S.E.M. of  5 e xpe r im en t s .
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FIGURE 3 .4  Anaphy lact ic  c o n t r a c t u r e  of  t r a c h e a l  muscle from s e n s i t i z e d  
gu inea -p ig
G uinea-p igs  were s e n s i t i z e d  to  ovalbumin as d e s c r ib e d  in  S e c t io n  2 .5 ,  
and t r a c h e a l  muscle s t r i p s  prepared  i n  t h e  usua l  manner ( Sec t ion  2 . 1 ) .  
The t r a c e  shows a t y p i c a l  r e s p o n s e  to  t h e  a d d i t i o n  o f  ovalbumin (OA;
0.1 yg/ml) to  t h e  organ b a t h .  When th e  an t ig e n  was removed by r e p l a c i n g  
t h e  b a th in g  medium wi th  f r e s h  Ringer s o l u t i o n ,  t h e  p r e p a r a t i o n  r e l a x e d .  
A f t e r  a s i n g l e  exposure to  t h e  a n t i g e n ,  t h e  p r e p a r a t i o n  was d e s e n s i t i z e d  
to  ovalbumin,  bu t  not  t o  h i s t a m ine  (HA; 10 pM). Trachea l  s t r i p s  from
c o n t r o l  an imals  did  no t  respond to  ovalbumin.
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TABLE 3.2
ANAPHYLACTIC CONTRACTURES: DEPENDENCE ON
ANTIGEN CONCENTRATION AND SENSITIVITY TO MEPYRAMINE
ADDITIONS CONCENTRATION RESPONSE1(grams) n
Ovalbumin 0.01 Ug/ml 0.80 ± 0.11 8
11 0.1 " 1.21 ± 0.20 16
it 1.0 . " 1.44 ± 0.18 9
ii 10 " 1.76 ± 0.71 5
Mepyramine 2.5
+ Ovalbumin 0.1 yg/ml 1.32 ±. 0 . 4 4 2 10
1 .
2 .
Means ± S .E .M.
Not s i g n i f i c a n t l y  d i f f e r e n t  to  c o n t r o l
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although significant amounts of cyclic AMP are released into the 
medium during preincubation, the action of exogenously added adenylate 
cyclase stimulators is predominantly on the tissue content of cyclic AMP.
3.5 Discussion
The guinea-pig tracheal strip preparation used in these studies 
provides a useful and sensitive method for investigating regulation of 
contraction of airways smooth muscle. The strips are easy to prepare, 
and recording of isometric tension allows sensitive measurement of 
contractile responses. The maximum responses to bronchoconstrictor 
agents is as much as 3 to 4 grams, greater than that obtained with 
spirally cut strips of guinea-pig trachea (Spilker and Minotoya, 1975; 
Hanna and Roth, 1978) . Furthermore, up to eight strips can be obtained 
from a single trachea, although strips taken from the lower end of the 
trachea tend to be less sensitive to contractile agents. Other methods 
of preparation commonly used, such as the spirally cut trachea or intact 
tracheal tube, yield only one or two preparations from each animal.
The order of relative effectiveness of bronchoconstrictor agents 
(acetylcholine > histamine > PGF201) , and EC50 values, accord with data 
reported for other preparations of guinea-pig tracheal muscle (Hanna and 
Roth, 1978; Takano et al., 1978).
The sensitivity to antigen or tracheal strips for ovalbumin- 
sensitized animals is similar to that reported by others (Sorenby, 1975; 
Wong et al., 1978) , but is much greater than that observed in animals 
sensitized to human serum albumin (HSA) (Alonso-deFlorida and Del 
Castillo, 1977) . On the other hand, the maximum contractile response of 
ovalbumin-sensitive tracheal muscle (about 50% of maximum drug-induced 
contractures) is less than that of muscle from HSA-sensitized animals 
(Sorenby, 1975; Alonso-deFlorida and Del Castillo, 1977). The delayed 
response to antigen suggests that the contraction is caused by the
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release of chemical mediators. The preliminary observation that 
mepyramine has only a partial inhibitory action on anaphylactic 
contractures indicates that histamine is not the only mediator involved 
in the response. FPL 55712, an antagonist of SRS-A, has also been 
reported to inhibit anaphylactic contractures of airways smooth muscle, 
suggesting that SRS-A may also be released (Adams and Lichtenstein, 1977).
Previous reports of the cyclic AMP content of guinea-pig tracheal 
tissue vary widely. Some of this variability derives from different 
experimental procedures (see Section 3.1), but a comparison of results 
obtained with similar procedures (removal of cartilage, omission of 
incubation medium) indicates that the basal level of cyclic AMP determined 
in Section 3.4 is lower than previously reported values of 8.8 or 21.9 
pmoles/mg protein (Inamasu et al., 1974; Ohkubo et al., 1976). The 
reason for this difference may be the smaller size of the animals used 
by these other authors. Tracheal cyclic AMP levels decrease with age in 
cattle (Andersson et al., 1978a), and a similar trend in guinea-pigs 
could explain the low levels of cyclic AMP in tracheal muscle of the 
larger guinea-pigs used in these studies. The results of Section 3.4 
also show that drug-induced changes in the cyclic AMP content occur 
mainly within the tissue, rather than in the bathing medium. Thus, 
inclusion of the bathing medium in the determination of cyclic AMP 
levels (e.g. the method of Murad and Kimura, 1974) would tend to mask 
drug-induced changes in cyclic AMP levels.
The low concentration of cyclic AMP in tracheal smooth muscle 
necessitates the use of a single longitudinal tracheal muscle strip 
for each determination of cyclic AMP. Consequently, it was not practical 
to perform large numbers of determinations, and nor was it possible to 
compare control values and drug responses on tissue from the same 
animal. . However, the variability of both basal cyclic AMP levels 
and drug-induced responses was not as great as for contractile responses,
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so that meaningful results could be obtained using as few as four 
tracheal strips from different animals (see Chapters 6 and 7).
3.6 Summary
Guinea-pig tracheal smooth muscle can be used to study contractile 
responses, allergic reactions and cyclic AMP metabolism of airways smooth 
muscle. The strip preparation of guinea-pig tracheal smooth muscle used 
in these studies is easily prepared, is sensitive to bronchoactive agents, 
and is characterized by greater maximal responses that other methods of 
preparation commonly used. Greater sensitivity of the determination of 
tracheal cyclic AMP levels to drug-induced changes is obtained by remov­
ing the cartilage and omitting the bathing medium from the determination.
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CHAPTER 4
CALCIUM METABOLISM OF AIRWAYS SMOOTH MUSCLE
4.1 Introduction
The roles of calcium ions in smooth muscle in general, and in 
tracheal muscle in particular, have been discussed in Sections 1.6 and
1.6.1 respectively. Contractile responses of tracheal smooth muscle, 
like other types of smooth muscle, utilize calcium ions derived from 
both the extracellular space and intracellular storage sites (Section 
1.6.1). The relative contributions of these two sources of calcium 
ions depend on the contractile agent, and also its concentration. In 
bovine tracheal muscle, histamine-induced contractions are more depen­
dent on extracellular calcium than are contractile responses to acetyl­
choline (Kirkpatrick et al., 1975), and in canine tracheal muscle, 
contractile responses to low concentrations of acetylcholine are more 
dependent on extracellular calcium than are those to higher concentra­
tions (Farley and Miles, 1978). The dependence of contractile responses 
of guinea-pig tracheal smooth muscle on extracellular calcium ions has 
not previously been investigated.
Airways smooth muscle cells have a stable resting membrane 
potential of -48mV in bovine trachea (Kirkpatrick, 1975), or from 
-54 to -60mV in canine trachea (Stephens and Kroeger, 1970; Farley 
and Miles, 1977). Stimulation of the muscle with high external 
potassium concentrations, acetylcholine or other drugs causes depolari­
zation of the membrane, allowing an influx of calcium ions which 
initiates contraction. However, membrane depolarization is not the 
only coupling mechanism, since some drugs can contract smooth muscles 
previously depolarized by high potassium concentrations in the bathing 
medium (Evans et al., 1958). The mechanism of smooth muscle contraction
which involves membrane depolarization has been called "electromechanical
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coupling", whilst contraction independent of depolarization involves 
"pharmacomechanical coupling" (Somlyo and Somlyo, 1968).
By measuring acetylcholine-induced changes of membrane potential, 
and then determining the contractile response to a KCl-induced 
depolarization of equivalent magnitude, Farley and Miles (1977) con­
cluded that the maximal contribution of electromechanical coupling to 
acetylcholine-induced contractures of canine tracheal 'muscle was only 
30%. On the other hand, Kirkpatrick et al. (1975) measured the 
contractile responses of bovine tracheal muscle depolarized by a high 
potassium concentration, and found that the amplitude of contractures 
induced by acetylcholine or histamine was about 30% of that obtained 
in normal solution. They also suggested that electromechanical coupling 
involved an influx of extracellular calcium ions, and that release 
of Ca from intracellular stores was independent of changes in membrane 
potential.
A23187 is a calcium ionophore, a substance which complexes calcium 
ions and transports them across biological membranes (Reed and Lardy, 
1973). In this way it can increase cytoplasmic calcium ion concentra­
tions, thereby supporting excitation-contraction and stimulus-secretion 
coupling in a variety of systems. It is usually assumed that A23187 
causes an influx of calcium ions from the extracellular medium, but
o 4*recent evidence suggests that the ionophore may also mobilize Ca from 
intracellular stores (Borle and Studer, 1978). A23187 and another
calcium ionphore, X-537A, contract vascular and intestinal smooth muscle 
preparations (Levy et al., 1973; Pressman, 1973; Swamy et al., 1975; 
Mandrek and Golenhofen, 1977), and isolated smooth muscle cells (Murray 
et al., 1975). However, their effects on airways smooth muscle are 
not known. A23187 also stimulates mediator release from mast cells 
(Foreman et al., 1973; Pearce et al., 1978), and enhances prostaglandin 
and thromboxane production by various tissues, including tracheae of
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dogs (Coburn et al., 1978) and rats (Knapp et al., 1977).
TMB-8 (8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate 
hydrochloride) is a calcium ion antagonist, and inhibits contractility 
of both smooth and skeletal muscles (Malagodi and Chiou, 1974 a, b). In 
intestinal smooth muscle, TMB-8 inhibits the responses to all contractile 
agents, but only contractures induced by.'barium chloride are competitive­
ly antagonized by TMB-8 (Malagodi and Chiou, 1974a). .Since BaCl2 acts by 
releasing bound calcium (Daniel, 1964), this observation suggests that
"4 *TMB-8 may produce its inhibitory effects by blocking Ca release from 
intracellular stores. TMB-8 also inhibits caffeine-induced Ca release 
from sarcoplasmic reticulum of skeletal muscle, and Ca fluxes in 
smooth muscle (Chiou and Malagodi, 1975). It seems, therefore, that 
TMB-8 may act by inhibiting mobilization of calcium ions from both 
intracellular and extracellular sources. The effects of TMB-8 on air­
ways smooth muscle have not been previously investigated, and the 
possibility of an action of TMB-8 on cyclic AMP metabolism has not been 
considered.
Thus, the objectives of the experiments described in this Chapter
were:
(1) To determine the relative contributions of extracellular and 
intracellular calcium ion stores to contractions of guinea-pig tracheal 
strips produced by varying doses of histamine, acetylcholine and KC1.
This was achieved by obtaining cumulative concentration-response curves 
in normal Ringer and in zero-calcium medium (see Section 2.2). In 
addition, contractile responses were examined after treating the tissue 
with EGTA, a calcium chelating agent, to remove residual calcium ion 
stores from the tissue.
(2) To determine the extent of the electromechanical coupling in 
drug-induced contractures, by examining contractile responses in the 
presence of depolarizing concentrations of KC1, both in normal and
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calcium-depleted tissues.
(3) To study the effects of A23187 and TMB-8 on the tracheal 
smooth muscle.
4.2 Calcium dependence of contractile responses
(a) Effect of zero-calcium medium. When the bathing medium was 
changed from the usual modified Ringer solution (containing 2.5 mM Ca2+) 
to one lacking calcium ions, the tension of the tracheal preparation 
decreased gradually to a lower resting level. The magnitude of the 
relaxation was 1.35 - 0.14 grams (n=20). After 40 minutes exposure to 
the zero-calcium medium, contractile responses of the muscle were 
diminished. Figure 4.1 compares the concentration-response curves for 
histamine, acetylcholine and KC1 in the presence and absence of extra­
cellular calcium ions. The response to 300 pM histamine (maximal 
response) was decreased by 63 - 6% (n=6; p < 0.02, paired t-test) by 
the omission of Ca , and the percentage inhibition was greater at lower 
concentrations. The responses to high acetylcholine concentrations were 
not inhibited by the zero-calcium medium, but significant reduction was 
observed at lower concentrations (43 ± 3% at 10 pM acetylcholine, p < 
0.01, n=6) . The dependence of KCl-induced contractures on extracellular 
calcium was intermediate to those of histamine and acetylcholine, with 
the maximal response (40 mM KC1) being inhibited by 34 - 5% (n=6;
p < 0.01, paired t=test).
(b) Repeated doses of contractile agents in zero-calcium. Figure
4.2 shows the effects of a zero-calcium medium on the contractile 
responses to histamine and acetylcholine. The histamine response was 
diminished more than that of acetylcholine. Repeated doses of either 
agent in the continued absence of extracellular calcium produced 
progressively smaller responses (Figures 4.2, 4.4). This gradual 
reduction of responsiveness during repeated applications suggests that
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FIGURE 4.1 Effect of zero-calcium medium on concentration-response 
curves of KC1, histamine and acetylcholine
Cumulative concentration-response curves for the contractile agents were 
first obtained in normal Ringer solution, and then repeated after 40 
minutes incubation in zero-calcium medium. Points represent means - 
S.E.M. of six tracheal strips from three animals for each contractile 
agent.
* p < 0.05
** p < 0.01
p < 0.001, paired t-test.* *  **
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FIGURE 4.2 Repeated doses of contractile agents in zero-calcium medium
Contractile responses were first obtained to (A) histamine (10 pM), 
and (B) acetylcholine (10 pM). The strips were then incubated in zero- 
calcium medium for 40 minutes, and additions of histamine or acetylcholine 
were repeated five times. The strips were washed (W) after each response 
and 15 minutes was allowed between additions. After the fifth response, 
CaCl2 (2.5 mM) was added in the continued presence of the contractile 
agent. Some of the baseline trace has been omitted.
84
an intracellular pool of calcium ions, which is not removed simply by 
incubation in zero-calcium medium, is depleted by repeated contractions.
It is possible, however, that the diminuition of responsiveness merely 
reflects the increased time of exposure to zero-calcium medium (Farley 
and Miles, 1978). This possibility was eliminated by measuring histamine 
responses after 100 minutes incubation in zero-calcium medium. This 
procedure gave histamine-induced contractures similar .to those obtained 
after 40 minutes incubation in zero-calcium medium. Furthermore, 
readdition of 2.5 mM calcium ions caused an increase in tension equiva­
lent to the normal contracture (Figure 4.2), indicating that the decreased 
responsiveness to histamine or acetylcholine was not due to tiring of the 
muscle or desensitization.
(c) Readdition of calcium ions. After a contractile agent had been 
added to a muscle strip in zero-calcium medium, readdition of 2.5 mM 
CaCl2 restored the tension to approximately the level observed after the 
contractile response in a normal medium. Cumulative dose-response 
curves were obtained by stepwise addition of CaCl2 (Figure 4.3). The 
threshold calcium ion concentration for an increase in tension in the 
presence of KC1 (16 mM) was 0.05 mM, and the maximal response was 
observed at 2.5 mM CaCl2 - The concentration required for a half maximal 
effect (EC50) was 0.40 - 0.03 mM (n=4).. Similar responses to added 
calcium were observed when histamine (3 yM) or PGF201 (2.1 yM) had been 
added to the muscle in zero-calcium medium, with EC50S for calcium of 
0.30 ± 0.04 mM (n=3) and 0.48 mM (n=l) respectively. Readdition of 
calcium also caused a return to the normal resting tension after 
incubation in zero-calcium in the absence of any contractile stimuli. 
However, the threshold calcium ion concentration (0.2 to 0.5 mM) and 
EC50 (1.18 ± 0.02 mM, n=2) were greater than for calcium readdition in 
the presence of KC1 or histamine.
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FIGURE 4.3 R e a dd i t ion  of  calcium ions  a f t e r  c o n t r a c t i l e  responses  in  
ze ro -ca lc ium  medium
A c o n t r a c t i l e  r e sponse  t o  KCI (16 mM) was f i r s t  ob ta ined  in  normal 
Ringer  s o l u t i o n ,  and then  the  p r e p a r a t i o n  was incubated  f o r  40 minutes  
i n  ze ro -ca lc ium  medium. P a r t  of  t h e  t r a c e  du r ing  t h i s  t ime has been 
om i t t e d .  KCI was added, in  the  absence o f  calcium ions,  a f t e r  which 
v a r i o u s  c o n c e n t r a t i o n s  o f  CaCl2 were added cum ula t ive ly  in  the  cont inued 
p resence  o f  KCI. From th e  cumula t ive  c o n c e n t r a t i o n - r e s p o n s e  curve  o f  
CaCl2 an EC50 v a lu e  was c a l c u l a t e d  ( see  t e x t ) .
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(d) Effects of EGTA. Incubation of tracheal strips in zero- 
calcium medium containing EGTA (2.5 mM) caused a decrease of the resting 
tension. This relaxation (1.22 - 0.09 grams, n=20) was not significantly 
different to that induced by zero-calcium medium without EGTA.
After 40 minutes treatment with EGTA, responses to contractile 
agents were severely inhibited (Table 4.1). KCl-induced contractures 
were completely abolished, whilst the response to histamine (10 pM) was 
only 3.3 - 1.6% (n=10) of the response in the presence of calcium. 
Readdition of CaCl2 (2.5 mM) to the bathing medium completely restored 
the responsiveness of the strips to KC1 and histamine.
4.3 Effect of depolarization on contractile responses
(a) In the presence of extracellular calcium. Depolarization of 
tracheal smooth muscle with high potassium solutions resulted in a slow 
contractile response (see Figure 3.1). The response to KC1 (80 mM)
(3.42 - 0.20 grams, n=18) was less than the maximal contractures induced 
by acetylcholine (5.21 4 0.72 grams, n=6; p < 0.01), but not signifi­
cantly different from the maximal response to histamine (see Table 3.1).
The addition of bronchoconstrictor agents after a maximal response 
to KC1 (80 mM) resulted in small additional contractures. The response 
to histamine (10 pM) was reduced from 2.83 - 0.30 grams in normal 
Ringer to 0.17 - 0.03 grams in depolarized tissues (n=6, p < 0.001, 
paired t-test), whilst the contracture induced by acetylcholine 
decreased from 1.93 ±  0.24 grams to 0.41 - 0.08 grams (n=8; p < 0.001, 
paired t-test) . The contractile response of depolarized strips to 
PGF2a (2.1 pM) was 0.36 - 0.03 grams, but this was not significantly 
different from the value of 0.69 - 0.22 grams (n=4) obtained in normal 
Ringer. In all three cases the total increase in tension induced by 
the combination of KC1 and drug was greater than the simple drug-induced 
contracture in normal Ringer.
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TABLE 4.1
EFFECTS OF ZERO-CALCIUM AND EGTA TREATMENT 
ON CONTRACTILE RESPONSES
AGONIST CONTROL ZERO-CALCIUM ZERO-CALCIUM
(- EGTA) (+ EGTA)
Histamine (10 pM) 2.25 ± 0.24(16) 0.26 ± 0.05(6) 0.06 ± 0.02(10)
PGF206 (2.1 pM) 0.79 ± 0.18(6) 0.07 ± 0.04(3) 0.04 ± 0.02(3)
KC1 (80 mM) 4.39 ± 0.44(10) 3 .50 ± 0.67(6) 0.04 ± 0.02(4)
After obtaining control responses in normal Ringer (containing 2.5 mM 
CA ), tracheal strips were incubated for 30 minutes in zero-calcium 
medium (± 2.5 mM EGTA), and then washed in zero-calcium medium (without 
EGTA). Contractile responses were then repeated. Values represent 
the magnitude of contractile responses in grams, and are means ± S.E.M. 
of the number of experiments indicated in parentheses.
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(b) Calcium-depleted tissues. The calcium content of the 
tracheal smooth muscle was depleted by treatment with EGTA, or by 
repeated additions of histamine in zero-calcium medium (without EGTA). 
Both these procedures considerably diminished the contractile responses 
to histamine (Section 4.3). However, depolarization of these calcium- 
depleted tissues enhanced the responsiveness of the muscle to histamine 
(Figure 4.4 and Table 4.2). Figure 4.4 shows histamine responsiveness 
was reduced by five repeated additions of histamine in the absence of 
extracellular calcium, after which the addition of 80 mM KC1 caused a 
small contracture and potentiated the histamine response by over 100%. 
After treatment with EGTA, high potassium solutions caused an even 
greater increase of histamine responsiveness (Table 4.2). The KC1- 
potentiated histamine responses were still less than those in normal 
Ringer solution. Contractures induced by PGF201, which were almost 
completely abolished by EGTA treatment, were restored by depolarization 
(Table 4.2). PGF201 responses of the depolarized, calcium-depleted 
muscle were in fact greater than those in the normal Ringer solution, 
but this difference was not significant.
4.4 Effects of a calcium ionophore and a calcium antagonist
(a) A23187. The calcium inophore contracted the tracheal smooth
muscle in a dose-dependent fashion (Figure 4.5). A maximal response 
was observed at a concentration of 6 pM, with a half maximal effect 
at 1.19 - 0.19 pM (n=4). Equivalent volumes of the two solvents used 
(ethanol/CaCl2 or dimethyl sulphoxide) did not contract the muscle.
The A23187-induced contracture was slower than that of acetylcholine or 
histamine, and the maximal response of 1.89 - 0.34 grams (n=9) was 
significantly less than that of histamine (p < 0.01, unpaired t-test, 
df=19). Unlike other contractile responses, it was not possible to 
reverse the A23187-induced contracture by washing with fresh medium.
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FIGURE 4.4 Potentiation by KC1 of histamine-induced contractures after 
repeated additions in zero-calcium medium
A contractile response to histamine (HA; 10 pM) was first obtained 
in normal Ringer solution, and then the tissue was incubated in zero- 
calcium medium. The responsiveness of the muscle to HA diminished during 
repeated additions of HA. KC1 (80 mM) was still able to contract the 
calcium-depleted muscle, and also partially restored responsiveness to 
HA, equivalent to a 5-fold potentiation in this example.
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TABLE 4.2
POTENTIATION OF CONTRACTILE RESPONSES 
BY KC1 AFTER CALCIUM DEPLETION
CONTRACTILE RESPONSES (grams)
AGONIST TREATMENT BEFORE
TREATMENT
AFTER
TREATMENT
(-KC1)
AFTER 
TREATMENT 
(+80 mM KC1)
10 yM Histamine A(n=5) 2.50 ± 0.47 0.38 ± 0.09 0.85 ± 0.12 *
10 pM Histamine B(n=8) 2.26 ± 0.35 0.14 ± 0.05 1.16 ± 0.34 *
2.1 pM PGF2a B(n=4) 0.69 ± 0.22 0.06 ± 0.02 1.61 ± 0.42 *
Treatment A consisted of repeated administration (5 times) of 10 pM 
histamine in zero-calcium medium, and treatment B consisted of incubation 
in zero-calcium medium containing 2.5 mM EGTA for 30 minutes. Contractile 
responses after both treatments were measured in the absence of EGTA. 
Values are means ± S.E.M.
* p < 0.05 compared to response in absence of KC1 after calcium depletion.
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A23187 CONCENTRATION (M)
FIGURE 4.5 Concen t ra t ion  dependence of A25187-induced c o n t r a c t u r e s
The graph shows the  c o n t r a c t i l e  responses  o f  t r a c h e a l  muscle s t r i p s  to 
v a r io u s  c o n c e n t r a t i o n s  of  A23187 added cumula t ive ly  to  the  organ b a th .  
Poin ts  a re  means 1 S.E.M. of  10 exper iments .
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The contractile response to A23187 (2.9 pM) was completely 
abolished in zero-calcium medium without EGTA (2 experiments), and was 
inhibited by mepyramine maleate (25 pM) by 61 - 14%(n=4; p < 0.05).
This concentration of mepyramine completely abolished histamine-induced 
contractures, but also caused a contraction by itself of 1.06 - 0.26 
grams (n=4). Atropine sulphate (1 pM) had no effect on the A23187 
response.
A single strip of human bronchial smooth muscle, obtained from 
surgery for carcinoma of the lung, also contracted in response to 
A23187 (2.9 pM).
(b) TMB-8. 100 pM TMB-8 relaxed the tracheal preparation by 0.81
- 0.20 grams, similar to the relaxation induced by zero-calcium medium. 
TMB-8 also relaxed the muscle in the presence of acetylcholine (10 pM), 
and the EC50 for this effect was 40 ±  5i pM (n=2).
Drug-induced contractures were antagonized by TMB-8. Incubation 
of tracheal strips for 20 minutes with 300 pM TMB-8 completely -abolished 
the response to histamine (10 pM), whilst 50% inhibition was achieved 
at a TMB-8 concentration of 45 - 3 pM (n=2). Contractile responses to 
KC1, PGF20t and acetylcholine were also inhibited by TMB-8 (single 
experiments only). Addition of up to 10 mM CaCl2 to the medium did 
not restore the responsiveness of the muscle to contractile stimuli.
The inhibitory effect of TMB-8 was not readily reversible by washing 
with fresh medium.
The possibility that the relaxant and inhibitory actions of TMB-8 
on the tracheal muscle involve increased cytoplasmic concentrations of 
cyclic AMP was also investigated. After 6 minutes incubation with TMB-8 
(100 pM), the cyclic AMP content of the muscle was 2.22 - 0.25 pmoles/ 
mg protein (n=3), and after 20 minutes incubation was 3.87 - 0.74
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pmoles/mg protein (n=4). These levels were not significantly different 
to the basal value of 2.70 - 0.23 pmoles/mg protein (n=7).
4.5 Discussion
In the absence of extracellular calcium ions, the contractures 
induced by histamine, acetylcholine and KC1 were reduced but not abolished, 
suggesting that these contractile responses involve both influx of 
calcium ions from the extracellular medium across the plasma membrane 
and release of Ca from intracellular stores. Although Keatinge (1972) 
suggests that 30 minutes incubation in zero-calcium medium without 
chelating agents is not sufficient to completely remove extracellular 
calcium from arterial smooth muscle, several observations indicate that 
extracellular calcium ions are completely removed from the tracheal 
muscle by 40 minutes incubation in zero-calcium medium without EGTA: 
the resting tension reaches a steady level which is not affected by the 
inclusion of EGTA, contractile responses to histamine are similar at 
40 and 100 minutes of incubation in zero-calcium, and A23187 and PGF2a 
responses are completely abolished after 40 minutes treatment. Thus, 
the contractile responses to histamine, acetylcholine and KC1 observed 
in zero-calcium medium do not involve influx of residual extracellular 
calcium ions in the centre of the tissue, but result from the release 
of intracellular stores.
The responses to histamine and KC1 are more dependent on extra­
cellular calcium than the acetylcholine-induced contracture, in agreement 
with the results of Kirkpatrick (1975) in bovine tracheal muscle. A 
similar relative dependence on extracellular calcium was also observed 
for histamine- and acetylcholine-induced contractures of rabbit taenia 
coli (Takayanagi et al., 1977). Responses to low doses of acetylcholine 
were diminished in zero-calcium medium, but those to higher concentra­
tions were not affected, indicating that contractions induced by low
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doses rely on the influx of extracellular calcium ions, whereas at 
higher concentrations the release of intracellular calcium ions is more 
important. A similar observation has been made in canine tracheal 
muscle (Farley and Miles, 1978). The dependence of contractile 
responses to histamine and KC1 on extracellular calcium also decreased 
with increasing concentration of the contractile agent. The contractile 
responses of the guinea-pig trachea to PGF2a and A23187 were almost 
completely abolished in zero-calcium medium, indicating that these 
result solely from an influx of extracellular calcium ions. Thus, 
the relative contributions of extracellular and intracellular sources of 
calcium ions may depend on both the contractile agent and its concentra­
tion .
Treatment of the tracheal muscle with EGTA further diminished 
the contractile effect of histamine and abolished that of KC1. The 
effect of EGTA may be to chelate residual calcium ions in the "zero- 
calcium" medium, but since the contractile responses were actually 
measured in the absence of EGTA, this is unlikely. Rather, EGTA could 
remove loosely bound calcium associated with plasma membranes of the 
smooth muscle cells, or even from intracellular stores (Keatinge, 1972). 
Thus, EGTA treatment results in "calcium depletion" of the tissue, 
although it is not clear to what extent or from what sites calcium ions 
are removed by EGTA. The results of the few experiments with calcium- 
depleted guinea-pig trachea are similar to those reported for bovine 
tracheal smooth muscle, in which EGTA treatment abolished KCl-induced 
contractures, and reduced histamine- and acetylcholine-induced responses 
to 6.3% and 15.6% of control responses in normal medium (Kirkpatrick 
et al., 1975). Thus, although EGTA severely depletes the tissue of 
calcium ions, there are intracellular calcium stores resistant to EGTA 
which may be mobilized during drug-induced contractures, but not in 
response to KC1. Furthermore, it is concluded that loosely bound
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calcium, possibly associated with the plasma membrane, contributes to 
both KC1- and drug-induced responses in normal and zero-calcium media.
This calcium pool is removed by EGTA, but not by incubation in zero- 
calcium medium.
The decline in the contractile responses to repeated applications 
of histamine or acetylcholine in the absence of extracellular calcium 
suggests that intracellular calcium pools are depleted during the
r\ *4“contractions. This could result from Ca release from membrane-bound 
stores during contraction, followed by transport of these ions across 
the plasma membrane to the extracellular medium during relaxation. The 
effect of repeated contractile stimuli after EGTA was not investigated, 
but in bovine tracheal muscle such treatment also resulted in depletion 
of intracellular calcium stores (Kirkpatrick et al., 1975), indicating 
that the pools of calcium removed by EGTA and by repeated drug applica­
tions in zero-calcium are not identical. These results suggest that 
calcium transport by the plasma membrane plays an important role in the 
relaxation of airways smooth muscle, since calcium accumulation by intra­
cellular organelles during relaxation would not lead to calcium depletion. 
Similar results have been obtained in vascular smooth muscle (Hiraoka 
et al., 1968) .
Omission of extracellular calcium ions (with or without EGTA) 
also decreased the resting tension of the guinea-pig tracheal smooth 
muscle, indicating that extracellular calcium ions contribute to the 
maintenance of intrinsic tone. Thus, intrinsic tone may result from 
the balance between calcium ion movement across the plasma membrane and 
calcium uptake mechanisms, establishing a cytoplasmic calcium ion 
concentration which is too high for complete relaxation of the contrac­
tile machinery. A similar effect of calcium depletion was not reported 
in bovine tracheal muscle (Kirkpatrick et al., 1975), but it is not
clear whether or not this preparation has any intrinsic tone. The
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resting tension of turtle aortic smooth muscle is also dependent on 
extracellular calcium (Bozler, 1969).
Readdition of calcium after contractile stimuli in zero-calcium 
medium completely and rapidly restored the contractile responses. The 
threshold concentration of CaCl2 required for an increase in tension 
in the presence of KC1, and the concentration required for a half 
maximal effect are similar to those reported for bovine tracheal muscle 
(Kirkpatrick et al., 1975). The calcium concentrations required for 
restoration of intrinsic tone after incubation in zero-calcium medium 
in the absence of any contractile agent were greater than for the 
responses observed in the presence of KC1 or histamine, demonstrating 
that the action of both these agents involves an increased calcium ion 
permeability of the plasma membrane.
The greater maximal contractile response of the tracheal muscle 
to acetylcholine than to depolarizing KC1 solutions suggests that 
coupling mechanisms other than depolarization operate during acetylcho­
line-induced contractures. In canine tracheal muscle, 80 mM KC1 reduced 
the membrane potential by 40 mV, whereas acetylcholine induced a 
depolarization of only 20 mV but caused a maximal contracture 50% 
greater than that of KC1 (Farley and Miles, 1977). The involvement of 
coupling mechanisms other than depolarization in drug-induced contrac­
tures is also demonstrated by the persistence of contractile responses 
to histamine, acetylcholine and PGF201 in the depolarized guinea-pig 
tracheal muscle. However, it is not possible to determine the relative 
contributions of electromechanical and pharmacomechanical coupling in 
these experiments, since the contractile responses to bronchoconstrictor 
agents after a KC1-induced contraction are limited by the maximal 
contractile capability of the muscle, and the relatively small responses 
of the depolarized muscle do not imply a large dependence on electro­
mechanical coupling.
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Potentiation of histamine and PGF2a responses by KC1 was observed 
after the muscle’s intracellular calcium stores had been depleted by 
either incubation with EGTA or repeated drug applications. Similar 
results have been reported in the turtle aorta (Bozler, 1969) and in the 
bovine trachea(Kirkpatrick et al., 1975). Kirkpatrick postulates the 
existence of a pool of tightly bound calcium ions which is resistant 
to EGTA, and which is not normally mobilized during drug-induced 
contractures. Depolarization by KC1 could reduce the binding affinity 
of this site for calcium ions without actually releasing them, so that 
they are sufficiently labile for mobilization in response to other 
contractile agents. Such a mechanism also appears to operate in the 
guinea-pig tracheal smooth muscle. The calcium storage site involved in 
the KCl-potentiated contractile responses of calcium-depleted tissues 
may be the inner surface of the cell membrane (Kirkpatrick et al., 1975), 
or the endoplasmic reticulum, which may be activated by depolarization 
at junctions with the plasma membrane (Bozler, 1969).
The potentiation of contractile responses of calcium-depleted tracheal 
strips by depolarizing high potassium solutions represents a possible in 
vitro model of bronchial hyperreactivity. Although it is difficult to 
compare the calcium-depleted tissues of these studies with the in vivo 
situation, these results indicate that perturbations in the resting membrane 
potential may give rise to altered reactivity of airway smooth muscle. The 
membrane potential of smooth muscle cells is regulated by cyclic AMP 
(Somlyo et al., 1970; Kroeger and Marshall, 1973), so that the defective 
cyclic AMP metabolism observed in asthma (Section 1.3.2) could result in 
abnormal regulation of the membrane potential giving rise to bronchial 
hyperreactivity.
The contractile effect of A23187 on both guinea-pig and human airways 
smooth muscle has not previously been reported. The concentration of the
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ionophore required for these effects (about 10-6 M) is similar to that 
for contraction of other smooth muscle preparations (Swamy et al., 1975) 
and isolated smooth muscle cells (Murray et al., 1975), or for the release 
of histamine from guinea-pig mast cells (Pearce et al., 1978). The contrac­
tile effect of A23187 on the guinea-pig tracheal muscle could be due to a 
direct Ca -transporting action on the smooth muscle cell (Swamy et al., 
1975), or could be secondary to the release of histamine (Foreman et al., 
1973) or thromboxanes (Knapp et al., 1977). Partial inhibition of the 
A23187 response by mepyramine suggests that histamine release may 
contribute to the response. The concentration of mepyramine used, however, 
was high and contracted the muscle by itself, an effect also reported by 
Hawkins (1955) . The role of prostaglandins and thromboxanes in the 
A23187 response was not investigated, but the major prostaglandin released 
may be PGE2 (Coburn et al., 1978) which relaxes guinea-pig tracheal muscle. 
Thus, the contractile effect of A23187 on guinea-pig tracheal smooth 
muscle appears to involve both histamine release from mast cells in the 
tracheal tissue and a direct action on smooth muscle cells.
The inhibitory and relaxant effects of TMB-8 on guinea-pig tracheal 
smooth muscle represents an extension of the studies of Malagodi and 
Chiou (1974a) in other types of smooth muscle. The concentrations 
required for these effects (10 5 to 10 4 M) were similar to those 
used by Malagodi and Chiou on intestinal smooth muscle. Although these 
authors concluded that TMB-8 acted by inhibition of Ca influx and 
release, they failed to consider the possible involvement of cyclic AMP. 
Since cyclic AMP also inhibits Ca2+ release from microsomal preparations 
of smooth muscle (Andersson and Nilsson, 1977), it is possible that 
the action of TMB-8 involves increased cytoplasmic levels of cyclic AMP. 
Although TMB-8 had no significant effects on the cyclic AMP content of 
the muscle after 6 or 20 minutes, the number of observations was too small 
to allow a definitive conclusion.
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Thus the mode of action of TMB-8 needs further investigation. If 
it is found to act as a direct antagonist of calcium ion movements, 
then it will be a useful tool in further studies of calcium ion metabolism 
in airways smooth muscle.
4.6 Summary
Calcium metabolism of guinea-pig tracheal smooth muscle is similar 
to that of bovine tracheal muscle which has been described previously. 
Drug-induced contractions involve both Ca influx and release from 
intracellular stores. The relative contributions of these two sources 
of Ca depend on both the contractile agent and its concentration. The 
order of dependence on extracellular Ca is acetylcholine < KC1 < 
histamine. Responses to high concentrations of all three agents were 
less dependent on extracellular Ca than those to low concentrations. 
Coupling mechanisms other than membrane depolarization contribute to the 
initiation of drug-induced contractions. Depolarization of calcium- 
depleted tissues potentiates contractile responses, and represents a 
possible mechanism of bronchial hyperreactivity. A23187 has a contractile 
effect on airways smooth muscle, and TMB-8 inhibits drug-induced 
contractures.
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CHAPTER 5
THE EFFECTS OF IMIDAZOLE ON AIRWAYS SMOOTH MUSCLE 
5.1 Introduction
Cyclic AMP has an important role in the regulation of airways 
smooth muscle (Section 1.7.3). The concentration of cyclic AMP in 
smooth muscle cells depends on the activities of two enzymes, adenylate 
cyclase and cyclic nucleotide phosphodiesterase (Figure 1.2). When 
cyclic nucleotide phosphodiesterase was first isolated from beef heart 
in 1962, Butcher and Sutherland also reported that the activity of 
the enzyme was greater when assayed in an imidazole buffer than in a 
Tris buffer. Since then imidazole has been shown to stimulate the 
activity of phosphodiesterase from canine heart (Nair, 1966), guinea- 
pig heart (Kukovetz and Pöch, 1969), and mouse brain (Roberts and 
Simonsen, 1970). A suggested mechanism for the activating action of 
imidazole on phosphodiesterase activity is an increased rate of dissocia­
tion of the product (5'-adenylic acid; 5’-AMP) from the enzyme (Roberts 
and Simonsen, 1970). Thus, imidazole has become widely known as an 
activator of cyclic nucleotide phosphodiesterase (Appleman et al., 1973; 
Amer and Kreighbaum, 1975) and many of its effects in various tissues 
have been attributed to this action.
In adipose tissue, imidazole inhibits the lipolytic responses to 
adrenaline, glucagon and theophylline (Kleisbauer et al., 1968; Camu, 
1969; Goodman, 1969; Nakano et al., 1970). These responses are 
thought to be mediated by cyclic AMP, suggesting that the inhibitory 
action of imidazole is due to activation of phosphodiesterase preventing 
the accumulation of cyclic AMP normally induced by these agents.
In intestinal smooth muscle, imidazole antagonizes the cyclic AMP- 
mediated relaxation induced by ß-adrenergic stimulation (Bueding and
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Bulbring, 1967; Wilkenfeld and Levy, 1969; Takagi et al., 1972), 
or by bradykinin (Paeglow et al., 1977). Imidazole also directly 
contracts intestinal smooth muscle (Andersson and Mohme-Lundholm, 1969; 
Bowman and Hall, 1970), and potentiates the contractile responses to 
KCl-induced depolarization, electrical stimulation, histamine, carbachol 
and prostaglandin E2 (Andersson, 1973b; Moritoki et al., 1976; Crocker 
et al., 1977; Kazic, 1977). Andersson (1973b) showed that imidazole- 
induced contraction of rabbit colon muscle is preceded by activation of 
phosphodiesterase and by reduction of cyclic AMP levels. Other studies 
also suggested that the effects of imidazole on intestinal smooth muscle 
could be related to its action on phosphodiesterase (Kazic, 1977) . 
However, other mechanisms of action have also been proposed for the 
potentiating effect of imidazole, such as facilitation of calcium ion 
movements (Moritoki et al., 1976).
Contractile responses to histamine of various smooth muscle pre­
parations of the guinea-pig including trachea, ileum and uterus, are also 
potentiated by imidazole (Arunlakshana et al., 1954). However, these 
effects were shown to be due to inhibition of the histamine catabolizing 
enzyme diamine oxidase (histaminase), which has high activity in these 
tissues.
Imidazole also has a direct contractile action on the smooth 
muscle of guinea-pig and bovine trachea (Szaduykis-Szadurski and Berti, 
1972; Olsson and Persson, 1976; Andersson et al., 1978b). Szaduykis- 
Szadurski and Berti (1972) showed that this response is not inhibited 
by cholinergic,, a-adrenergic or histaminergic antagonists, and concluded 
that the contraction results from the stimulatory action of imidazole on 
phosphodiesterase. Andersson et al. (1978b), however, demonstrated 
inhibition of imidazole-induced contraction of bovine tracheal muscle 
by clemastine, a histamine H 1-antagonist, suggesting that the contraction 
is mediated by histamine Hi-receptors.
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Thus imidazole directly contracts airways and other smooth muscle 
preparations, and also enhances contractile responses to other agents. 
These effects may result from a stimulatory effect on cyclic nucleotide 
phosphodiesterase, resulting in decreased cyclic AMP levels and inhibi­
tion of hormone-induced accumulation of cyclic AMP. Asthmatic patients 
display an impaired responsiveness of the cyclic AMP system to adrenergic 
stimulation (Section 1.3.2), and this defect may be the underlying cause 
of bronchial hyperreactivity. Thus, treatment of isolated airways 
smooth muscle with imidazole could provide an analogous in vitro 
situation to bronchial hyperreactivity by suppressing the responsiveness 
of the cyclic AMP system.
This Chapter examines the effects of imidazole on guinea-pig 
tracheal smooth muscle in an attempt to establish a useful in vitro 
model of bronchial hyperreactivity based on enhanced phosphodiesterase 
activity. The effects of imidazole on the contractile responses to 
histamine and other bronchoconstrictor agents, as well as the contractile 
action of imidazole itself, have been investigated.
5.2 Contractile responses to imidazole
Imidazole, in concentrations from 0.1 to 30 mM caused an increase 
in the tension of the tracheal smooth muscle preparation. Typical 
contractile responses to imidazole are shown in Figure 5.1. Tension 
development induced by imidazole is significantly slower than the 
responses to approximately equiactive concentrations of histamine or 
acetylcholine. The time required for a half maximal response to 10 mM 
imidazole was 2.8 - 0.3 minutes (n=16), whereas the corresponding 
values for histamine and acetylcholine were 0.45 - 0.1 (n=6) and 0.3 - 
0.05 (n=8) respectively (both p < 0.001). Relaxation of the muscle 
after replacing the bathing medium was also slower after an imidazole- 
induced contracture than after histamine or acetylcholine.
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10 mins
1
imidazole
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10 acetylcholine
100  jjlM
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FIGURE 5.1 C o n t r a c t i l e  responses  to  imidazole
The t r a c e  shows the r e sponse s  o f  t h e  i s o m e t r i c  t e n s io n  o f  a t r a c h e a l  
s t r i p  t o  a d d i t i o n s  of  v a r i o u s  c o n c e n t r a t i o n s  o f  im idazo le .  When t h e  
t e n s i o n  reached a s te ady  l e v e l ,  t h e  p r e p a r a t i o n  was washed twice with 
Ringer s o l u t i o n  and allowed to  r e l a x  t o  the  b a s e l i n e  t e n s i o n  be fo re  the  
next  a d d i t i o n  was made. A c o n t r a c t i l e  r e sponse  t o  a c e t y l c h o l i n e  i s  
shown f o r  comparison.
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Figure 5.2 is a concentration-response curve for the contractile 
effect of imidazole. A maximal response was observed at about 30 mM 
imidazole, and the pÜ2 value was 2.60 ± 0.07 (n=6), corresponding to 
an EC50 of 2.5 mM.
The contractile response to imidazole was antagonized by a range 
of drugs and experimental conditions (Table 5.1). The inhibitory action 
of theophylline (0.5 mM) was significantly greater on'the response to 
10 mM imidazole than on the contractures induced by approximately 
equiactive concentrations of histamine (p < 0.05, df = 5) or acetylcho­
line (p < 0.01, df = 6). The calcium antagonist TMB-8 (100 yM) was 
also more effective in inhibiting imidazole than histamine contractures 
(p < 0.02, df = 2).
Mepyramine, at a concentration which completely blocked histamine 
responses without affecting acetylcholine responses, had a significant 
partial inhibitory action on imidazole responses (p < 0.02). In the 
presence of 1 yM atropine, which completely inhibited acetylcholine 
responses without affecting histamine contractures, imidazole caused a 
biphasic response (Figure 5.3): 10 mM imidazole caused an initial
relaxation of 0.29 grams (± 0.11, n=6), which reached a maximum after 
1.1 ± 0.1 minutes and was followed by a contracture of 0.68 ± 0.10 
grams. The net effect was an increase in tension which was 50%
(Table 5.1) of the control response (p < 0.05).
In the absence of extracellular calcium (zero-calcium medium, see 
Section 2.2), the response to 10 mM imidazole was reduced by 70 ± 8%
(n=4), compared to the contracture in normal medium (Table 5.1). This 
represents a similar dependence on extracellular calcium ions as the 
histamine-induced contracture, but is significantly greater than the 
dependence of contractions induced by approximately equiactive concentra­
tions of acetylcholine (p < 0.02, df =8) (see also Section 4.2). After
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IMIDAZOLE CONCENTRATION (mM)
FIGURE 5.2 Concen t ra t ion  dependence of  imidazole- induced c o n t ra c tu r e s
The graph shows the  c o n t r a c t i l e  responses  of  t r a c h e a l  muscle s t r i p s  to  
va r ious  c o n c e n t r a t i o n s  of  im idazo le ,  added cumula t ive ly  to  the  organ 
b a th .  Po in ts  a re  means - S.E.M. of  6 exper iments.
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10 minutes
o 2 -
imidazole atropine imidazole
FIGURE 5.3 E f fec t  of  a t ro p i n e  on the  c o n t r a c t i l e  response  to  imidazole
The t r a c e  shows a c o n t ro l  response to  imidazole (10 mM), and a response 
a f t e r  5 minutes p re t r e a tm e n t  with a t r o p i n e  (1 yM). Between the two 
responses  the  p r e p a r a t i o n  was washed twice with f r e s h  Ringer s o lu t i o n  
and 20 minutes  was al lowed f o r  th e  t e n s io n  to  r e t u r n  to  b a s e l i n e .
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treatment of the tissue for 30 minutes with EGTA (2.5 mM). The contractile 
response to imidazole was completely abolished (Figure 5.4, n=4) , whereas 
the contracture induced by histamine was still evident after such treat­
ment (Chapter 4). Readdition of calcium ions caused an increase in 
tension equivalent to the contracture observed in normal medium.
5.3 Potentiating effects of imidazole
As well as contracting the tracheal muscle itself, low concentra­
tions of imidazole also enhanced the reactivity of the tissue to 
histamine. Figure 5.5 shows a histamine-induced contracture in the 
absence and presence of 0.2 mM imidazole. This low concentration of 
imidazole caused a small contracture (0.34 ± 0.05 grams, n=8), and 
also significantly increased the magnitude of the histamine-induced 
response by 76 - 17% (n=8, p < 0.005, paired t-test). The histamine- 
induced contracture returned to control values when imidazole was 
removed from the bathing medium. The concentration dependence of the 
potentiating effect of imidazole is shown in Figure 5.6. Significant 
enhancement of 10 pM histamine responses was observed at imidazole 
concentrations of 50 pM to 2 mM. The maximum potentiation of 126 ± 30% 
(n=ll) was obtained with an imidazole concentration of 0.5 mM.
The effect of 0.5 mM imidazole on the histamine concentration- 
response curve is shown in Figure 5.7. Contractile responses to hista­
mine concentrations of 10 7 to 10 5 M were significantly enhanced in 
the presence of imidazole. The potentiation of 10 pM histamine response 
was 55% (p < 0.01, df = 35), somewhat less than that obtained in the 
previous experiment (Figure 5.7). Contractures induced by high concen­
trations of histamine (10 4 M and above) were not affected by imidazole. 
The pÖ2 value (negative logarithm of EC50) for histamine was increased 
from a control value of 5.02 ± 0.07 to 5.73 ± 0.07 in the presence of 
imidazole (p < 0.001, df = 35).
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2.5 mM C a2+ |_______ zero C a2*
I +EGTA -EGTA 
(30 mins) (30 mins]
2.5 mM Ca 2+
imidazole
(10 mM)
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imidazole CaCI2 
(10 mM) (2.5 mM)
FIGURE 5.4 The e f f e c t  of calcium d e p le t io n  on the c o n t r a c t i l e  response  
to imidazole
A control response to  imidazole (10 mM) was f i r s t  obtained in normal 
Ringer s o lu t io n ,  a f te r  which the t i s s u e  was incubated for 30 minutes 
in zero-calcium  medium contain ing  2.5 mM EGTA. The bathing so lu t io n  
was then changed to  zero-calcium  medium without EGTA, and the add it ion  
o f  imidazole was repeated . No change in  ten sion  occurred u n t i l  CaCl2 
(2.5 mM) was readded.
no
3
0 J
10 mins
histamine imidazole histamine
IO juM 0.2 mM 10 >iM
histamine
10 j jM
FIGURE 5 .5  P o t e n t i a t i o n  of  h is tam ine  c o n t r a c tu r e s  by imidazole
The t r a c e s  show c o n t r a c t i l e  responses  to h is tamine  (10 mM) in  the 
absence and presence  o f  im idazole (0.2 mM) . The p r e p a r a t i o n  was washed 
tw ice  between h is tam ine  a d d i t i o n s  and al lowed to  r e l a x  to  b a s e l i n e  
te n s io n  (about 20 minutes ,  not  shown) .
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FIGURE 5.6 Concentration dependence of the potentiating action of 
imidazole
The graph shows the magnitude of contractile responses to histamine 
(10 yM) in the presence of various concentrations of imidazole. Each 
point is the mean - S.E.M. of 5 to 11 experiments. The dashed line 
represents the mean of 69 control responses in the absence of imidazole, 
obtained before each imidazole-pretreated response.
* p < 0.05
p < 0.01
p < 0.001, paired t-test.* * *
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LOG HISTAMINE CONCENTRATION (M)
FIGURE 5.7 Ef fec t  of  im idazole  on h i s ta m in e  co n ce n t r a t i o n - r e s p o n se
curve
The graph shows the  magnitude o f  c o n t r a c t i l e  responses  to  v a r io u s  doses 
o f  h is tam ine  (added cum ula t ive ly )  in  th e  absence and p resence  of 
im idazole (0.5 mM). Each p o in t  r e p r e s e n t s  t h e  mean - S.E.M. o f  19 
(con t ro l )  or  18 (+ imidazole)  t r a c h e a l  muscle s t r i p s  from 8 an imals .
** p < 0.01,  *** p < 0.001.*  *  **
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The effect of imidazole on contractile responses to other agents 
was also investigated (Table 5.2). 0.5 mM imidazole had no significant
effect on the contractures induced by KC1 (20 mM), acetylcholine (10 7 
to 10 2 M) , PGF201 (2.2 x 10 8 to 2.2 x 10 5 M) , or the calcium ionophore 
A23187 (6 x 10 8 to 2.9 x 10 6M). Furthermore, imidazole did not affect 
the anaphylactic contractions produced by antigen in tracheal prepara­
tions from guinea-pigs sensitized to ovalbumin.
5.4 Discussion
The observation that imidazole contracts guinea-pig tracheal smooth 
muscle accords with previous reports (Szaduykis-Szadurski and Berti,
1972; Olsson and Persson, 1976; Andersson et al., 1978b). It is not 
possible to compare the potency of imidazole as a contractile agent 
observed in these experiments to other studies: Andersson et al. (1978b)
did not report concentration-response data for the effect of imidazole 
on guinea-pig tracheal smooth muscle, whilst the concentrations of 
imidazole used by Szaduykis-Szadurski and Berti (1972) were omitted 
from their report. However, the EC50 for the contractile effect of 
imidazole observed in these experiments (2.5 mM) is ten times greater 
than the value deduced from the data of Andersson et al. (1978) for 
bovine tracheal muscle.
The greater sensitivity of imidazole-induced contractures to 
inhibition by theophylline, compared to histamine- or acetylcholine- 
induced responses, suggests that the mechanism of action of imidazole 
may involve stimulation of cyclic nucleotide phosphodiesterase. 
Theophylline, an inhibitor of this enzyme, would directly antagonize the 
stimulatory action of imidazole. However, the calcium antagonist TMB-8 
was also a more effective inhibitor of imidazole-induced contractures 
than of the responses to histamine. This result suggests that imidazole 
may have a direct facilitatory action on calcium ion movements in the
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TABLE 5.2
EFFECT OF IMIDAZOLE (0 .5  mM) ON CONTRACTILE 
RESPONSES TO VARIOUS AGENTS
CONTRACTILE AGENT CONCENTRATION CONTROL RESPONSE RESPONSE AFTER
(grains) IMIDAZOLE
(grams)
KC1 20 mM 1.47 + 0.13(5) 1.43 + 0.20(5)
A c e ty l c h o l i n e 10"7 M 0.27 + 0.05(9) 0.45 ± 0.25(10)
10 6 M 0.96 + 0.11(9) 1.24 + 0.25(10)
10 5 M 1.90 ± 0 .17(9) 2.18 ± 0 .30(10)
1 0 ' 4 M 3.01 + 0 .23(9 ) 3.25 + 0.33(10)
10 3 M 4.08 + 0.30(9) 4.17 ± 0.38(10)
10 2 M 4.54 ± 0 .47(5) 4.44 + 0 .4 6 (  6)
P r o s t a g l a n d i n  F201 2 . 2x 10""8 M 0.10 + 0 .05(8) 0.26 + 0 .13(8 )
2.2x10 7 M 0.45 + 0.18(8) 0.65 + 0.27(8)
2.2x10 6 M 1.67 + 0 .40(8) 1.52 + 0.14(8)
2 . 2 x l 0 ' 5 M 2.47 + 0 .47(8 ) 1.98 ± 0 .4 3 (8 )
A23187 2 . 9x 10 " 7 M 0 .75 + 0.28(10) 0.77 ± 0 .26(10)
2.9x10 6 M 2.:23 ± 0.48(10) 2.69 ± 0.54(10)
Ovalbumin 0.1 pg/ml 1.52 + 0.16(20) 1.40 + 0.16(20)
R e s u l t s  a re  means ± S.E.M. and the  numbers o f  o b s e r v a t i o n s  a r e  i n d i c a t e d  
i n  p a r e n t h e s e s .  R e s u l t s  f o r  a c e t y l c h o l i n e  and PGF2a  r e p r e s e n t  cum ula t ive  
c o n c e n t r a t i o n - r e s p o n s e  c u r v e s .  Con tro l  KCl-induced c o n t r a c t u r e s  were 
o b ta in e d  a f t e r  t h e  i m i d a z o l e - p r e t r e a t e d  r e s p o n s e s  on the  same s t r i p s ;  
a l l  o t h e r  r e s p o n s e s  used d i f f e r e n t  p r e p a r a t i o n s  f o r  c o n t r o l  and im idazo le  
t r e a t m e n t .  C o n t r a c t i l e  r e s p o n s es  t o  ovalbumin were produced in  
p r e p a r a t i o n s  from s e n s i t i z e d  an imals  ( see  S e c t io n  3 . 3 ) .
115
smooth muscle cells. Such a mechanism has also been proposed for the 
potentiating action of imidazole in intestinal smooth muscle (Moritoki 
et al. , 1976) or in cardiac muscle (Massingham and Nasmyth, 1972).
Contractures induced by imidazole were partially inhibited by 
mepyramine, indicating that imidazole-induced histamine release 
contributes to the contractile response. Andersson et al. (1978b) 
also observed antagonism of imidazole-induced contractures by an Hi- 
receptor antagonist, clemastine, but Szaduykis-Szadurski and Berti 
(1972) failed to show any effect of cyproheptadine, another antihistamin- 
ic agent. The possibility that imidazole may induce release of histamine 
from mast cells in the tracheal tissue is supported by the observation 
that imidazole induces degranulation of rat peritoneal mast cells (Taylor 
et al., 1974), an action which may involve stimulation of cyclic 
nucleotide phosphodiesterase. On the other hand, imidazole antagonizes 
antigen-induced histamine release from leucocytes (Andersson and 
Colldahl, 1974; Andersson et al., 1978b). It is possible that the 
antagonism of imidazole-induced contractures by mepyramine is unrelated 
to its anti-Hi-receptor activity, since mepyramine also inhibits the 
positive inotropic action of imidazole on guinea-pig atrium, a tissue 
which possesses only histamine H2-receptors (Korsak et al., 1975).
The biphasic response to imidazole in the presence of atropine 
suggests that the contractile response to imidazole in the absence of 
atropine is not a simple one, and may represent the combined effect of 
several different actions. Overall inhibition of the contractile 
response by atropine suggests the involvement of acetylcholine release 
from nerve terminals in the tracheal tissue, and subsequent stimulation 
of muscarinic receptors. Imidazole has been shown to enhance the 
release of acetylcholine from guinea-pig ileal smooth muscle during 
electrical stimulation (Moritoki et al., 1976), and from skeletal
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muscle (Gotgil'f, 1972). Szaduykis-Szadurski and Berti (1972) claimed 
that atropine had no effect on the contractile response of guinea-pig 
tracheal smooth muscle to imidazole, but their data actually indicate 
a significant (p < 0.05) inhibition of 24%, in agreement with the result 
of Table 5.1.
The relaxation observed in response to imidazole in the presence 
of atropine suggests that imidazole has an effect on cyclic AMP 
metabolism opposite to that expected from activation of phosphodiester­
ase, or that imidazole induces the release of relaxant prostaglandins 
or catecholamines. Szaduykis-Szadurski and Berti (1972) reported 
that the contraction induced by imidazole was potentiated by propranolol, 
indicating the involvement of endogenous catecholamines released in 
response to imidazole. However, the effect of indomethacin, an 
inhibitor of prostaglandin synthesis, on the contractile response to 
imidazole has not been examined.
As well as contracting the tracheal smooth muscle by itself, 
imidazole at low concentrations also potentiated contractile responses 
to histamine. The optimal concentration of imidazole for this effect 
(0.5 mM) is similar to the value of 1 mM reported by Arunlakshana et al. 
(1954) . At higher concentrations of imidazole, the contracture produced 
by imidazole itself masks any enhancement of the histamine response.
The potentiation of histamine responses was effected by a parallel shift 
of the histamine concentration-response curve to the left, with no effect 
on the maximal response to histamine.
If imidazole does have a stimulatory action on cyclic nucleotide 
phosphodiesterase in guinea-pig tracheal tissue, then enhancement of 
histamine-induced contractures by imidazole may be explained by postula­
ting an intracellular accumulation of cyclic AMP in response to histamine. 
Such an effect on cyclic AMP metabolism would modulate the contractile
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response, acting as a negative feedback regulatory mechanism. Imidazole, 
by stimulating phosphodiesterase, would abolish such a cyclic AMP- 
mediated modulating mechanism, thereby enhancing the contractile response. 
This hypothesis is further investigated in Chapter 6.
The potentiating effect of imidazole was specific for contractures 
induced by histamine: there was no enhancement of the contractures
induced by KC1, acetylcholine, PGF201 or A23187, or of anaphylactic 
contractures. If histamine were the major mediator involved in anaphy­
lactic contractions of guinea-pig tracheal smooth muscle, as has been 
suggested for human bronchial smooth muscle (Schild et al., 1951), then 
imidazole would be expected to potentiate the response. The lack of 
effect of imidazole on anaphylactic contractures suggests that histamine 
is not the major mediator of this response. However, it is possible 
that antigen-induced histamine release from mast cells in the tracheal 
preparation was inhibited by imidazole, counteracting the potentiating 
effect of imidazole on the contractile action of histamine on smooth 
muscle cells. Imidazole has been reported to inhibit antigen-induced 
histamine release from leucocytes (Andersson and Colldahl, 1974;
Andersson et al., 1978b).
Potentiation of histamine-induced contractures of isolated guinea- 
pig trachea by imidazole is analogous to the bronchial hyperreactivity 
to histamine displayed by asthmatic patients in vivo (Section 1.1).
If the potentiating action of imidazole on tracheal muscle involves 
stimulation of phosphodiesterase, then it could serve as a useful in 
vitro model of bronchial hyperreactivity. However, the usefulness 
of such a model is limited by its applicability only to histamine- 
induced contraction of airways smooth muscle, whereas asthmatic patients 
also display bronchial hyperreactivity to cholinergic agents, prosta­
glandin F201 and allergic reactions.
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5.5 Summary
Imidazole contracts guinea-pig tracheal smooth muscle and also 
potentiates the contractile action of histamine. The contractile 
response to imidazole is a complex one and may involve liberation of 
one or more of acetylcholine, histamine, catecholamines and prostaglan­
dins. The intracellular mechanism of action of imidazole, whether on 
smooth muscle cells, mast cells or nerve terminals, may be related to 
stimulation of phosphodiesterase or to an effect on calcium ion fluxes
across cell membranes.
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CHAPTER 6
MECHANISM OF IMIDAZOLE-INDUCED HYPERREACTIVITY 
6.1 Introduction
Imidazole, as well as contracting guinea-pig tracheal smooth 
muscle, also potentiates contractile responses to histamine (Chapter 5). 
Stimulation of phosophodiesterase activity was the basis of an hypothesis 
explaining imidazole-induced hyperreactivity to histamine. It was 
postulated that a negative feedback regulatory mechanism, involving an 
intracellular accumulation of cyclic AMP, was associated with the 
contractile response to histamine. Imidazole, by accelerating the 
hydrolysis of cyclic AMP, would antagonize such regulation, thereby 
permitting the full expression of the contractile response to histamine.
Stimulation of phosphodiesterase by imidazole has been reported, 
and has been used to explain many of the actions of imidazole on a 
variety of tissues (Section 5.1). However, studies reporting increased 
hydrolysis of cyclic AMP in the presence of imidazole have used imidazole 
concentrations of 5 to 40 mM (Butcher and Sutherland, 1962; Roberts and 
Simonsen, 1970), an order of magnitude greater than the concentration 
required for maximum potentiation of histamine-induced contractures of 
guinea-pig tracheal muscle. Furthermore, the concentrations of cyclic 
AMP used by various authors to determine the activity of phosphodiester­
ase have been higher than physiological levels (0.1 mM or greater). 
Imidazole has no effect on the hydrolysis of lower, more physiological 
concentrations (less than 10 pM) by enzyme preparations from bovine 
heart, rat liver or rat brain (Chasin and Harris, 1976; Donnelly, 1976). 
Phosphodiesterase activity in cat pancreas is also unaffected by 
imidazole when assayed with micromolar concentrations of cyclic AMP, but 
stimulated at a higher (2 mM) substrate concentration (Bonting et al.,
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1977).
The significance of these observations is that at least two forms 
of cyclic nucleotide phosphodiesterase exist in most tissues (Appleman, 
et al., 1973). These two enzyme activities differ in their affinities 
for substrate (cyclic AMP) having values of approximately 10 6 and 
10 4 M, and are commonly called low and high forms of the enzyme 
respectively. Airways smooth muscle is no exception: canine bronchial
smooth muscle has phosphodiesterase activities with values of 1.4 
and 48 pM (Triner et al., 1977) . Because of the low cyclic AMP concen­
trations found in most tissues, the low form of the enzyme is general­
ly considered to be more physiologically important (Chasin and Harris, 
1976). Thus the above studies suggest that imidazole only stimulates 
the activity of the high Km form of the enzyme, which may not have any 
physiological significance. However, stimulation of a purified low 
phosphodiesterase enzyme, from rabbit skeletal muscle, has been reported 
(Huang and Kemp, 1971) .
The observation that stimulation by imidazole is generally limited 
to the high form of phosphodiesterase may explain why imidazole does 
not have a cyclic AMP lowering effect in tissues such as liver and 
adipose tissue (Tizabi et al., 1977), heart (Verma and McNeill, 1976), 
platelets (Needleman et al., 1977), and leucocytes (Bourne et al.,
1972). However, an effect of imidazole on cyclic AMP levels is observed 
in other tissues. In rabbit colon smooth muscle, the contractile 
response to imidazole is preceded by a reduction of the cyclic AMP 
content of the tissue (Andersson, 1973b), and the enhancement by imida­
zole of antigen-induced release of mediators from human lung is 
accompanied by reduced levels of cyclic AMP (Kaliner and Austen, 1974). 
The effect of imidazole on the cyclic AMP content of airways smooth 
muscle has not been previously investigated.
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In addition to its possible stimulating effect on cyclic nucleotide 
phosphodiesterase, imidazole has other biochemical actions which could 
explain its potentiating effect on histamine-induced contractures of 
airways smooth muscle. These include stimulation of acetylcholine 
release, inhibition of prostaglandin or thromboxane synthesis, facilita­
tion of calcium ion fluxes, and inhibition of histaminase activity.
(a) Acetylcholine release. Imidazole enhances contractions of 
guinea-pig ileal smooth muscle in response to electrical stimulation, 
and this effect is associated with an increased release of acetylcholine 
into the bathing medium (Moritoki et al., 1976). In skeletal muscle, 
imidazole enhances neuromuscular transmission by acting presynaptically 
to enhance the release of the neurotransmitter acetylcholine (Poletaev, 
1970; Gotgil’f, 1972; Korsak et al., 1974). It is possible that the 
action of imidazole on cholinergic nerve terminals could involve 
stimulation of phosphodiesterase and decreased levels of cyclic AMP. 
However, this is unlikely, since the release of neurotransmitter is 
usually associated with elevated levels of cyclic AMP (Kebabian, 1977).
Airways smooth muscle is parasympathetically innervated in vivo 
(Section 1.4.1), so that the isolated guinea-pig tracheal muscle 
preparation is expected to contain cholinergic nerve terminals. The 
release of acetylcholine from these nerve terminals may contribute to 
the contractile response to high doses of imidazole (Chapter 5). It 
is possible that the potentiating action of imidazole results from 
histamine-induced release of acetylcholine stores rendered more labile 
by low concentrations of imidazole.
(b) Thromboxane synthesis. Thromboxane A2 is synthesized by 
platelets, lung and other tissues from cyclic endoperoxides (PGG2 and 
PGH2) by- the enzyme thromboxane synthetase (Needleman et al., 1976) 
(Figure 1.1). Recently it has been reported that this conversion in
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platelets is inhibited by imidazole (Moncada et al., 1977; Needleman 
et al. , 1977; Nijkamp et al., 1977). The concentrations of imidazole 
required for this effect are comparable to those which induce hyperreac­
tivity of the tracheal muscle to histamine (Chapter 5). Imidazole 
also inhibits the release of thromboxane A2 , but not of prostaglandins, 
from guinea-pig lung challenged with SRS-A (Engineer et al., 1978a). 
Thromboxane A2 contracts airways smooth muscle (Svensson et al., 1977) , 
so that it seems unlikely that inhibition of thromboxane production 
per se could explain either the contractile or potentiating effects 
of imidazole. However, inhibition of thromboxane synthesis is associa­
ted with enhanced formation of other metabolites of the cyclic 
endoperoxides. Imidazole increases the release of PGF201 from human 
platelets (Nijkamp et al., 1977); and during anaphylactic challenge 
of guinea-pig heart, imidazole decreases the release of thromboxane 
B2 and increases the release of PGF2CI and PGD2 (Anhut et al., 1978) .
Thus, the potentiating effect of imidazole on histamine-induced contrac­
tures of guinea-pig trachea could involve enhancement of the release of 
prostaglandins with bronchoconstrictor activity, such as PGF201 and 
PGD2 (Section 1.5.2), consequent to inhibition of thromboxane snythesis. 
If enhanced prostaglandin release is the mechanism of imidazole-induced 
hyperreactivity to histamine, then the phenomenon should disappear in 
the presence of the cyclooxygenase inhibitor indomethacin.
(c) Prostaglandin synthesis. Although imidazole is thought to 
be a selective inhibitor of thromboxane synthetase (Needleman et al., 
1977), it is possible that this compound may affect other pathways of 
arachidonate metabolism. It has been suggested that the analgesic and 
anti-inflammatory actions of imidazole involve a mechanism similar to 
that of aspirin (Puig-Parellada et al., 1973), but imidazole, unlike 
aspirin,.does not inhibit the cyclooxygenase enzyme of sheep seminal 
vesicles (Moncada et al., 1977). However, the anti-inflammatory action
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of imidazole on urate-induced arthritis involves inhibition of the 
synthesis of both thromboxane B2 and prostaglandins E2 and F2a (Peskar 
et al., 1978). These authors suggested that imidazole inhibits the 
activity of phospholipase, which releases arachidonate from membrane 
phospholipids (see Figure 1.1). Inhibition of the release of relaxant 
prostaglandins, such as PGE2, by imidazole could explain imidazole- 
induced hyperreactivity to histamine, and this possibility was also 
investigated by examining the effect of indomethacin on histamine 
responses potentiated by imidazole.
(d) Calcium fluxes. Although one early report indicated that 
imidazole depresses cardiac contractility (Kukovetz and Poch, 1967), 
later studies have shown that imidazole enhances contractility of 
cardiac muscle (Massingham and Nasmyth, 1972; Knope et al., 1973;
Verma and McNeill, 1976). It is difficult to attribute this action of 
imidazole to an action on phosphodiesterase activity, since increased, 
rather than decreased levels of cyclic AMP are associated with the 
positive inotropic effect of catecholamines (Tsien, 1977) . It has been 
suggested, on the other hand, that the positive inotropic effect of 
imidazole may result from a direct action on calcium ion fluxes into 
myocardial cells (Massingham and Nasmyth, 1972; Knope et al., 1973). 
Stimulation of 45Ca influx has been demonstrated in isolated frog 
ventricles (Massingham and Nasmyth, 1972) .
Furthermore, microsomal fractions of rabbit colon smooth muscle, 
preloaded with 45Ca, release the isotope on addition of imidazole 
(Andersson et al., 1975). Sarcoplasmic reticulum vesicles from skeletal 
muscle also release calcium ions in response to imidazole (Chapman et al., 
1976). Thus the effects of imidazole on tracheal smooth muscle could 
be the result of a direct action of imidazole on plasma or intracellular 
membranes to facilitate calcium ion movements into the cytoplasm.
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(e) Histaminase. Histaminase (diamine oxidase) is an enzyme 
which catalyzes the oxidative deamination of histamine to imidazoleace- 
tic acid. This enzyme is inhibited by imidazole with an approximate 
IC50 of 0.5 mM, and has a relatively high activity in guinea-pig tracheal 
tissue (Arunlakshana et al., 1954). Histaminase released from the 
guinea-pig tracheal preparation could destroy histamine in the bathing 
medium, thereby reducing the effective concentration of exogenously 
added histamine. Inhibition of histaminase by imidazole would therefore 
increase the effective concentration of histamine and enhance the 
contractile response.
Thus, other mechanisms besides stimulation of phosphodiesterase 
could account for the potentiating effect of imidazole. In order to 
determine if stimulation of phosphodiesterase is involved, the effects 
of imidazole on cyclic AMP accumulation in guinea-pig trachea were 
investigated. Possible contributions from enhanced release of acetyl­
choline or an effect on prostaglandin/thromboxane metabolism were 
examined by determining the effects of atropine and indomethacin 
respectively on imidazole-induced hyperreactivity to histamine. The 
role of enhanced calcium fluxes was determined by omission of extra­
cellular calcium ions.
6.2 Effects of imidazole and histamine on cyclic AMP metabolism
The basal concentration of cyclic AMP in guinea-pig tracheal muscle 
tissue was 2.40 - 0.23 pmoles/mg protein (n=10) (see Section 3.4). 
Incubation of the tissue with histamine (10 OM) for six minutes caused 
a two-fold increase of the cyclic AMP content (p < 0.05, df = 13) (Table 
6.1). Cyclic AMP levels were also increased by prostaglandin Ei (7-fold) 
isoprenaline(3.4-fold) and a combination of isoprenaline and theophylline
(5.7-fold).
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TABLE 6,1
EFFECT OF IMIDAZOLE ON CYCLIC AMP ACCUMULATION 
IN RESPONSE TO VARIOUS AGENTS
TREATMENT CONTROL + IMIDAZOLE (1 mM)
Basal 2.40 ± 0 .23(10)  2.07 ± 0 .28 (8 )
H is tamine  (10 yM) 4.74 ± 0.61 ( 5) 4 .02  ± 0 .44 (5 )
P r o s t a g l a n d i n  Ei (2 .8  yM) 16.94 ± 2 .49 (  6) 16.64 ± 2 .19(4)
I s o p r e n a l i n e  (5 yM) 8.13 ± 0 .72  ( 2) 7 .85 ± 0 .5 2 (2 )
I s o p r e n a l i n e  (5 yM) 13.62 ± 1.50 ( 4) 14.05 ± 1 .60(4)
+ t h e o p h y l l i n e  (0 .5  mM)
R e s u l t s  a r e  expressed  as p moles/mg p r o t e i n / 6  mins,  and a r e  means 
± S.E.M. The number o f  exper iments  i s  i n d i c a t e d  i n  p a r e n t h e s e s .
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After six minutes incubation of the tissue with imidazole (1 mM) 
there was no significant change in the basal level of cyclic AMP 
(Table 6.1). Cyclic AMP levels were also unaltered after incubation 
with a higher concentration (50 mM) of imidazole (2.51 - 0.31 pmoles/mg 
protein, n=2). The accumulation of cyclic AMP induced by histamine was 
slightly diminished in the presence of imidazole (1 mM), but this 
difference was not significant. Similarly, imidazole did not affect 
the cyclic AMP responses to prostaglandin Ei, isoprenaline, or the 
combination of isoprenaline and theophylline (Table 6.1).
Cyclic AMP accumulation in response to histamine was investigated 
further. Figure 6.1 compares the concentration-response curves for the 
cyclic AMP elevating and contractile effects of histamine. Increased 
levels of cyclic AMP were observed at histamine concentrations of 
10 yM or greater, and the concentrations required to elevate cyclic AMP 
levels were similar to those which contracted the smooth muscle. The 
time course of the cyclic AMP response to 100 yM histamine is shown in 
Figure 6.2. Cyclic AMP levels rose rapidly to a maximum after two 
minutes incubation with histamine, and then gradually declined to about 
60% of the maximum response after six minutes. The maximum response 
represented a 3-fold increase in the cyclic AMP content. On the other 
hand, the contractile response was not fully expressed until 6 minutes 
after the addition of histamine.
6.3 Potentiation by imidazole in the presence of atropine or
indomethacin
Table 6.2 shows the effect of atropine on imidazole-induced 
hyperreactivity to histamine, in the absence of atropine, 0.1 mM 
imidazole enhanced the contractile response to 4 yM histamine by 26 ±
9% (p < 0.05, paired t-test) . This potentiation was somewhat less than 
that expected from the data of Figures 5.6 and 5.7. Atropine (1 yM)
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FIGURE 6.1 C o n c e n t r a t i o n  dependence o f  c y c l i c  AMP ac cum ula t ion  and 
c o n t r a c t i o n  induced by h i s t a m i n e
The s o l i d  l i n e  r e p r e s e n t s  t h e  c y c l i c  AMP c o n t e n t  o f  t r a c h e a l  smooth 
muscle  a f t e r  6 m inu te s  i n c u b a t i o n  with v a r i o u s  c o n c e n t r a t i o n s  o f  h i s t a m i n e  
(means - S.E.M. o f  3 i n c u b a t i o n s  f o r  each p o i n t ) .  The dashed l i n e  i s  a 
c u m u la t iv e  c o n c e n t r a t i o n - r e s p o n s e  c u rve  f o r  t h e  c o n t r a c t i l e  e f f e c t  o f  
h i s t a m i n e  (means ± S.E.M. o f  42 e x p e r i m e n t s ) .
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FIGURE 6 .2  Time c o u r s e s  o f  c y c l i c  AMP a c cum ula t ion  and c o n t r a c t i o n  
induced by h i s t a m i n e
The s o l i d  cu rve  shows t h e  c y c l i c  AMP c o n t e n t  of  t r a c h e a l  t i s s u e  i n c u b a te d  
wi th  h i s t a m i n e  (100 pM) f o r  v a r i o u s  t i m e s .  Each p o i n t  r e p r e s e n t s  t h e  
mean - S.E.M. o f  t h r e e  i n c u b a t i o n s .  The dashed c u rv e  i s  t h e  t ime c o u r s e  
o f  t h e  c o n t r a c t i l e  r e s p o n s e  t o  h i s t a m i n e  (10 pM) e xp res sed  as a p e r c e n ­
t a g e  o f  t h e  o v e r a l l  r e s p o n s e  (means - S.E.M. o f  20 r e s p o n s e s ) .
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TABLE 6.2
EFFECT OF ATROPINE ON IMIDAZOLE-INDUCED 
HYPERREACTIVITY TO HISTAMINE
TREATMENT CONTROL + ATROPINE
Histamine (4 pM) 1.12 ± 0.10 0.97 ± 0.09
Imidazole (0.1 mM) 0.29 ± 0.01 0.22 ± 0.03
Histamine (4 pM) in the 1.36 ± 0.04 1.26 ± 0.08
presence of imidazole
Results are mean (± S.E.M.) contractile responses in grams of 6 tracheal 
strips from a single animal. After the control responses to histamine 
(without and with imidazole), the strips were pretreated with atropine 
for two minutes and the additions of histamine were repeated in the 
continued presence of atropine.
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had no significant effect on the resting tension of the tracheal, strip, 
but had slight inhibitory effects on the contractures 
induced by 4 yM histamine (13 ± 2%, p < 0.01) and 0.1 mM imidazole (not 
significant). This concentration of atropine was sufficient to 
completely block acetylcholine-induced contractures (Table 5.1).
In the presence of atropine, imidazole potentiated histamine-induced 
contractures by 32 ± 6% (p < 0.01, paired t-test). The potentiating 
effect was not significantly different in the absence and presence of 
atropine.
The effect of indomethacin on imidazole-induced hyperreactivity 
to histamine is shown in Table 6.3. The potentiation of histamine 
contractures in the absence of indomethacin was 71 ± 14% (p <0.001, 
paired t-test). This effect was greater than that obtained in the 
experiments of Table 6.2, but closer to the value expected from the 
results of Chapter 5. Indomethacin caused a gradual decrease in the 
resting tension of the tracheal strip (see Section 7.2) and potentiated 
histamine-induced contractures (Table 6.4; see also Section 7.3). In 
this experiment, indomethacin potentiated the contractile response to 
4 yM histamine by 97 ± 31% (p < 0.01, paired t-test). Indomethacin had 
no significant effect on the response to imidazole alone. In the 
presence of indomethacin, imidazole enhanced the histamine-induced 
contracture by 85 ± 13% (p < 0.001, paired t-test). When expressed as 
a percentage, the potentiating effect of imidazole was not significantly 
different before and after treatment with indomethacin. However, the 
absolute increase in the magnitude of the histamine contracture caused 
by imidazole changed from 0.65 ± 0.11 grams in the absence of indometha­
cin to 1.51 ± 0.22 grams after indomethacin treatment (p < 0.001, paired 
t-test). The contractile response to histamine in the combined 
presence-of indomethacin and imidazole represented an enhancement of 
237 - 36% of the contracture obtained in the absence of both agents.
TABLE 6.3
EFFECT OF INDOMETHACIN ON IMIDAZOLE-INDUCED 
HYPERREACTIVITY TO HISTAMINE
TREATMENT CONTROL + INDOMETHACIN (2.8 pM)
Histamine (4 pM) 1.03 ± 0.11 1.99 ± 0.23***
Imidazole (0.1 mM) 0.42 ± 0.05 0.37 ± 0.04
Histamine (4 pM) in the 1.68 ± 0.16 3.50 ± 0.29***
presence of imidazole
Results are mean (± S.E.M.) contractile responses in grams of 10 tracheal 
strips from two guinea-pigs. After the control responses to histamine 
(without and with imidazole), each strip was pretreated with indomethacin 
for 30 minutes and the additions of histamine and imidazole plus histamine 
were repeated in the continued presence of indomethacin. The pretreatment 
with indomethacin caused a mean relaxation of 0.76 ± 0.24 grams'.
* * * p < 0.001 (paired t-test) relative to control.
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6.4 Potentiation by imidazole in zero-calcium medium
Table 6.4 shows the effect of zero-calcium medium on the 
potentiation of histamine contractures by imidazole. In this experiment, 
imidazole (0.5 mM, a higher concentration than used in the experiments of 
Tables 6.2 and 6.3) potentiated the contractile response by 149 ± 36%
(p < 0.001, paired t-test) in normal Ringer solution containing 2.5 mM 
calcium ions. Incubation of the tracheal strips in zero-calcium medium 
for 40 minutes decreased the resting tension by 0.86 - 0.12 grams 
(n=8), and reduced the contractile responses to histamine and imidazole 
by 63 4 14% and 95 -  4% respectively (see also Figure 4.1 and Table 5.1). 
However, histamine-induced contractures in the presence of imidazole 
were significantly decreased by the omission of extracellular calcium 
ions, so that the potentiating effect of imidazole was more pronounced 
in zero-calcium medium. The contractile response to 4 pM histamine in 
the absence of extracellular calcium ions was enhanced more than 7-fold 
by 0.5 mM imidazole.
The effect of imidazole on the histamine concentration-response 
curve in zero calcium medium is shown in Figure 6.3. As was the case 
in normal Ringer (Figure 5.7), the maximum response to histamine was 
not affected by imidazole. However, contractile responses to histamine 
concentrations of 10 to 3 x 10 M were significantly enhanced by 
imidazole. The potentiation of a 4 PM histamine response can be inter­
polated to be about 9-fold, similar to the result of Table 6.4. The 
control pÖ2 value (negative logarithm of EC50) for histamine in zero- 
calcium medium was 4.82 ± 0.15 (n=4), similar to the value of 5.02 ± 0.07 
obtained in normal Ringer (Section 5.4). Imidazole shifted the concen­
tration-response curve to the left by 1.33 ± 0.26 (S.D.) log units (n=4) . 
This effect was significantly greater than the increase in the pÖ2 value 
of 0.71 ± 0.29 (S.D.) log units, induced by imidazole in the presence of
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TABLE 6 .4
EFFECT OF CALCIUM ION CONCENTRATION ON 
IMIDAZOLE-INDUCED HYPERREACTIVITY TO HISTAMINE
TREATMENT 2.5 mM Ca2+ Zero Ca2 +
H i s t a m in e (4 yM) 1.40 ± 0 .2 2 0 .37  ± 0.07
I m i d a z o l e ( 0 .5  mM) 1.31 ± 0 . 2 7 0 .04  ± 0 .03
H i s t a m in e
p r e s e n c e
(4 yM) i n  t h e  
o f  i m i d a z o l e
3 .08 ± 0 . 3 4 2 .72  ± 0 .19
R e s u l t s  a r e  mean (± S.E.M.)  c o n t r a c t i l e  r e s p o n s e s  i n  gram s .  C o n t r o l  
r e s p o n s e s  t o  h i s t a m i n e  ( w i t h o u t  o r  w i t h  i m i d a z o l e )  were o b t a i n e d  on 
8 t r a c h e a l  s t r i p s  f rom two a n i m a l s ,  a f t e r  which t h e  s t r i p s  were 
i n c u b a t e d  i n  z e r o - c a l c i u m  medium f o r  30 m i n u t e s .  H i s t a m in e  a lo n e  was 
t h e n  added t o  f o u r  o f  t h e  s t r i p s ,  and i m i d a z o l e  p l u s  h i s t a m i n e  t o  t h e  
r e m a i n d e r .  I n c u b a t i o n  i n  z e r o - c a l c i u m  medium caused  a mean r e l a x a t i o n
o f  0 .8 6  ± 0 .1 2  g ram s.
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FIGURE 6 .3  Im id a zo le - in d u c ed  h y p e r r e a c t i v i t y  to  h i s t a m i n e  i n  z e r o - 
ca lc ium  medium
The graphs  show c u m ula t ive  c o n c e n t r a t i o n - r e s p o n s e  c u rve s  f o r  t h e
c o n t r a c t i l e  a c t i o n  o f  h i s t a m i n e  i n  t h e  absence  (dashed l i n e s )  and
p r e s e n c e  ( s o l i d  l i n e s )  o f  im i d a z o l e ,  (A) i n  normal  R inger  s o l u t i o n
2 +c o n t a i n i n g  2.5 mM Ca , and (B) in  z e ro - c a l c iu m  medium. The c o n t r a c t i l e  
r e s p o n s e  i s  e x p re s s e d  as a p e r c e n t a g e  o f  t h e  maximum, which v a r i e s  wi th  
Ca2+ c o n c e n t r a t i o n  ( s e e  F ig u re  4 . 1 ) .  R e s u l t s  a re  means - S.E.M. o f  t h e  
number o f  expe r im en t s  i n d i c a t e d  i n  p a r e n t h e s e s .
** p < 0.01;  *** p < 0 .001 .
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calcium ions (Figure 5.7) (p < 0.001, df = 43).
Since the potentiation of histamine contractures was more pronoun­
ced in zero-calcium medium, it was of interest to determine if imidazole 
had any effect in zero-calcium medium on other contractile responses 
which were not enhanced by imidazole in normal Ringer. However, 
imidazole had no effect on the contractile responses to acetylcholine or 
PGF201 in zero-calcium medium (Table 6.5).
6.5 Discussion
Inhibition of negative feedback regulation involving histamine- 
induced accumulation of cyclic AMP was proposed as a possible mechanism 
of imidazole-induced hyperreactivity to histamine. The observation that 
histamine increases cyclic AMP levels in guinea-pig tracheal muscle 
indicates that cyclic AMP-mediated feedback regulation may modulate 
the contractile response to histamine. Histamine-induced accumulation 
of cyclic AMP in incubations of guinea-pig tracheal rings has been 
previously reported (Murad and Kimura, 1974) . However, these authors 
used a high concentration (100 pM) of histamine, and were only able to 
demonstrate significant accumulation of cyclic AMP (2-fold) at two 
minutes, not after six minutes. The results of Figures 6.1 and 6.2 
indicate a more pronounced effect of histamine on cyclic AMP levels: 
significant accumulation was observed in response to a lower concentra­
tion of histamine (10 pM), there was a 3-fold increase after two minutes 
in response to 100 pM histamine, and significant accumulation was 
apparent after six minutes of incubation. These differences may be due 
to the inclusion of incubation medium and tracheal cartilage in the 
determination of cyclic AMP levels by Murad and Kimura (see Chapter 3).
Histamine-induced accumulation of cyclic AMP may be secondary to 
the release of catecholamines, as suggested by Murad and Kimura (1974). 
The cyclic AMP response to histamine could also be mediated by histamine
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TABLE 6.5
EFFECT OF IMIDAZOLE ON CONTRACTILE RESPONSES 
IN ZERO-CALCIUM MEDIUM
CONTRACTILE AGENT CONTROL + IMIDAZOLE (0.5 mM)
Histamine (4 yM) 0.37 ± 0.07 2.72 ± 0.19
Acetylcholine (10 yM) 2.70 ± 0.35 2.85 ± 0.32
Prostaglandin F20t (2.1 yM) 0.40 ± 0.22 0.37 ± 0.16
Results are means (± S.E.M.) of contractile responses (in grams) of four 
tracheal strips in zero-calcium medium. Different strips were used for 
control and imidazole-pretreated responses.
H2-receptors coupled to adenylate cyclase, as is the case in mast cells 
(Lichtenstein and Gillespie, 1973), leucocytes (Busse and Sosman, 1977), 
lung (Mathe et al., 1974), brain (Hegstrand et al., 1976) and gastric 
mucosa (Dousa and Code, 1974). Alternatively, the response could be 
mediated by prostaglandins of the E series, which are released during 
contraction of guinea-pig trachea (Orehek et al., 1975), and which 
stimulate adenylate cyclase of airways smooth muscle ('Section 1.7.3.3). 
This possibility is examined in Section 7.4.
Since increased levels of cyclic AMP are usually associated with 
smooth muscle relaxation (Section 1.7.1), cyclic AMP accumulation in 
response to histamine may represent a regulatory mechanism which 
modulates the contractile response to histamine. It was suggested that 
antagonism of this regulatory system by stimulation of cyclic AMP 
hydrolysis was the mechanism of imidazole-induced hyperreactivity to 
histamine. However, the results of Table 6.1 showed that imidazole 
does not affect the accumulation of cyclic AMP induced by histamine. 
Furthermore, imidazole had no effect on the basal level of cyclic AMP, 
nor on the accumulation of cyclic AMP induced by a variety of agents.
The enhancement of cyclic AMP accumulation by the phosphodiesterase 
inhibitor theophylline was not antagonized by imidazole. These results 
strongly suggest that imidazole does not stimulate the hydrolysis of 
intracellular cyclic AMP in guinea-pig trachea, and that the mechanism 
of imidazole-induced hyperreactivity to histamine does not involve 
activation of phosphodiesterase. This conclusion accords with the 
suggestion that imidazole does not affect the high form of phospho­
diesterase, and only stimulates the hydrolysis of unphysiological 
concentrations of cyclic AMP (Chasin and Harris, 1976; Donnelly, 1976).
Imidazole was still able to potentiate histamine-induced contrac­
tures in the presence of atropine, indicating that the enhanced response
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is not due to the release of acetylcholine. The slight inhibition of 
histamine-induced contractures by atropine is not necessarily an 
indication that histamine does induce release of acetylcholine from 
nerve terminals, since atropine also has weak antihistaminic activity 
(Innes and Nickerson, 1970). Histamine-induced release of acetylcholine 
from isolated tracheal preparations was also suggested by Murad and 
Kimura (1974).
The potentiation of histamine-induced contractures by imidazole, 
expressed as a percentage, was not significantly altered in the presence 
of the cyclooxygenase inhibitor indomethacin. Indomethacin alone also 
enhanced the response to histamine, and the synergism observed between 
imidazole and indomethacin indicates different mechanisms of potentiation 
by the two agents. Thus the hyperreactivity to histamine induced by 
imidazole does not involve any action on the metabolism of prostaglandins 
or thromboxanes.
The observation that imidazole-induced hyperreactivity to. histamine 
still persists after omission of extracellular calcium ions indicates 
that the action of imidazole does not involve facilitation of calcium 
ion movements across the cell membrane. However, the possibility 
remains that calcium ion release from intracellular sites is enhanced 
by imidazole. Potentiation by imidazole was in fact more pronounced 
in zero-calcium medium than in normal Ringer solution, a situation 
similar to the potentiation of contractile responses by KC1 in zero- 
calcium medium (Section 4.4). It is possible that imidazole acts on 
the same intracellular calcium store as KC1, rendering it more labile 
for subsequent mobilization by contractile agents. It would be interes­
ting to investigate the interaction between imidazole and KC1 in zero- 
calcium. However, a difference between the actions of imidazole and KC1
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is that KCl also potentiates contractile responses other than those to 
histamine, whereas the hyperreactivity induced by imidazole is limited 
to histamine-induced contractures, even in zero-calcium (Table 6.5).
Another possible mechanism for the potentiating action of imidazole 
which was not investigated is inhibition of histaminase activity. 
Arunlakshana et al. (1954) demonstrated that iminazole (imidazole)
inhibits the activty of histaminase in pig kidney, and also that guinea- 
pig tracheal tissue has a high activity of this enzyme. Furthermore, 
other inhibitors of histaminase also potentiated the contractile effects 
of histamine on various smooth muscle preparations, and their activities 
as potentiators correlated with their activities as inhibitiors of the 
enzyme. Thus it seems likely that the potentiating effect of imidazole 
on histamine-induced contractures of guinea-pig tracheal smooth muscle 
is due to inhibition of histaminase. However, inhibition of histaminase 
activity in guinea-pig trachea by imidazole has not been demonstrated.
The presence of histaminase activity in guinea-pig tracheal 
preparations is not widely recognized, but has important implications 
for the interpretation of experimental data obtained in this tissue.
For example, concentration-response data for the contractile effects of 
histamine on guinea-pig trachea underestimate the potency of histamine as 
a bronchoconstrictor agent, since the effective concentration may be 
reduced by the action of histaminase. Furthermore, effects of various 
agents on histamine-induced contractures are not necessarily due to an 
action on the contractile response itself, but could involve a stimula­
tory or inhibitory action on histaminase activity. For example, the 
potentiation of histamine responses by histamine H2-receptor 
antagonists (Okpako et al., 1978) may be due to inhibition of histaminase 
activity by the antagonists rather than blockade of H2 -receptors. H2-
receptor'antagonists can inhibit or activate histamine methyltransferase, 
another histamine metabolizing enzyme (Taylor, 1973; Barth and Lorenz,
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1978), but their effect on diamine oxidase has not been reported.
Thus, any investigation of the effects of histamine on guinea-pig 
tracheal smooth muscle should take into consideration the high 
activity of histaminase in this tissue.
6.6 Summary
Imidazole has no effect on the accumulation of cyclic AMP in 
tracheal smooth muscle, suggesting that the mechanism of imidazole- 
induced hyperreactivity to histamine is not due to stimulation of 
phosphodiesterase. Furthermore, the phenomenon does not involve enhance­
ment of acetylcholine release, inhibition of thromboxane synthesis or 
facilitation of calcium fluxes across the plasma membrane, although the 
experiments do not exclude a contribution from enhanced release of 
calcium ions from intracellular stores. It is concluded that the most 
likely explanation of the potentiating effect is inhibition of histamin­
ase activity in the tracheal tissue.
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CHAPTER 7
REGULATION OF AIRWAYS SMOOTH MUSCLE BY PROSTAGLANDINS 
7.1 Introduction
Non-steroidal anti-inflammatory drugs (NSAID), such as aspirin 
and indomethacin, inhibit the formation of cyclic endoperoxides from 
fatty acid precursors by the enzyme cyclooxygenase (Figure 1.1), and 
thereby inhibit the release of prostaglandins from various tissues (Vane, 
1971). Treatment of smooth muscle preparations with indomethacin has 
shown that endogenous prostaglandins released from the tissue contribute 
to, or modulate, the resting tone and contractile responses of smooth 
muscle. In intestinal smooth muscle, endogenous prostaglandin E2 
limits spontaneous activity and modulates the stimulation of motility 
by acetylcholine, so that indomethacin enhances both basal and acetyl­
choline-stimulated activity (Bottling and Salzmann,1974; Sanders and 
Ross, 1978). On the other hand, indomethacin reduces the spontaneous 
activity and antagonizes oxytocin-induced contractures of uterine 
smooth muscle, suggesting that the release of contractile prostaglandins 
contributes to both spontaneous activity and contractile responses 
(Vane and Williams, 1973).
Guinea-pig tracheal preparations are relaxed by indomethacin 
(Farmer et al., 1974; Lambley and Smith, 1975) and other NSAID (Orehek 
et al., 1975; Ono et al., 1977; Temple and McKnight, 1977). The 
concentration of indomethacin required to relax guinea-pig tracheal 
muscle (EC50 approximately 1.4 yM; Farmer et al., 1974) is similar to 
that used by Vane (1971) to inhibit prostaglandin snythesis by human 
lung. Similar concentrations of indomethacin, however, increase the 
baseline tension of canine tracheal muscle (Yamaguchi et al., 1976), 
although higher concentrations have a relaxant action. The prostaglandin
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antagonist, SC-19220, also relaxes guinea-pig tracheal muscle (Lambley 
and Smith, 1975). These results indicate that the synthesis of 
contractile prostaglandins (e.g. PFG20t, PGD2) may contribute to the 
maintenance of intrinsic tone of airways smooth muscle.
In addition to relaxing the resting tone of guinea-pig tracheal 
muscle, NSAID also modify contractile responses to various agents. Low 
concentrations of indomethacin enhance contractions iiiduced by histamine 
(Grodzinska et al., 1975), acetylcholine and prostaglandin F201 (Farmer 
et al., 1974). However, Orehek et al. (1973 and 1975) observed that 
only the responses to high doses of contractile agents are potentiated 
by NSAID, and that contractions induced by low agonist doses are inhibit­
ed. On the other hand, all contractile responses are inhibited in the 
presence of higher doses of indomethacin (Farmer et al., 1974; Orehek 
et al., 1975).
The effect of high doses of indomethacin can be attributed to a 
non-specific inhibition of smooth muscle activity, possibly involving 
a calcium ion antagonistic activity (Northover, 1977) . However the 
biphasic effects of lower NSAID concentrations suggest that contractile 
responses to low agonist concentrations are amplified by the concomitant 
release of contractile prostaglandins such as PGF201, and that responses 
to high concentrations of these agents are modulated by the release of 
relaxant prostaglandins such as PGE2 . This hypothesis has been 
confirmed by demonstration of the release of both PGE2 and PGF201 from 
contracting guinea-pig trachea (Orehek et al., 1975). However, 
Grodzinska et al. (1975) were unable to detect any release of PGF20t, 
and showed that the major prostaglandin released from guinea-pig 
trachea has PGE2-like activity. They concluded that the release of 
PGE-like material is a "self-defensive mechanism protecting airways 
against overconstriction".
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Indomethacin also abolishes the contractile response of guinea- 
pig tracheal smooth muscle to arachidonic acid (Farmer et al., 1974), 
and reverses the relaxant effect of bradykinin (Chand and Eyre, 1978), 
suggesting that these responses are due to the release of prostaglandins 
with contractile or relaxant activity respectively.
The hypothesis implicating prostaglandins in the regulation of 
airways smooth muscle has been derived from in vitro experiments. In 
vivo studies, however, have failed to demonstrate such regulation in 
intact animals. Administration of indomethacin to guinea-pigs slightly 
reduces airways resistance, but does not affect the bronchoconcstrictor 
response to aerosolized histamine (Brink et al., 1975 and 1978). On 
the other hand, intravenous administration of aspirin to guinea-pigs 
antagonizes bronchoconstriction induced by SRS-A, whilst higher doses 
produce bronchoconstriction after ß-adrenergic blockade (Mielens and 
Rosenberg, 1976) . In normal humans, NSAID have no consistent effects 
on airways resistance, but some asthmatic patients develop severe 
bronchoconstriction after ingestion of NSAID (Section 1.5.4). Regula­
tion of airway smooth muscle by prostaglandins may be important in such 
subj ects.
This Chapter aims to further investigate the role of prostaglan­
dins in the regulation of guinea-pig tracheal smooth muscle, by studying 
the effects of indomethacin on resting tension, contractile responses 
and cyclic AMP metabolism. In particular, the contribution of prosta­
glandin release to the histamine-induced accumulation of cyclic AMP 
has been investigated.
7.2 The relaxant effect of indomethacin
Addition of indomethacin (2.8 yM) to the organ bath caused a 
gradual relaxation of the guinea-pig tracheal preparation (Figure 7.1).
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10 minutes
INDOMETHACIN
FIGURE 7.1 E f f e c t s  o f  in dometh ac in  on r e s t i n g  t e n s i o n  and h i s t a m i n e - 
induced c o n t r a c t u r e s
A c o n t r o l  c o n t r a c t i l e  r e s p o n s e  t o  h i s t a m i n e  (HA; 10 yM) was f i r s t  
o b t a i n e d ,  a f t e r  which t h e  b a t h i n g  medium was r e p l a c e d  wi th  f r e s h  Ringer  
s o l u t i o n  (W). When t h e  t e n s i o n  r e t u r n e d  t o  b a s e l i n e ,  indomethac in  (1 pM) 
was added.  A f t e r  20 m in u tes  i n c u b a t i o n  w i th  indom ethac in ,  a second 
c o n t r a c t i l e  r e s p o n s e  t o  h i s t a m i n e  was o b t a i n e d .
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The maximal response of 0.67 ± 0.09 grams (n=9) was attained 25 
to 30 minutes after the addition of indomethacin, and the time required 
for a half-maximal response was 9.9 - 0.8 minutes. Aspirin (220 pM), 
however, had no effect on the resting tension of the preparation.
7.3 Potentiation of contractile responses by indomethacin
Section 6.3 (Table 6.2) reported that indomethacin (2.8 pM) 
potentiated the contractile response to 4 pM histamine by 97 - 31% (p < 
0.01, paired t-test) . Figure 7.1 also illustrates the potentiation of 
histamine-induced contractures by indomethacin, and Figure 7.2 shows the 
effects of both indomethacin and aspirin on the histamine concentration- 
response curve. Contractile responses to all concentrations of hista­
mine were enhanced in the presence of 14 pM indomethacin, although 
significance was only attained at concentrations of 10 pM or greater.
The percentage enhancement of contractile responses was similar at all 
histamine concentrations (150-200%). The pÜ2 value for histamine was 
unchanged in the presence of indomethacin (4.84 ± 0.17 compared to the 
control value of 4.76 ± 0.11, both n=5) . Similar results were obtained 
with aspirin, but the enhancement of contractile responses to histamine 
was less than that produced by indomethacin(40 to 70%).
Since the effective concentration of histamine added to the organ 
bath may be decreased by the action of histaminase (Chapter 6), the 
experiment of Figure 7.2 was repeated in the presence of the histaminase 
inhibitor, imidazole (Figure 7.3 B). In the presence of imidazole 
(0.5 mM), the control concentration-response curve was shifted to the 
left, with a pÖ2 value of 6.06 ± 0.11 (n=8), somewhat greater than the 
value of 5.73 reported in Section 5.4. Contractile responses to 
histamine were potentiated by indomethacin (5 pM), but the effect was 
only 30-50% enhancement.
Indomethacin also potentiated contractile responses to
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FIGURE 7.2 E f f e c t s  of  NSAID on h is tam ine  c o n c e n t r a t i o n - r e s p o n se  curve
The graph shows c o n c e n t r a t i o n - r e s p o n s e  curves fo r  the  c o n t r a c t i l e  
a c t i o n  o f  h is tam ine ;  c o n t ro l  ( # ) ,  p r e t r e a t e d  with a s p i r i n  (220 pM) 
fo r  15 minutes  ( A ) ,  and p r e t r e a t e d  with  indomethacin (14 pM) fo r  30 
minutes ( H ) . One muscle s t r i p  from each of  5 animals was used fo r  
each exper imenta l  c o n d i t i o n ,  and the  r e s u l t s  compared us ing  a pa i re d
* p < 0.05,  ** p < 0.005.t - t e s t . *  * 
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FIGURE 7.3 Effects of indomethacin on concentration-response curves of 
contractile agents
The graphs show cumulative concentration-response curves for the contrac­
tile actions of (A) acetylcholine, and (B) histamine in the presence of 
imidazole (0.5 mM). The dashed lines represent- control curves, and the 
solid lines were obtained after preincubating the tracheal strips with 
5 yM indomethacin for 30 minutes. Points are means ± S.E.M. of 6 (A) 
or 8 (B) experiments. * p < 0.05.
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acetylcholine. Figure 7.3A shows the effect of indomethacin on the 
acetylcholine concentration-response curve. Indomethacin had no 
significant effect on the pÖ2 value for acetylcholine (5.77 ± 0.15 
compared to a control value of 5.36 ± 0.13, both n=6). In the presence 
of indomethacin, the maximum response to acetylcholine was enhanced by 
54%, but this was not significant.
7.4 Effect of indomethacin on cyclic AMP metabolism
Histamine (10 pM) increased the cyclic AMP content of the tracheal 
tissue 2-fold (p < 0.01, df = 13) (Table 7.1; see also Table 6.1). 
However, after 30 minutes preincubation with indomethacin, no elevation 
of cyclic AMP levels was observed in response to histamine (Table 7.1). 
Indomethacin alone had no significant effect on the cyclic AMP content. 
Mepyramine (1 pM) also diminished the cyclic AMP response to histamine 
(p <!0.05, df = 12), but atropine (1 pM) and propranolol (10 pM) were 
without effect.
7.5 Discussion
Relaxation of the guinea-pig tracheal strip preparation by indome­
thacin confirms previous reports of NSAID-induced relaxation of tube 
and spiral preparations of guinea-pig trachea (Farmer et al., 1974; 
Orehek et al., 1975). However, aspirin, another NSAID did not affect 
the resting tension, even though the concentration of aspirin used 
(220 pM) was only slightly less than that which relaxed the spirally 
cut tracheal preparation of Orehek et al. (1975). On the other hand, 
the effects of aspirin on contractile responses were similar to those 
reported by Orehek et al. (1975) .
Relaxation of airways smooth muscle by inhibitors of prostaglandin 
synthesis suggests that the resting tone of the muscle may arise from 
the local production of prostaglandins which accumulate in the bathing
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TABLE 7 .1
EFFECTS OF ANTAGONISTS ON HISTAMINE-INDUCED 
ACCUMULATION OF CYCLIC AMP
ADDITIONS NUMBER OF CYCLIC AMP CONTENT
EXPERIMENTS (p- moles/mg p r o t e i n )
None 7 3 .09 + 0.24
H i s t a m in e 8 6 .32 +
cdoo
A t r o p i n e  (1 pM) + h i s t a m i n e 4 6 .3 3 + 1 . 3 0 b
Mepyramine (1 pM) + h i s t a m i n e 6 3 .71 + 0 . 4 8 d
P r o p r a n o l o l (10 pM) + h i s t a m i n e 3 6 .2 3 ± 1 .7 3 b
I n d o m e th a c in  (2 pM) + h i s t a m i n e 7 2 .80 + 1 .1 9 °
I n d o m e th a c in  (2 pM) 2 3 .91 + 1.44
R e s u l t s  a r e  means ± S.E.M. A t r o p i n e  and mepyramine were added 5 m in u t e s  
b e f o r e  h i s t a m i n e , p r o p r a n o l o l  20 m i n u t e s ,  and in d o m e th a c i n  30 m i n u t e s .  
H i s t a m in e  (10 pM) was added f o r  two m i n u t e s .
a) p < 0 .0 1  compared t o  c o n t r o l  w i t h  no a d d i t i o n
b) p < 0 .05  " " " " " "
c) p < 0 .0 1  compared t o  h i s t a m i n e  a lo n e
d) p < 0 .0 5  " " " n
medium surrounding the tissue. However, attempts to demonstrate the 
release of prostaglandins from resting tracheal tissue have shown either 
no release (Grodzinska et al., 1975) or only very small amounts (Orehek 
et al. , 1975) . Relaxation of the tracheal muscle by indomethacin is 
not associated with any increase in the intracellular concentration of 
cyclic AMP.
Potentiation of contractile responses of guinea-'pig tracheal smooth 
muscle by NSAID has been reported previously (Orehek et al., 1973 and 
1975; Grodzinska et al., 1975). However, Figures 7.2 and 7.3 show that 
responses to both high and low doses of bronchoconstrictor agents were 
potentiated by indomethacin, whereas Orehek et al. (1975) reported 
that NSAID only enhanced responses to high agonist concentrations and 
inhibited responses to low doses of contractile agents. They suggested 
that this effect was due to inhibition of the release of PGF2O6 
associated with the contractile response. The results of Figures 7.2 
and 7.3 are more in agreement with the findings of Grodzinska et al.
(1975) who were unable to detect any release of PGF201 from contracting 
guinea-pig trachea.
The potentiation of contractile responses by indomethacin suggests 
that there is a release of relaxant prostaglandins associated with the 
contraction. Such prostaglandins act to reduce the magnitude of the 
contractile response, so that inhibition of their production causes an 
enhanced contraction. Further evidence for this suggestion is the 
demonstration of the release of PGE-like material from contracting 
guinea-pig trachea (Grodzinska et al., 1975; Orehek et al., 1975). 
Aspirin, another inhibitor of prostaglandin synthesis had similar 
effects to indomethacin, although the enhancement of contractile 
responses was not as great. The reason for this may be the lower 
effectiveness of the aspirin concentration used in inhibiting prosta­
150
glandin production.
The relaxant action of the E prostaglandins on airways smooth 
muscle is thought to involve stimulation of adenylate cyclase. PGEi 
causes a seven-fold increase in the cyclic AMP content of guinea-pig 
tracheal smooth muscle (Table 6.1). PGE2 released in response to 
contractile stimuli would similarly be expected to stimulate adenylate 
cyclase and increase the intracellular concentration of cyclic AMP. 
Accumulation of cyclic AMP in response to bronchoconstrictor agents has 
been reported (Section 1.7.3.5; Figure 6.1). Previous reports indica­
ted that histamine-induced accumulation of cyclic AMP was sensitive to 
atropine and suggested that the response was due to acetylcholine- 
mediated release of catecholamines (Murad and Kimura, 1974). However, 
the results of Table 7.1 are not consistent with such a mechanism, 
since neither propranolol nor atropine had any effect on the cyclic AMP 
response to histamine. On the other hand, indomethacin abolished the 
effect of histamine on cyclic AMP levels, indicating that prostaglandin 
release is the major mechanism of cyclic AMP accumulation in response to 
contractile stimuli.
Acetylcholine also causes elevation of cyclic AMP levels in 
guinea-pig lung slices, and this response is inhibited by indomethacin 
and aspirin (Stoner et al., 1973), indicating the involvement of prosta­
glandin production. Cyclic AMP accumulation by lung tissue has also 
been demonstrated in vivo, in response to administration of histamine to 
dogs (Barnett et al., 1978) , and this effect is also sensitive to 
indomethacin. However, Table 7.1 is the first report of prostaglandin- 
mediated accumulation of cyclic AMP in response to bronchoconstrictor 
stimuli in isolated airways smooth muscle (Creese and Denborough, 1978) .
Another possible mechanism of cyclic AMP accumulation in response 
to histamine is the stimulation of histamine H 2-receptors coupled to 
adenylate cyclase. It has been suggested that inhibitory H 2-receptors
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FIGURE 7.4 Negative feedback regulation of airways smooth muscle
The proposed model demonstrates how the contractile response to histamine 
is modulated by a negative feedback control loop involving the release 
of prostaglandin E2 and elevation of cyclic AMP levels. Inhibition of 
this loop by indomethacin enhances contractility.
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are present in guinea-pig tracheal smooth muscle (Okpako et al., 1978), 
and such receptors have been shown to mediate cyclic AMP accumulation 
in other tissues, including lung (Mathe et al., 1974). Although 
prostaglandin production appears to be the major contributing factor 
to the accumulation of cyclic AMP induced by histamine in guinea-pig 
tracheal smooth muscle, stimulation of H2-receptors may also play an 
important role. This possibility has not yet been investigated. The 
results of this Chapter have confirmed the existence of an important 
regulatory mechanism in guinea-pig tracheal smooth muscle (Figure 7.4). 
Contractile stimuli, as well as increasing cytoplasmic calcium ion 
concentrations, also cause a release of prostaglandins. The signal for 
prostaglandin release may either be the elevated calcium ion concentra­
tion in the cytoplasm of the smooth muscle cells, or the distortion of 
cell membranes produced by the contraction itself. The source of the 
prostaglandins may either be the mucosal layer as suggested by Orehek 
et al. (1975) or smooth muscle cells (Yamaguchi et al., 1976). Relaxant 
prostaglandins such as PGE2 released from the tracheal tissue act by 
stimulating prostaglandin receptors coupled to adenylate cyclase and 
increasing cyclic AMP levels in the smooth muscle, thereby opposing 
the contractile effect of elevated cytoplasmic calcium ion concentrations. 
Indomethacin, by inhibiting the synthesis of prostaglandins, prevents 
the accumulation of cyclic AMP in the smooth muscle and allows the 
complete expression of the contractile response.
7.6 Summary
The results confirm the relaxant effect of prostaglandin synthesis 
inhibitors on airways smooth muscle, and their potentiating effects on 
contractile responses. Indomethacin abolished the accumulation of 
cyclic AMP induced by histamine in guinea-pig tracheal smooth muscle.
The results support the concept of a negative feedback regulatory
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mechanism involving the release of prostaglandins from the tissue and 
accumulation of cyclic AMP in smooth muscle cells in response to
bronchoconstrictor stimuli.
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CHAPTER 3
GENERAL DISCUSSION AND CONCLUSIONS
8.1 Regulation of guinea-pig tracheal smooth muscle
In the intact animal, airways smooth muscle tone is largely 
determined by the autonomic nervous system. Airways smooth muscle 
receives cholinergic excitatory, adrenergic inhibitory and non- 
adrenergic inhibitory innervation (Sections 1.3 and 1.4). Chemical 
mediators released during allergic reactions, such as histamine and 
SRS-A, and circulating catecholamines also affect airways smooth muscle 
tone.
At the cellular level, the primary determinant of the contractile 
state of airways smooth muscle is the cytoplasmic calcium ion concentra­
tion (Section 1.6.1). Bronchoconstrictor stimuli such as neurotransmit­
ters (acetylcholine) and mediators (histamine) interact with cellular 
membranes to increase cytoplasmic calcium ion concentrations. 'Calcium 
ion movements are also regulated by the cyclic AMP system of the smooth 
muscle cell (Section 1.7.3). At the tissue level, the local release of 
prostaglandins also modulates airways smooth muscle contraction. Thus, 
in isolated denervated airways smooth muscle preparations, the contrac­
tile state is determined by the interactions of exogenously added 
agents with at least three distinct but interactive biochemical systems: 
calcium ion movements, cyclic AMP metabolism and prostaglandin synthesis. 
The experiments described in this thesis have examined various aspects 
of these systems and their interactions in isolated guinea-pig tracheal 
smooth muscle.
The preparation of guinea-pig tracheal muscle used in these 
investigations consists of a small strip obtained by opening single 
tracheal rings. Chapter 3 characterized the contractile responses of
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this preparation, and showed that it is a sensitive and convenient 
in vitro model for the investigation of airways smooth muscle.
Guinea-pig tracheal muscle strips contract in response to a range 
of agents which includes acetylcholine, histamine, PGF2CI and high 
potassium ion concentrations. The contractile response consists of a 
rapid, sustained increase in the isometric tension of the smooth muscle, 
brought about by an elevated calcium ion concentration' in the cytoplasm 
of the smooth muscle cell. The importance of calcium ions to the 
contraction is underlined by the ability of the calcium ionophore 
A23187 to contract the muscle, presumably by causing an influx of 
calcium ions into the cytoplasm.
Since drug-induced contractures may still be obtained after 
depolarization of the muscle preparation with high potassium ion 
concentrations (Section 4.3), these responses depend on both pharamco- 
mechanical and electromechanical coupling mechanisms (see Section 4.1), 
although it was not possible to determine the relative contributions 
of each.
The sources of calcium ions supporting contractile responses are 
both intracellular sites and the extracellular medium. The contribution 
of extracellular calcium ions depends on both the contractile agent and 
its concentration: histamine contractures are more dependent on
extracellular calcium than acetylcholine contractures, and responses to 
high concentrations of both these agents are less dependent than those 
to low doses (Section 4.2). Thus the elevation of cytoplasmic calcium 
ion concentration during contraction is a complex process, involving 
diverse coupling mechanisms and pathways of calcium ion movements, which 
require further investigation. Similarly, the mechanisms involved in 
removal of cytoplasmic calcium ions to cause relaxation are not well 
understood, especially the acceleration of this process by cyclic AMP.
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The plasma membrane of smooth muscle cells, as well as intracellular 
membranes, may have an important role in regulating calcium ion movements 
during both contraction and relaxation (Section 4.5).
Although the primary action of a bronchoconstrictor agent such as 
histamine on tracheal muscle is the elevation of cytoplasmic calcium 
ion levels to cause contraction, histamine interacts with various 
regulatory systems other than calcium ion movements, which modulate the 
contractile response. The accumulation of cyclic AMP in the guinea-pig 
tracheal smooth muscle in response to histamine (Chapter 6) is an inter­
action of histamine additional to its action on calcium ion movements. 
Since elevated cyclic AMP levels are usually associated with bronchodila- 
tion (Section 1.7.3), this action of histamine on cyclic AMP metabolism 
may represent a negative feedback regulatory mechanism, whereby the 
extent of the contractile response to histamine is limited by the 
concomitant elevation of intracellular cyclic AMP levels. The fact 
that inhibition of the histamine-induced accumulation of cyclic AMP 
by indomethacin is associated with an enhancement of the contractile 
response further supports this hypothesis. Cyclic AMP-mediated negative 
feedback regulation may also modulate the contractile responses to 
other bronchoconstrictor agents. Elevation of the cyclic AMP content of 
airways smooth muscle has been reported in response to other, but not 
all, bronchoconstrictors (Section 1.7.3.5).
Inhibition of histamine-induced accumulation of cyclic AMP by 
indomethacin suggests that the mechanism of this response involves the 
release of prostaglandins. The release of PGE-like material, determined 
by bioassay, during contraction of airways smooth muscle has been 
previously demonstrated (Grodzinska et al., 1975; Orehek et al., 1975). 
Potentiation of contractile responses to a range of agents suggests that 
prostaglandin release may be triggered by the contraction itself, 
possibly related to distortion of cell membranes. Further evidence for
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this concept is the inhibition of prostaglandin release by specific 
antagonists and by the omission of extracellular calcium (Orehek et al., 
1975). Thus, when the contractile response to histamine is abolished by 
a histamine Hi-antagonist or by zero-calcium medium no prostaglandins 
are released. An alternative mechanism is that prostaglandins are 
released as a biochemical rather than a mechanical consequence of con­
traction. The elevation of cytoplasmic calcium ions in response to 
histamine could trigger the release of arachidonic acid from cell 
membranes and synthesis of prostaglandins. Thus prostaglandin release 
is an important negative feedback regulatory pathway in tracheal 
smooth muscle which is also manifested as an accumulation of cyclic AMP 
in response to histamine and probably other bronchoconstrictor stimuli 
(Figure 7.4).
It is possible that another regulatory system in airways smooth 
muscle involves the participation of histamine H2-receptors. Inhibitory 
H2-receptors have been reported in guinea-pig trachea (Okpako et al., 
1978) and in human bronchus (Dunlop and Smith, 1977). Activation of 
adenylate cyclase mediated by H2-receptor function in airways smooth 
muscle could involve elevation of intracellular cyclic AMP levels. It 
has been shown that histamine-induced accumulation of cyclic AMP in 
guinea-pig tracheal smooth muscle involves the release of prostaglandins, 
and is inhibited by indomethacin and mepyramine, but any possible con­
tribution from Ü2-receptors has not been investigated.
Histamine also elevates cyclic AMP in lung tissue of guinea-pigs 
(Mathe et al., 1974) and humans (Kaliner, 1978) , and these responses 
are inhibited by histamine H2-antagonists. Cyclic AMP accumulation 
also occurs in lung in response to other bronchoconstrictors such as 
acetylcholine by an indomethacin-sensitive mechanism (Stoner et al.,
1973). Thus, both histamine H2-receptors and prostaglandin release
159
may contribute to histamine-induced accumulation of cyclic AMP in lung, 
so that the demonstration of the involvement of prostaglandins in the 
tracheal cyclic AMP response to histamine does not exclude a possible 
contribution from II2-receptors.
The cell types in which changes in lung cyclic AMP levels occur is 
not known, but the observation that histamine-induced accumulation of 
cyclic AMP is not associated with inhibition of antigen-induced mediator 
release from human lung (Kaliner, 1978) suggests that mast cells are not 
involved in the cyclic AMP response. On the other hand, it is probable 
that cyclic AMP levels increase in smooth muscle cells, since H2-receptors 
mediate both the cyclic AMP response and relaxation of lung strips by 
histamine (Yen, 1978). If the observed changes in lung cyclic AMP 
levels in response to histamine occur in airways smooth muscle in the 
lung, then negative feedback regulatory mechanisms similar to those 
described for tracheal muscle may also operate in the peripheral airways.
Another system regulating contraction of guinea-pig tracheal smooth 
muscle is the enzymatic degradation of bronchoconstrictor agents. The 
presence of histaminase was demonstrated many years ago (Arunlakshana 
et al., 1954), but the significance of this activity is not widely 
appreciated. In vitro, exogenously added histamine is catabolized by 
the tracheal tissue, which reduces its contractile effects. Guinea-pig 
trachea also has cholinesterase activity, so that the contractile 
effects of exogenous acetylcholine are enhanced in vitro in the presence 
of anticholinesterases (Douglas, 1951; Carlyle, 1963). In the presence 
of the anticholinesterase eserine, the acetylcholine concentration- 
response curve is shifted to the right (Hanna and Roth, 1978), similarly 
to the effect of imidazole on the histamine concentration-response curve 
(Figure 5.7). The in vivo significance of cholinesterase activity is 
to regulate cholinergic nerve stimulation of airways smooth muscle.
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Histaminase activity may also have an important regulatory role in the 
intact animal, since this enzyme is released during anaphylaxis in 
guinea-pigs (Giertz and Hahn, 1969; Mileva et al., 1978).
8.2 Models of bronchial hyperreactivity
In vivo models of bronchial hyperreactivity may be established 
by biochemical or pharmacological modification of isolated airways 
smooth muscle in such a way as to enhance its responsiveness to one or 
more contractile stimuli. One example of such a model, the enhancement 
of contractility induced by potassium chloride in calcium-depleted 
tissues, has already been discussed (Chapter 4). Several regulatory 
systems of guinea-pig tracheal smooth muscle which modify contractile 
responses were described in Section 8.1. Pharmacological antagonism of 
these systems has been used to demonstrate bronchial hyperreactivity 
in vitro.
Indomethacin blocks the release of prostaglandins from contracting 
tracheal smooth muscle (Orehek et al., 1975) , and also abolishes the 
histamine-induced accumulation of cyclic AMP (Table 7.1). These related 
effects result in potentiation of contractile responses to histamine, 
acetylcholine and other bronchoconstrictor agents (Section 7.3;.
Orehek et al., 1975). Aspirin and other NSAID have similar effects on 
contractility and prostaglandin synthesis, but their actions on cyclic 
AMP metabolism in guinea-pig trachea have not yet been examined.
Thus inhibition of prostaglandin synthesis gives rise to an in 
vitro model of bronchial hyperreactivity. Like the bronchial hyperreacti­
vity characteristic of human asthma, this model applies to a range of 
bronchoconstrictor agents. Early attempts to induce bronchial hypereac- 
tivity with indomethacin in vivo were unsuccessful (Brink et al., 1975). 
However, more recently it has been shown that under some conditions 
(pretreatment with glucocorticoids or ascorbic acid, or after chronic
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treatment with isoprenaline), administration of indomethacin to guinea- 
pigs can affect their sensitivity to aerosolized histamine (Brink et al., 
1977 and 1978). Furthermore, NSAID potentiate the bronchoconstrictor 
responses to antigen in sensitized guinea-pigs (Miller and Robson, 1976) 
and allergic monkeys (Patterson et al., 1978).
The potentiating action of indomethacin on the isolated guinea- 
pig tracheal smooth muscle involves inhibition of a negative feedback 
regulatory mechanism involving prostaglandin release and accumulation 
of cyclic AMP. It seems probable that inhibition of this mechanism 
at stages other than the cyclooxygenase enzyme would also result in 
enhanced contractility of the muscle. It was suggested that imidazole, 
by activating cyclic nucleotide phosphodiesterase, would prevent the 
accumulation of cyclic AMP induced by bronchoconstrictor agents and 
thereby potentiate contractile responses. However, although imidazole 
does potentiate histamine-induced contractures (Section 5.3), the 
mechanism of this effect was shown to be unrelated to activation of 
phosphodiesterase (Section 6.2). It is possible that other substances 
which do activate phosphodiesterase or inhibit adenylate cyclase could 
abolish the elevation of cyclic AMP levels associated with contractile 
responses and thereby potentiate them. Nicotinic acid stimulates 
phosphodiesterase in platelets (Abdulla, 1969), and inhibitors of 
adenylate cyclase in various tissues include adenosine (Weinryb and 
Michel, 1974), lithium (Ebstein et al., 1976) and RMI 12330 A 
(Guellaen et al., 1977).
The potentiating action of imidazole on histamine-induced contrac­
tures, although unrelated to any action on cyclic AMP metabolism, 
nevertheless constitutes an in vitro model of bronchial hyperreactivity 
(Creese and Denborough, 1977). It seems likely that the action of
imidazole on tracheal smooth muscle involves inhibition of histaminase
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activity (Chapter 6). This is another example of how inhibition of a 
regulatory system results in hyperreactivity. Similarly, potentiation 
of tracheal smooth muscle responses to acetylcholine by cholinesterase 
inhibitors (Douglas, 1951; Hanna and Roth, 1978) may also be considered 
as an in vitro model of bronchial hyperreactivity. Hyperreactivity 
induced by inhibitors of degradative enzymes is limited to contractile 
responses to the substrates of the particular enzymes.
The potentiation of histamine-induced contractures of guinea-pig 
tracheal smooth muscle by metiamide (Okpako et al., 1978) is another 
possible in vitro model of bronchial hyperreactivity. It involves 
blockade of histamine H2-receptors in airways smooth muscle which oppose 
the Hi-receptor mediated contractile response. Such a model may be 
particularly useful in view of the recent observation of impaired 
histamine H2-receptor function in asthmatic patients (Busse and Sosman, 
1977) .
A commonly used in vivo model of bronchial hyperreactivity is the 
3-adrenergically blocked guinea-pig. Administration of propranolol to 
guinea-pigs enhances their bronchoconstrictor responses to intravenous 
or aerosolized histamine (McCulloch et al., 1967; Douglas et al.,
1973). This effect is due to antagonism of catecholamines released 
into the circulation in response to histamine (Drazen, 1978) . Histamine- 
induced contractures of isolated tracheal muscle, however, are unaffected 
by propranolol (McCulloch et al., 1967), indicating that the local 
release of catecholamines is not a regulatory mechanism in this prepara­
tion. Furthermore, propranolol does not affect the histamine-induced 
accumulation of cyclic AMP (Table 7.1), indicating the lack of any 
contribution of released catecholamines to this response. Another 
3-adrenoceptor antagonist, practolol, does potentiate the contractile 
actions of acetylcholine, histamine and serotonin on isolated guinea-pig
163
trachea (Chang et al., 1978). However, it seems unlikely that this 
effect is related to ß-adrenergic blockade, since practolol, a cardio- 
selective ß-antagonist, is considerably less active than propranolol 
in inducing bronchial hyperreactivity to histamine in vivo (Diamond,
1972) .
The release of catecholamines into the circulation in response to 
histamine is an in vivo example of a regulatory mechanism which modulates 
contractile responses. Like the in vitro release of prostaglandins, 
catecholamine release is expected to result in stimulation of adenylate 
cyclase and accumulation of cyclic AMP in airways smooth muscle. In 
fact, the inability of indomethacin per se to induce bronchial hyperreac­
tivity in vivo indicates that catecholamine release, rather than 
prostaglandin release, is the major regulatory phenomenon opposing 
bronchoconstriction in the intact animal. However, in cases where 
adrenergic responsiveness is diminished (chronic pretreatment with 
isoprenaline) or prostaglandin synthesis is enhanced (administration of 
ascorbic acid), then indomethacin is capable of increasing airways 
reactivity (Brink et al., 1978) .
8.3 Possible mechanisms of bronchial hyperreactivity in asthma
Bronchial hyperreactivity, the characteristic feature of human 
asthma, may theoretically result from an abnormality in any of the 
regulatory systems which control airways smooth muscle, and which have 
been discussed in Chapter 1. Three major concepts concerning the aetio­
logy of asthma are the release of chemical mediators (Section 1.2.4), 
ß-adrenergic blockade (Section 1.3.2), and parasympathetic reflex bron­
choconstriction (Section 1.4.2). In Chapter 1, experimental evidence 
for each of these theories was discussed and their shortcomings outlined.
The studies described in this thesis have concentrated on bio­
chemical and pharmacological regulatory mechanisms of airways smooth
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muscle contraction in an isolated preparation, and have shown that 
interference with such mechanisms can give rise to bronchial hypereacti- 
vity in vitro. The question arises as to whether such studies have 
any implications for the pathogenesis of bronchial hyperreactivity in 
asthma.
Negative feedback regulation of tracheal smooth muscle contraction 
in vitro involves the release of prostaglandins and accumulation of 
cyclic AMP. Elevation of cyclic AMP levels has also been shown in human 
lung tissue in response to histamine (Kaliner, 1978) and anaphylaxis 
(Platshon and Kaliner, 1978). Thus accumulation of cyclic AMP in airways 
smooth muscle in response to bronchoconstrictor stimuli, whether 
mediated by prostaglandins, H2-receptors or catecholamines, is likely 
to be an important defensive mechanism counteracting bronchoconstriction 
in vivo. In asthma, cyclic AMP responses to adrenergic agents are 
diminished (Section 1.3.2), suggesting that a defect in such a regulatory 
mechanism may contribute to bronchial hyperreactivity. Asthmatic 
patients also have impaired cyclic AMP responses to histamine H2-receptor 
stimulation (Busse and Sosman, 1977).
Although it is thought that diminished cyclic AMP responses in 
asthma are due to impaired 3-adrenoceptor function, it is possible that 
a defect in other elements of the cyclic AMP metabolic pathway could 
also suppress cyclic AMP responses and give rise to bronchial hyperreac­
tivity. For example, leucocyte phosphodiesterase activity of asthmatic 
patients, although normal during remission, is elevated during broncho- 
spasm (Mue et al., 1975). A similar increase in cyclic AMP hydrolysis 
in bronchial smooth muscle would counteract negative feedback regulatory 
pathways and enhance bronchoconstriction. It has also been suggested 
that phosphodiesterase activity in rat tracheal muscle is affected by 
chronic pretreatment with 3-adrenergic agents, associated with
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diminished ß-adrenergic responsiveness (Avner and Noland, 1978).
An attempt to investigate the effect of increased phosphodiesterase 
activity on tracheal smooth muscle reactivity was not successful, since 
imidazole was found to have no significant effects on this enzyme in 
guinea-pig trachea (Chapters 5 and 6).
The imidazole-induced hyperreactivity of isolated tracheal muscle, 
involving inhibition of a histamine degradative pathway, raises the 
possibility that impaired histamine metabolism may contribute to bronch­
ial hyperreactivity in asthma. However, studies of histamine metabolism 
in asthmatic subjects have shown that bronchial hyperreactivity does 
not involve impaired degradation of histamine (Dowell et al., 1966;
Thom et al., 1973). It is possible, however, that the degradative 
metabolism of other mediators, such as SRS-A, is defective in asthma.
The role of prostaglandins in asthma is currently a topic of 
great interest (Section 1.5.3). The results presented in this thesis 
suggest that prostaglandin release from isolated airways smooth muscle 
is an important regulatory mechanism, inhibition of which causes 
significant increases (30-150%) in contractile responses to various 
agents. In vivo it appears that the importance of prostaglandin 
release as a regulatory mechanism is less than that of the adrenergic 
bronchodilator reflex mechanism. Thus, indomethacin and other NSAID 
have little effect on the regulation of airway calibre in normal 
subjects and most asthmatic subjects. However, in aspirin-sensitive 
asthmatic patients it has been suggested that bronchodilator prostaglan­
dins play an important role in the control of airways smooth muscle 
(Section 1.5.4). Furthermore, the results of Brink et al. (1978) in
guinea-pigs suggest that the importance of prostaglandins as regulators 
of airways function increases as ß-adrenergic responsiveness decreases. 
If similar changes in the relative contributions of ß-adrenergic
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and prostaglandin-mediated regulation occur in asthmatic patients, then 
indomethacin-induced hyperreactivity of isolated tracheal smooth muscle 
could serve as a useful in vitro model.
8.4 Summary
Regulatory phenomena in isolated guinea-pig tracheal smooth 
muscle include elevation of cyclic AMP levels, release of prostaglan­
dins, histamine H 2-receptors and degradation of bronchoconstrictor 
agents. The release of prostaglandins and the associated elevation of 
cyclic AMP levels constitutes a negative feedback regulatory system.
In vitro models of bronchial hyperreactivity may be established 
by interference with these regulatory mechanisms. Indomethacin enhances 
contractile responses by abolishing negative feedback regulation 
involving prostaglandin release. Imidazole and metiamide potentiate 
histamine-induced contractures by inhibition of histamine degradation 
and antagonism of inhibitory H 2-receptors respectively. Another in vitro 
model of bronchial hyperreactivity involves calcium depletion and 
membrane depolarization, and it may be possible to establish further 
models by directly interfering with cyclic AMP metabolism. The possible 
relevance of these in vitro studies to bronchial hyperreactivity in vivo 
is discussed, and it is concluded that indomethacin-induced hyperreactiv­
ity may be a useful model for aspirin-sensitive asthma. Bronchial 
hyperreactivity may be caused by defects in more than one of the 
regulatory systems controlling airways smooth muscle tone.
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